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Out-of-hospital cardiac arrest (OHCA) is a significant cause of death and severe neurological
disability in Scotland. Optimal pre-hospital resuscitation is required for the patient to achieve
return of spontaneous circulation (ROSC). The only post-ROSC therapy shown to increase
survival is mild therapeutic hypothermia (MTH), but its mechanism of action and optimal
application are still unknown. The quality of pre-hospital resuscitation in Scotland is
unmeasured. The relationship between body temperature post-OHCA, systemic
inflammation, markers of brain injury and outcome are still poorly defined. This study
examines two aspects of OHCA; firstly, the clinical practice of resuscitation in the pre¬
hospital and Emergency Department (ED) setting and, secondly, the post-ROSC
physiological changes of body temperature, systemic inflammation and serum markers of
brain injury.
Methods
Prospective observational study of all OHCA patients admitted to a single centre for a 14-
month period (1/08/2008 to 1/02/2010). Oesophageal temperature was measured, blood
samples assayed for markers of systemic inflammation (TNF-a, IL-ip, 1L-6, IL-8, IL-10, 1L-
12, elastase, cell surface markers of neutrophil activation) and markers of brain injury
(neuron-specific enolase [NSE], SI00b, glial fibrillary acidic protein [GFAP]) in the ED and
Intensive Care Unit (ICU). Selected patients had pre-hospital temperature monitoring and
blood sampling. Routine physiological variables were recorded. Patients who survived to
ICU had repeat blood samples taken at 24-,48-,72- and 120-hours post-ROSC. Patients were
followed up for 6-months. We conducted qualitative analysis of the effect of having a doctor
on-scene at an OHCA and performed a Scottish national survey on the ED management of
post-OHCA patients.
Results
236 OHCA patients were included in the study. 161 (68%) were pronounced dead at the
scene or in the ED. 75 (32%) were admitted to ICU for cooling; 49 (21%) died in ICU and
27 (11%) survived to hospital discharge. We have characterised the natural progression of
core body temperature post-OHCA. Patients who achieved ROSC and had oesophageal
temperature measured pre-hospital all had temperatures below normal. Quality of pre¬
hospital resuscitation performed by ambulance crews was observed to be highly variable.
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Standard ED care of post-OHCA patients varied across Scotland. All patients arriving in the
ED post-OHCA had a relatively low temperature (34.3°C, 95% CI 34.1-34.5). Patients
surviving to hospital discharge were warmer on admission to ICU than patients who died in
hospital (35.6°C vs. 34.4°C, p<0.01). Patients surviving to hospital discharge also took
longer to reach target therapeutic hypothermia level than non-survivors (222 vs. 313 min,
p<0.05). Cell surface markers of neutrophil activation, IL-6, IL-8, IL-10 and elastase were
all significantly raised in the early post-ROSC period. The degree of cytokinaemia at 24-
hours was related to survival outcome. In the context of MTH, SI00b at 24-hours was
superior to NSE and GFAP at predicting in-hospital death following OHCA, with an AUC-
ROC of 0.90 (95% CI 0.82-0.98).
Conclusions
The quality of pre-hospital and in-hospital resuscitation in Scotland is variable. Both pre¬
hospital and ED management of OHCA patients varied on a local and national scale.
Following OHCA all patients have oesophageal temperatures below normal in the pre¬
hospital phase and on arrival in the ED. Patients who achieve ROSC following OHCA and
survive to hospital discharge are warmer on arrival in ICU and take longer to reach target
MTH temperatures compared to patients who die in hospital.
A systemic inflammatory response occurs earlier in the post-ROSC phase than previously
anticipated. SI00b is a more reliable predictor of outcome following OHCA than NSE or
GFAP. The mechanisms of action underlying changes in oesophageal temperature and
survival from OHCA remain unclear. This study adds to the information around oesophageal
temperature post-OHCA and MTH further studies are warranted to clarify the mechanism of
action of MTH post-OHCA and the role of inflammatory response in determining survival.
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Chapter 1
Introduction, Background and Literature Review
1.1 The problem of OHCA
Out-of-hospital cardiac arrest (OHCA) is a leading cause of morbidity and mortality in the
developed world. Resuscitation is attempted in 66 per 100,000 population across Europe
every year (Atwood, 2005). Of those that survive to leave hospital, over 50% are left with
permanent neurological sequalae (de Vreede-Swagemakers, 1997). The only clinical
intervention in the post resuscitation phase of OHCA shown to decrease mortality and
improve neurological outcome is mild therapeutic hypothermia (MTH) (Bernard, 2002; The
Hypothermia after Cardiac Arrest Study Group, 2002).
1.2 The 3-phase model of cardiac arrest
It has been suggested that survival from OHCA depends on the implementation of
therapeutic measures in a temporal sequence (Weisfeldt, 2002). In the early phase (0-4
minutes) following loss of cardiac output, defibrillation is required to achieve return of
spontaneous circulation (ROSC). Maintenance of circulation by cardiopulmonary
resuscitation (CPR) is required if the period of cardiac arrest is prolonged (4-10 minutes) and
ROSC is not achieved. Resuscitation must then deal with the metabolic consequences of
prolonged cardiac arrest and MTH is thought to be pivotal during this phase.
With the advent of therapeutic hypothermia as a new therapeutic option following OHCA,
many ambulance services and receiving hospitals have been eager to implement cooling.
This may have detracted from the other important elements of resuscitation - prompt
defibrillation and quality cardiopulmonary resuscitation (Olasveengen, 2007). "Hands-on-
the-chest" time has been shown to be closely linked to survival from OHCA (Berg, 2001).
1.3 The History of Mild Therapeutic Hypothermia
Descriptions of hypothermia being used to treat patients have been written for over 200 years
(Varon, 1991). There are documented cases of Hippocrates and several Greek physicians
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experimenting with its use. A Russian method of resuscitation in 1803 described OHCA
patients being covered in snow, in the hope this would achieve ROSC (Liss, 1986).
Therapeutic hypothermia was used by French physicians in the Napoleonic wars following
traumatic amputations and in 1912 by Temple Fay in a bid to slow the rate of cancer cell
multiplication. The first reported use of therapeutic hypothermia for neuroprotection of the
ischemic brain was described in 1950 by Bigelow and McBirnie (Bigelow, 1954). Using a
canine model, core body temperature was reduced to <25°C during cardiac surgery. The area
of neurological injury contained less oedema, less haemorrhage and a reduced inflammatory
response.
Benson and Yates described the first use of therapeutic hypothermia outside the operating
theatre in 1959 in Baltimore where they noted improvement in survival in patients treated
with hypothermia following OHCA (Benson, 1959). Twelve patients post-OHCA were
treated with therapeutic hypothermia using a cooling blanket, six of whom survived without
residual neurological deficit.
Despite the possibility of therapeutic hypothermia showing promise in improving the poor
survival rates from OHCA, it was largely abandoned until the 1990s, mainly due to is
significant clinical side effects. Clinical trials had been complicated by the effects of total
body cooling, including arrhthymias, shivering, vasospasm, coagulopathy and increased rates
of infection. At this time it was felt the moderate (28-32°C) was required to achieve
effective brain protection.
The concept of preserving the brain in the field, protecting it from hypoxia until the patient
could be transported to hospital for spontaneous circulation to be restored or placed on
cardiopulmonary bypass was first suggested by Peter Safar in 1984 (Safar, 1990; Safar,
2000). In the 1990s, a number of encouraging animal studies showed benefit and several
pilot human studies were conducted (Bernard, 1997; Yanagawa, 1998). In 2002, two
randomised trials demonstrated the benefit of cooling survivors of witnessed OHCA who
had ventricular fibrillation (VF) as the presenting rhythm (Bernard, 2002; The Hypothermia
after Cardiac Arrest Study Group, 2002). This lead to the International Liaison Committee
on Resuscitation, the American Heart Association and the European Resuscitation Council
recommending MTH in the management of unconscious patients following OHCA (Nolan,
2003; Nolan, 2008). Despite these recommendations, the use of MTH is not yet routine
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(Merchant, 2006b). Since 2002, further trials have explored the use of MTH for non-VF
OHCA, traumatic cardiac arrests and in paediatric patients.
1.4 Background to thesis
In this first chapter, the background of this thesis will be discussed. Current management of
adult OHCA patients and the available evidence for the use of MTH will be presented. The
scientific rationale for cooling, possible mechanisms of action and role of biomarkers post-
OHCA will be explored. We will highlight the areas of therapeutic hypothermia that remain
under investigation.
The optimum timing of initiation, method and duration of cooling are unclear (Nolan, 2005)
and calls have been made to address these questions in order to improve hypothermia as a
therapy. Animal research suggests cooling early, either pre-ROSC or immediately post-
ROSC, is associated with improved neurological outcome (Sterz, 1991; Wang, 2010; Zhao,
2008). Several human studies have also demonstrated benefit from early cooling (Castren,
2010). Some human studies show that delayed cooling also yields favourable results (The
Hypothermia after Cardiac Arrest Study Group, 2002; Wolff, 2009; Zhao, 2008).
Both invasive and non-invasive cooling methods have been developed and whole-body and
brain-only cooling methods have been trialled (Bernard, 2002; Castren, 2010). The majority
of cooling techniques have been trialled in critical care settings with few methods
specifically evaluated in the Emergency Department (ED) (Holzer, 2008b). Whilst MTH
initiated in the ED may reduce the time taken to reach target temperature, pre-hospital
cooling poses logistical and technical challenges. Patients arriving at hospital after OHCA
may require in-hospital transfer for imaging or cardiac intervention prior to Intensive Care
Unit (ICU) admission. Cooling techniques intended for early deployment must therefore
combine efficacy with ease of use.
While some ambulance services and Emergency Departments have adopted MTH as a
routine therapy for patients post OHCA, it is unclear whether the available evidence supports
this practice.
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1.5 Literature Review of the efficacy of therapeutic hypothermia post-
OHCA in the pre-hospital and Emergency Department setting
A literature review was performed by a single investigator (RL). All short-listed studies were
assessed for quality and to ensure the inclusion criteria were met. Search terms included
"therapeutic hypothermia", "hypothermia", "cardiac arrest", "heart arrest", "out-of-hospital
cardiac arrest", and "cardiopulmonary resuscitation". Outcome parameters included in-
hospital mortality, 6-month mortality and favourable neurological outcome (defined as
independent living) within 6 months.
Inclusion criteria were studies commencing cooling early post-ROSC. For human studies we
included those commencing cooling pre-hospital or in the ED. For animal studies we
included cooling before, during or immediately after cardiac arrest. Specific exclusion
criteria included non-cardiac arrest conditions e.g. myocardial infarction, cerebrovascular
accident and traumatic brain injury. In contrast to previous published systematic reviews
(Cheung, 2006; Holzer, 2005), we specifically examined MTH use in the pre-hospital and
ED setting. We found the number of randomised controlled trials (RCTs) on the use of MTH
post-OHCA to be small, therefore all randomised trials were screened for inclusion,
regardless of the timing of initiation of cooling.
We included literature searches from Ovid Medline 1950-2010, the Cochrane Library,
EMBASE 1988-2010, Google scholar and citation tracking. The search sought to identify
studies that evaluated the use of MTH post-OHCA using the search criteria above. Finally, a
Web of Science citation search was performed on all included studies. Reference lists of all
available primary studies and review articles were obtained to identify potentially relevant
citations. Previously published systematic review articles were sought, looking for particular
relevance to using MTH in the pre-hospital and ED setting. After a generalised search, limits
were applied for "trials".
Human trials were assessed using the Jadad system (Jadad, 1996) to assess internal validity.
This allows a measure of comparison of quality between trials. 1062 papers were screened
for inclusion. These were subdivided in animal studies, non-randomised studies, randomised
trials and systematic reviews. Two systematic reviews and five randomised clinical trials
were identified. Five animal trials comparing timing of cooling initiation were included.
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1.6 Animal Studies of therapeutic hypothermia
The first animal studies using hypothermia after cardiac arrest were reported in the 1950s. In
the early 1960s, Peter Safar observed that dogs that were mildly hypothermic at the initiation
of experimental cardiac arrest had a better neurological outcome than dogs that were
normothermic (Safar, 1988).
A summary of selected animal studies are shown in Table 1.1. These particularly relate to
early cooling and the potential effect this may have on outcome.
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30dogs.1minuteVFarrestodel. RCTofcoolingduringCPRvs.early postROSCc olingvs.normothermia
Coolingexter ally 34°C
20hours
Improvedneurologicalo tc mewh n coolingstarteddurinCPRrimmediately afterROSC.
ExternalCPRandr suscit tiondrugssed asperhumanpractice.
Kuboyama (Kuboyama,1993) 1993
22dogs,inducedVFf r12.5mins. ProspectiveRCTfnormothermiavs. immediatehypothermiavs.delayed(15 minsafterreperfusion)cooling
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27dogs.VFcardiacar estmodelwith 40minutesno-flowti e.RCTf normothermiavs.mildhypothermia moderatehypothermia
Coolingwith venovenous extracorporealshunt -34°C
12hours
Mildormode atehypothermiaduring prolongedCPRim rovesur ivala d functionaloutcome.
Invasivetechniqu su ed,noteasily applicabletohumans.
Abella<Abella- 2004) 2004
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The discovery of the neuroprotective effects of mild to moderate hypothermia led to the
investigation of resuscitative hypothermia in several animal models. Dogs treated with
immediate mild (34°C) or moderate (30°C) hypothermia showed improved functional and
histological outcome. Dogs treated with deep hypothermia (15°C), however, showed no
improvement in neurological function and had more severe cerebral histological changes
compared to mild or moderate hypothermia groups (Sterz, 1991; Weinrauch, 1992). In the
same model, delaying the onset of cooling until 15 minutes post reperfusion was not
associated with the same improvement in functional outcome but did improve histologic
damage compared to normothermic controls. MTH was not associated with any significant
side effects in these studies.
More recently a trend towards better outcomes after earlier initiation of therapeutic
hypothermia (<15 minutes post ROSC) has been demonstrated (Abella, 2004; Kuboyama,
1993). Kuboyama and colleagues demonstrated that survival without neurological deficit can
still be achieved after 40 minutes of VF cardiac arrest in dogs when intra-arrest hypothermia
is instigated using cold intravascular fluids. However, a delay in cooling after the induction
of VF was associated with an increased mortality and poorer neurological outcomes
(Kuboyama, 1993). Nozari showed that early intra-arrest cooling in dogs with 60 minutes of
VF resulted in a favourable neurological outcome (Nozari, 2004). But when cooling was
delayed until 20 minutes after onset of VF, 7 of 8 dogs did not survive. Abella and
colleagues showed that mice cooled 20-minutes after cardiac arrest showed a higher
mortality than mice cooled just prior to resuscitation from an 8-minute period of cardiac
arrest (Abella, 2004). Zhao demonstrated in a randomised, controlled, murine model that
delaying resuscitation to institute therapeutic hypothermia still resulted in a favourable
neurological outcome (Zhao, 2008).
The animal studies reviewed suggest that cooling should commence with a minimum of
delay after cardiac arrest and should continue for at least 24 hours to confer lasting
neuroprotection. Recent studies have demonstrated that intra-arrest cooling may improve
early resuscitation outcome (Castren, 2010; Wang, 2010) and randomised studies are
currently being undertaken in this field.
1.7 Non-randomised human trials of therapeutic hypothermia
The first reported human studies using therapeutic hypothermia were reported in 1958
(WILLIAMS, Jr., 1958). Since then over 20 non-randomized studies have been published.
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The target temperature has consistently been 32°-34°C using a variety of cooling techniques.
Reported favourable neurological outcome rates vary from 25 to 68%. A summary of non-
randomised trials is shown in Table 1.2.
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In 1997, Bernard and colleagues conducted a pilot study comparing patients treated with
MTH, induced by the application of ice packs, with normothermic controls. They
demonstrated improved outcome in the treatment group, without significant complications
(Bernard, 1997). Yanagawa cooled 13 patients who had survived initial resuscitation
(Yanagawa, 1998). Cooling to 33°C commenced on arrival to the Emergency Department
(time to target temperature of 5.5 hours post ROSC) and was maintained for 48 hours before
slowly rewarming at 1°C per day.
Further studies adopted progressively more sophisticated means of inducing therapeutic
hypothermia. A study using cold air surface cooling in the Emergency Department by Zeiner
and colleagues was successful in lowering core body temperature (Zeiner, 2000). Despite
non-significant results, these studies supported the evidence that MTH was a safe clinical
intervention and could improve outcome after OHCA.
Cooling modalities are summarised in Table 1.3. Methods of initiating pre-hospital cooling
have been investigated, with cold fluids and ice packs being the modalities of choice (Busch,
2006; Kim, 2005). Other methods of cooling, including body surface cooling with ice and
cold blankets, helmet devices, endovascular cooling catheters, haemofiltration and coronary
bypass have been studied (Hachimi-Idrissi, 2001; Haugk, 2007; Holzer, 2008a). None of
these combine efficacy with ease of use. A key finding is infusion of up to 2 litres of cold
(4°C) intravenous fluid (0.9% saline or Ringer's lactate) in the immediate post-ROSC phase
is an effective and safe method of cooling and is not associated with significant
complications or cardiovascular instability (Kim, 2005). Whatever the cooling technique
employed, the degree of hypothermia induced is important and Merchant and colleagues
have demonstrated that overcooling is a significant risk and careful core body temperature
monitoring is mandatory (Merchant, 2006a). The risks of overcooling include infection,
coagulopathy and cardiac arrhythmias (Polderman, 2008a).
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Table 1.3. Methods of inducing/maintaining therapeutic hypothermia
Invasive techniques Non-invasive techniques
Cold intravenous fluid infusion Ice packs
Extracorporeal cooling blood circuit Cooling blankets (water / air filled)
Cardiopulmonary bypass
Femoral-carotid bypass Cooling helmets (water / air filled)
Lavage Cold water immersion
Nasal / nasogastric / rectal / peritoneal
Ice slush Self adhesive cooling pads
Endovascular cooling catheter Intra-nasal cooling devices (eg Rhinochill)
1.8 Randomised trials of therapeutic hypothermia
Five randomised clinical trials of therapeutic hypothermia post out-of-hospital cardiac arrest
have been published (Bernard, 2002; Hachimi-ldrissi, 2001; Kim, 2007; Laurent, 2005; The
Hypothermia after Cardiac Arrest Study Group, 2002). These are summarised in Table 1.4.
The first clinical trial of therapeutic hypothermia, published in 2001 (Hachimi-ldrissi, 2001),
enrolled 30 patients following OHCA with asystole or pulseless electrical activity as initial
cardiac rhythm. Sixteen patients were cooled to 34°C for a maximum of 4 hours with a
helmet cooling device and then allowed to passively rewarm. Two of the patients treated
with MTH survived with a favourable neurological outcome compared to no patients in the
normothermia group.
In 2002, two prospective, randomised controlled trials of MTH in the post-resuscitation
management of witnessed OHCA were published (Bernard, 2002; The Hypothermia after
Cardiac Arrest Study Group, 2002). Both of these studies recruited a highly selected cohort
of patients, with 92% of patients initially assessed for eligibility excluded.
Recruitment criteria for both trials were similar and included ROSC in patients who
remained intubated and ventilated after OHCA due to VF of presumed cardiac aetiology.
The European trial cooled 136 patients to a core temperature of 32° to 34°C using a mattress
cover that delivered cold air. The aim was to reach target temperature within 4 hours of
ROSC, maintain it for 24 hours and then allow passive rewarming to occur. The study
showed NNT=6 (relative risk [RR] 1.40, 95% CI 1.08-1.81) for a favourable neurological
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outcome when MTH was used. The overall mortality at 6 months was reduced from 55% in
the normothermia group to 41% in the MTH group, NNT=7 (RR 0.74, 95% CI 0.58-0.95).
In the Australian study, cooling was initiated pre-hospital by applying ice packs to the head
and torso. The target temperature (33°C) was maintained for 12 hours post-hospital
admission before patients were actively rewarmed after 18 hours. 43 patients were cooled, 21
(49%) had a favourable neurological outcome of living at home or within a rehabilitation
facility compared to the control group (RR 1.85, 95% CI 0.97-3.49, NNT=4). Mortality was
reduced from 68% to 51% in the hypothermia group (RR 0.76, 95% CI 0.52-1.10, NNT=6).
These findings led to the European Resuscitation Council, in association with the
International Liaison Committee on Resuscitation and the American Heart Association,
recommending MTH as standard therapy for OHCA victims that achieve ROSC following a
VF arrest (Nolan, 2003).
A randomised trial (Laurent, 2005) of inducing MTH by isovolumic haemofiltration in
patients post-OHCA showed an increased survival benefit, but it was unclear whether this
was conferred by the hypothermic or filtration processes. This technique is not suitable for
use in the emergency and pre-hospital environment.
A recent clinical pilot study explored the benefit of cooling patients immediately after
OHCA using intravenous cold saline administered by paramedics in the field (Kim, 2007).
An infusion of 500 to 2000ml of 0.9% saline at 4°C was administered. Subsequent in-
hospital cooling was at the discretion of the attending physician. 63 patients were treated
with pre-hospital hypothermia. Only 78% of patients in the hypothermia group received
further cooling. Pre-hospital cooling led to a significantly lower temperature on arrival to
hospital (34.7C vs. 35.7C, p<0.0001). There was no significant difference in survival to
hospital discharge in the hypothermia vs. normothermia groups (33% vs. 29%, p=0.70).
Subgroup analysis of patients with VF as the initial cardiac rhythm showed a trend towards
increased survival to hospital discharge but there was a trend towards increased mortality in
the cooling group where the initial cardiac rhythm was PEA or asystole.
Pre-hospital, intra-arrest cooling using intra-nasal vapour is a novel concept that an early
study has shown to be safe and effective (Castren, 2010). Selective brain cooling with this
method negates then need for intravenous volume loading and further studies are currently
being conducted to evaluate this method in comparison to other cooling modalities.
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1.9 Systematic reviews of therapeutic hypothermia initiated in the pre¬
hospital or Emergency Department phase following OHCA
Cheung et al reviewed the data from 4 RCTs in 2006, representing 436 patients (Cheung,
2006). Inclusion criteria were adults with primary OHCA who remained comatose after
ROSC. The clinical trials ranged from score l to 3 on the Jadad scale and A-C on the
Cochrane grade score. The combined data showed that MTH deceased in-hospital mortality
(RR 0.75, 95% CI 0.62-0.84). The review concluded MTH had an NNT of 5 to improve
neurological outcome and an NNT of 7 to save a life. However, the review failed to draw
conclusions on the optimum cooling method, rate or exact duration of cooling. No evidence
of treatment-limiting side effects was reported.
A meta-analysis (Holzer, 2005) of 3 trials of witnessed OHCA patients with VF as the
presenting rhythm has shown that patients treated with hypothermia (32-34°C for 12-24
hours) show an increased rate of survival with favourable neurological outcome (RR 1.68,
95% CI 1.29-2.07). The calculated 95% confidence interval for the number needed to treat to
result in a patient being discharged from hospital with a favourable neurological outcome
ranged from 4 to 13.
1.10 Clinical application of therapeutic hypothermia
There is strong evidence to support the use of MTH in comatose patients after witnessed
OHCA whose initial cardiac rhythm was VF. There is less evidence supporting MTH use in
other presenting cardiac rhythms and further studies are required. Despite animal studies
demonstrating the benefit of immediate cooling, either during CPR or immediately post
ROSC (Abella, 2004; Kuboyama, 1993; Zhao, 2008), there is only limited existing evidence
from human studies supporting early cooling (Castren, 2010; Wolff, 2009). Practically,
initiating cooling in the pre-hospital environment is challenging, however several studies
have shown that initiating cooling in the ED is feasible and effective (Bernard, 2003a; Kim,
2005; Kliegel, 2007). Different techniques for initiating and maintaining MTH are shown in
Table 1.3. The use of ice packs is a simple, but relatively slow, means of cooling. A bolus of
cold intravenous fluids combines efficacy with ease of use but the potential cardiac effects of
intravascular volume loading are under debate. Intravenous fluids can be stored in a
refrigerator within the ED and administered to post-OHCA patients shortly after arrival in
hospital. Initiating cooling in the ED is likely to shorten the time-to-target temperature time,
particularly if the patient requires coronary intervention or radiological imaging prior to
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Intensive Care Unit admission. Cooling with cold intravenous fluids can continue during
transfer or during clinical procedures.
Core body temperature measurement is important during cooling. Ideally, core body
temperature needs to be measured using oesophageal, rectal or bladder temperature probes.
Tympanic temperature measurement, whilst convenient in the emergency setting, has been
shown to be inaccurate in the context of resuscitation (Craig, 2002). In the pre-hospital
setting, oesophageal temperature measurement is the most practical.
The three phases of therapeutic hypothermia include induction, maintenance and rewarming.
For all phases, accurate core body temperature measurement is essential to ensure accurate
cooling and prevent over cooling. For rapid induction, oesophageal or central venous
temperature should be measured as probes in the bladder or rectum may not reflect core body
temperature accurately (Stone, 1995). Overcooling is common (Merchant, 2006a). After
induction, therapeutic hypothermia can be maintained on the ICU with body surface cooling
techniques with accurate feedback mechanisms, or invasive, endovascular cooling
techniques. In order to prevent shivering, paralysis and sedation are required. The optimum
length of time for which MTH should be maintained remains unknown (Gazmuri, 2007;
Nolan, 2005) but previous studies have maintenance periods of 12-48 hours (Bernard, 2002;
The Hypothermia after Cardiac Arrest Study Group, 2002). The optimum means, whether
active or passive, and rate of warming is unknown and further research is required to
improve the induction, maintenance and rewarming phases.
1.11 Uptake of therapeutic hypothermia
Despite strong evidence suggesting benefit, uptake of therapeutic hypothermia in routine
clinical practice has been slow (Laver, 2006; Merchant, 2006b). Lack of awareness, fear of a
novel therapy and unknown side effects as well as lack of equipment have been cited as
barriers to therapeutic hypothermia implementation (Varon, 2008). If early achievement of
target therapeutic temperature is to be achieved, use of cooling post-OHCA will need to be
increased (Abella, 2005).
1.12 Percutaneous coronary intervention and therapeutic hypothermia
Immediate percutaneous coronary intervention (PCI) following OHCA has yet to be widely
accepted (Noc, 2008). There is evidence to suggest immediate PCI for OHCA with signs of
ST-segment myocardial infarction (STEMI) on the post-ROSC ECG improves outcome, but
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evidence for other presentations is limited (Merchant, 2008; Spaulding, 1997). Studies have
shown that PCI and initiation of MTH can occur simultaneously (Abella, 2008).
1.13 Summary - Clinical application of mild therapeutic hypothermia
following OHCA.
Despite strong evidence suggesting benefit, little is known about the mechanisms of action
of MTH as a therapy following OHCA. Possible mechanisms are discussed later in this
chapter. Uptake of therapeutic hypothermia in routine clinical practice has been slow (Laver,
2006; Merchant, 2006b). Lack of understanding, awareness, fear of a novel therapy and
unknown side effects, as well as lack of equipment, have been cited as barriers to MTH
implementation (Acosta, 2008).
1.14 Brain injury after global cerebral ischaemia
Cardiac arrest leads to systemic hypoperfusion and global cerebral ischaemia is thought to
result in brain injury. The post-cardiac arrest "syndrome" is complex (Nolan, 2008).
Numerous cellular and molecular processes have been described in a complex cascade
leading to a final common pathway of ischaemic neuronal injury. Animals models of
cerebral ischaemia have been developed to investigate target-specific cytoprotective
strategies (Bhardwaj, 2003). Global cerebral ischaemia involves decreased cerebral blood
flow across the entire brain and results in a predictable pattern of neuronal, histologic injury,
leading to selective cell ischaemic necrosis (Pulsinelli, 1985). If ROSC is achieved, cerebral
blood flow is restored but secondary brain injury can occur from influx of neutrophils,
reactive oxygen species, cerebral oedema and haemorrhage. Even after normalisation of
blood flow, there is continued tissue injury, driven mainly by oxygen free radicals in a
reperfusion syndrome thought to last hours to days. These detrimental post-ischaemic effects
are exacerbated when the patient's temperature rises above 37°C (Alzaga, 2006).
1.15 Models of global cerebral ischaemia
Both small (mouse, rat, gerbil) animal and large animal (rabbit, dog, pig) models of global
cerebral ischaemia have been developed. In the larger animals methods include ventricular
fibrillation and aortic occlusion. In these models, specific neuronal cells appear susceptible
to injury. CA1 pyramidal neurons in the hippocampus appear most susceptible to injury
after 3-5 minutes of ischaemia. Medium-sized neurons of the striatum appear more resistant
to injury, surviving for 15-20 minutes of ischaemia (Koehler, 1985). Following ROSC,
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differences in irreversible neuronal injury is seen. In medium-sized neurons of the striatum,
neuronal injury is observed within 3 hours following ROSC, but delayed to 48-72 hours in
CA1 hippocampal neurons, a finding known as "delayed neuronal death" (Koehler RC,
1996).
1.16 Components of the post-resuscitation syndrome - neuronal cell
injury
Distinct modes of cell death exist. Neuronal cell death is known to occur by two distinct
processes. Apoptosis is "programmed" cell death with the self-destruction of damaged cells
without injury to surrounding tissues. Necrosis is uncontrolled cell death with the release of
cell contents and the potential for damage to surrounding tissues. Although microscopically
distinct, apoptosis and necrosis coexist in a spatial distribution within ischaemic neuronal
tissue (Koehler RC, 1996). Neurons in the ischaemic core become necrotic and neurons in
the penumbra become apoptotic. The duration and severity of the ischaemic insult also
influences the mode of neuronal cell death. Neuronal cell necrosis is thought to occur as a
result of an excitotoxic cascade triggered by exposure to excitatory amino acids. A common
pathway leading to neuronal cell apoptosis has yet to be identified but a mitochondrial-
dependent "intrinsic" pathway and receptor-mediated "extrinsic" pathway have been
described (Sugawara, 2004).
There are different causes of neuronal cell death. Excitotoxic brain injury occurs when
neurotransmitters, such as glutamate and asparate, are released in abundance from neurons.
In a healthy, adult brain, extiacellulai glutamate is cleared by rapid uptake (Globus, 1995).
When energy stores are depleted, such as in cerebral hypoxia, cellular depolarisation leads to
glutamate being released into the extracellular compartment. Coupled with impaired
glutamate uptake, this leads to an increase in intracellular Ca2+ (Benveniste, 1984). An
increase in intracellular Ca2+ leads to lethal intracellular derangements. Glutamate activates
three major families of ionophore-linked receptors (N-methyl-D-aspartate [NMDA], a-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid [AMPA], and kainate) and
metabotropic receptors that activate second messengers (Sommer, 1992). In vitro studies
have shown that glutamate toxicity occurs in an early, rapid NMDA-mediated cascade and a
slowly triggered AMPA/kainate pathway. Reactive oxygen species and nitric oxide have also
been implicated in neuronal cell damage following cerebral ischaemia.
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A summary of the mechanisms of neuronal cell death following cerebral ischaemia is shown
in Figure 1.1.
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1.17 Systemic injury pro-inflammatory cytokines
Systemic ischaemia and reperfusion injury in OHCA patients results in an acute
inflammatory response, characterised by local and systemic production of inflammatory
cytokines, including interleukins (IL-1, IL-6, IL-8, IL-10, IL-12) and tumour necrosis factor
alpha (Meybohm, 2010a). Inflammatory cytokines are released by ischaemic neurons and
glial cells, which generate release of adhesion molecules in the cerebral vasculature,
breakdown of the blood-brain barrier, culminating in cerebral oedema (Danton, 2003). Pro¬
inflammatory cytokines are associated with activated neutrophils that can infiltrate into the
interstitium and lead to visceral and cell damage. The pathophysiological role of
inflammatory cytokines has been investigated in septic shock (Bone, 1996) and to a lesser
degree following ROSC in OHCA patients. Highly significant correlations between pro¬
inflammatory cytokines and mortality in patients with burns, trauma and sepsis have been
reported (Casey, 1993; Svoboda, 1994). Indeed, the post-ROSC phase of OHCA has been
described as a severe sepsis-like syndrome with associated pro-inflammatory cytokines and
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adhesion molecules, serum endotoxin and dysregulation of cytokine production by
neutrophils (Adrie, 2004). The post-ROSC reperfusion syndrome is thought to last for hours,
if not days after circulation is restored (Adrie, 2004).
The effect of MTH on pro-inflammatory cytokines in OHCA patients remains under
investigation. Several inflammatory cytokines have been shown to predict outcome in animal
models of OHCA (Sipos, 2010) but their role in humans is still under investigation. A greater
understanding of reperfusion injury after ROSC could, in future, allow more targeted
therapy, such as administration of antibodies to specific elements of the inflammatory
response (Shyu, 1997) and has been described in animal models (Sekido, 1993).
Previous studies have shown IL-8 and TNF-a to rise following OHCA, to reach a peak 12
and 6 hours post-OHCA respectively with higher levels being associated with an increased
early death rate (Ito, 2001). Marked complement and neutrophil activation has been
demonstrated in post-ROSC OHCA patients (Adrie, 2004).
1L-1 is known to be detrimental to ischaemic brain injury (Oto, 2008) but the role of IL-6, a
pro-inflammatory cytokine, and IL-10, an anti-inflammatory cytokine, are unclear in this
context. TNF-a appears to contribute to ischaemic tolerance (Ginis, 2002), as well as
propagating ischaemic brain injury (Bruce, 1996). Limited studies have shown that MTH
modulated serum pro-inflammatory cytokine levels, with both up and down regulation being
observed in different cytokines (Diestel, 2008; Fries, 2009). This study aims to investigate
key components of the inflammatory response of OHCA. A summary of cytokines
commonly investigated in OHCA is shown in Table 1.5.
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Table 1.5. Characteristics of inflammatory cytokines commonly measured
post-OHCA
Cytokine Production site Action
IL-lb
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(Moore, 2001; Pestka, 2004)
Monocytes and lymphocytes
Down regulates Th 1 cytokines,
MHC class II antigens
TNF-a
(Locksley, 2001)
Mainly macrophages but also
lymphoid cells, mast cells,
cardiac myocytes and neuronal
tissue.
Regulates immune cells, induces
apoptotic cell dath.
1.18 Leucocytes post-OHCA
Leucocytes have been implicated in the reperfusion injury following OHCA.
Polymorphonuclear neutrophils have been shown to significantly raised in the hours
following ROSC (Adrie, 2004; Bottiger, 2002). Leucocyte activation, adherence and sticking
is thought to block vessels in the microcirculation (Schmid-Schonbein, 1993). The effect of
neutrophil activation in the post-ROSC phase remains under investigation but few studies
have examined neutrophil activation post-OHCA in the context of MTH. Neutrophils in the
circulation exist in a quiescent state, however on stimulation with endogenous molecules,
such as interleukin-8, or exogenous ones, they enter an activated state. This state is
characterised by conformational and functional changes, and can be determined from the
expression of certain surface markers. Neutrophils contribute to tissue injury by releasing
cytotoxic and pro-inflammatory immune mediators.
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We chose to measure Human Neutrophil Elastase and several neutrophil cell surface markers
(CD1 lb, CD62L, CD64) as measures of neutrophil activation.
CD1 lb is a marker of neutrophil activation (Berger, 1984). CD1 lb has a variety of functions
including binding to C3b which is opsonises phagocytic targets and so triggering
phagocytosis (Brekke, 2007). It is also an integrin, and so is involved in cellular adhesion
and migration (Springer, 1995).
CD62L (also known as L-selectin) is involved in the adhesion of neutrophils to endothelial
surfaces prior to transmigration (Simon, 2000). In contrast to CDllb, CD62L is shed from
the surface of the neutrophil during in-vitro activation. The picture in-vivo is less clear with
groups reporting a diversity of responses, including both up and down regulation of surface
expression (Cocks, 1998). However soluble CD62L can be found in increased
concentrations in plasma following activation, in other conditions such as sepsis, even if cell
surface expression also increases.
CD64 (also known as Fcyl) is a receptor for the Fc portion of IgG antibodies, and is involved
in mediating cellular responses to IgG-opsonised targets including phagocytosis (van Spriel,
1999). It is generally found at very low levels on neutrophils, in contrast to monocytes which
express it highly. However on profound activation it is upregulated on neutrophils, and has
been postulated as a marker for severe inflammatory diseases such as sepsis (Layseca-
Espinosa, 2002).
As well as cell surface markers, there are neutrophil components released into the plasma on
activation. One of these is the enzyme Human Neutrophil Elastase (HNE), which is a
proteolytic enzyme involved in the destruction of dead tissue as well as non-oxygen
dependent killing of microbes. HNE is released when activated neutrophils degranulate
(Faymonville, 1991).
1.19 Markers of neurological injury
Many patients suffer severe neurological injury after OHCA. Strategies are needed to
determine as early and accurately as possible, which patients will have a poor neurological
outcome (Wijdicks, 2006). Accurate early prognostication is useful for selecting patients for
advanced, novel therapies, limiting critical care interventions, rationalising therapy and
informing relatives. Several prognostic markers of neurological injury following OHCA
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have been investigated but none found to be reliable enough to use in the clinical setting
(Shinozaki, 2009a). In particular, neuron specific enolase (NSE) and S-100B have been
widely studied. NSE is the neuronal form of the cytoplasmic enzyme enolase. It is a dimeric
enzyme (gamma-gamma) with a biological half-life of 24 hours. NSE is mainly found in
neurons and neuroendocrine cells (Marangos, 1987). Homodimer S-100B is a calcium
binding protein regulating neuronal differentiation, growth and apoptosis. It has a half life of
two hours and is mainly found in glial and Schwann cells (Korfias, 2006).
NSE and S-100B have been studied extensively but the majority of the studies were
conducted before the widespread adoption of MTH (Meynaar, 2003; Reisinger, 2007;
Schoerkhuber, 1999; Shinozaki, 2009b). A subgroup analysis of the Hypothermia after
Cardiac Arrest trial, showed a marked reduction in the efficacy of NSE as a predictive
marker when measured in cooled OHCA patients (Tiainen, 2003). The effect of MTH on
serum markers of brain injury is not known. Sampling time points for both serum biomarkers
have not been uniform and the definition of poor outcome ill-defined. Direct comparison
between studies is therefore difficult.
Multiple logistic regression analyses on mortality have found NSE and S-100B to be
superior to clinical predictors, however the ideal cut-off values and sampling time points
have yet to be determined (Shinozaki, 2009b). Few studies have attempted to measure serum
biomarkers in the immediate pre-hospital post-ROSC phase of OHCA. There is evidence that
NSE is useful as a prognostic marker when MTH is used, but only at 48 hours after ICU
admission (Meynaar, 2003; Oksanen, 2009). However, in the same study, a rise in NSE
levels was associated with poor neurological outcome at 6 months post OHCA (Oksanen,
2009). MTH has been associated with a decrease in NSE, but not S-100B levels in the 48
hours post-OHCA (Tiainen, 2003).
There have been calls to analyse the time-course of serum S-100B and NSE after CPR,
especially in the context of MTH (Sunde, 2009), to offer a reliable indication of what is
occurring within the brain following ROSC (Hijdra, 2007). This study investigates the time
course of NSE and S-100B from the earliest possible time point, in the context the MTH.
Glial fibrillary acidic protein (GFAP) is a filament protein found in astrocytes and
ependymal cells of the central nervous system (Hayashida, 2010). GFAP is involved with
many cellular functioning processes, such as cell structure and movement, cell
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communication and the functioning of the blood brain barrier. GFAP has been shown to be a
highly specific biomarker for traumatic brain injury (Honda, 2010; Pelinka, 2004), and
ischaemic stroke (Foerch, 2006).
Previous studies have shown varying results of the ability of GFAP to predict neurological
outcome following OHCA (Hayashida, 2010; Kaneko, 2009).
1.20 The role of temperature in the development of brain injury post-
OHCA
The roles both brain and systemic body temperature play in neurological outcome following
OHCA remain under investigation (Acosta, 2008). Animal models of both focal and global
cerebral ischaemia have shown the importance of temperature on determining functional and
histological outcome (Busto, 1987). Following an ischaemic insult, cerebral hyperthermia
leads to increased microvascular injury (Hajat, 2000), cerebral oedema and the conversion of
selective neuronal necrosis to infarction, resulting in increased mortality (Busto, 1987). The
rise in core body temperature observed following experimental models of cerebral ischaemia
is presumed to be a consequence of brain injury, possibly mediated by an inflammatory
response (Zhao, 1994). The precise mechanisms of action of hypothermia for neurological
protection are largely unknown (Polderman, 2008a).
1.21 Physiology of temperature regulation and hypothermia induction
Normal human body temperature is strictly regulated and maintained at a set point of
36.6±0.4°C. The set point can be adjusted and minimal variations in temperature occur
during the course of each day (Hasan, 2010). Central body temperature is thought to be
under hypothalamic control. Body temperature is regulated by limiting the blood supply to
peripheries through vasodilation and vasoconstriction. Heat loss from the peripheries is
dependent on skin perfusion and sweat production (evaporation). Heat loss can also occur by
convection, conduction and radiation. The amount of heat loss is influenced by the
temperature gradient, exposed surface and thermal conductivities. At rest under normal
circumstances, 50-70% of body heat loss in awake patients will occur through radiation
(Polderman, 2009). In unconscious patients in the supine position, most heat loss will occur
through radiation and convection (Laupland, 2009). Cooling of patients leads to immediate
physiological responses to counteract the disturbance in homeostasis. Vasoconstriction limits
heat loss through the skin and sympathetic tone increases to maximise central perfusion. The
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capacity and effectiveness to control body temperature decrease with age. During cardiac
arrest, lack of circulation and vasoactive tone lead to profound heat loss from the body,
although the exact rate and distribution of heat loss following OHCA is unknown.
1.22 The mechanisms of action of mild therapeutic hypothermia
Despite widespread interest in therapeutic hypothermia, little is known the mechanism by
which MTH confers benefit, including its cellular and molecular effects (Hansen, 1994).
MTH is thought to improve survival from OHCA, provide neuroprotection and possibly
increase the likelihood of ROSC when commenced intra-arrest. The mechanism of action
resulting in these three effects may be similar or different. The early assumption was that
hypothermia conferred survival benefit and neuroprotection mainly by slowing cerebral
metabolism and decreasing oxygen demand. Cerebral oxygen consumption, glucose
utilisation and lactate concentration are dependent on temperature (Yenari MA, 2005).
Hypothermia has been shown to reduce cerebral metabolism by reducing all of these
parameters. Metabolism is reduced by 5-7% for each °C reduction in core body temperature
(Small, 1999). Therapeutic hypothermia is now thought to exert its effect through several
mechanisms (Polderman, 2008b). Animal experiments have shown that the degree of
neuroprotection is similar when either mild or deep hypothermia is used, an effect not
explained by metabolism reduction alone (Polderman, 2008b). Also, hypothermia appears to
confer neuroprotection even when initiated several hours after the initial injury (The
Hypothermia after Cardiac Arrest Study Group, 2002).
1.23 Protective effects of mild therapeutic hypothermia
As discussed, hypothermia reduces cerebral metabolism, reducing oxygen and glucose
requirements and can limit the reperfusion injury following ROSC. Mild to moderate
hypothermia (temperature target of 32-34C) causes cerebral vasoconstriction, reducing
cerebral blood flow (Bernard, 2003b). This decreases intracranial pressure and may act as an
anti-convulsant (Bernard, 1997).
MTH has effects on the cardiovascular system. Heart rate is decreased and systemic vascular
resistance increases (Bernard, 2003b). MTH decreases cardiac output by approximately 7%
for each 1°C decrease in core body temperature, whilst stroke volume and mean arterial
pressure are maintained.
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Patients undergoing MTH have increased diuresis as cooling increases renal blood flow
(Zeiner, 2004). There is increased uptake of potassium inside the cells, leading to
hypokalemia (Koht, 1983). Similarly, hypothermia decreases phosphate concentrations.
MTH is not without side-effects. Coagulation is known to be affected, prolonging bleeding
time through effects on platelet function and prolongation of prothrombin and partial
thromboplastin times (Zeiner, 2000). Hypothermia has been associated with an increased
susceptibility to infection, particularly pneumonia (Bernard, 2003b).
Hypothermia may mitigate or block the pro-inflammatory response and production of pro¬
inflammatory cytokines following ischaemia, although the precise mechanism and which
cytokines are affected remain unknown (Diestel, 2008; Fries, 2009).
1.24 Neurological effects of mild therapeutic hypothermia
Injured brains can have areas with 2-3°C higher temperatures than surrounding areas (Zhao,
1994). Injured brain cells can lead to hyperthermia, which is known to propagate
neurological injury (Saini, 2009). Hypothermia of 32-34°C can mitigate this effect
(Minamisawa, 1990). Hypothermia is thought to improve ion homeostasis, limiting the
detrimental effect of glutamate accumulation and Ca2t influx into cells (Polderman, 2008a).
Permeability of cellular membranes is reduced, decreasing leakage with associated
improvements in cell function and cellular homeostasis, including decreasing intracellular
acidosis. Cerebral ischaemia can lead to disruption of the blood-brain barrier and the
vascular wall. Hypothermia can moderate this disruption, limiting cerebral oedema (Fischer,
1999). Production of reactive oxygen species (ROS), such as superoxide, peroxynitrite,
hydrogen peroxide and hydroxyl radicals is common after ischaemia. Hypothermia is able to
block production of ROS (Hashimoto, 2003; Kil, 1996).
1.25 Summary of introduction
MTH has been shown to influence outcome from OHCA in three ways. Firstly, it improves
survival (Bernard, 2002; The Hypothermia after Cardiac Arrest Study Group, 2002).
Secondly, it improves neurological outcome (Holzer, 2005). Thirdly, it may increase ROSC
when commenced intra-arrest (Castren, 2010; Tsai, 2008; Wang, 2010). Little is known
about the mechanisms of action of MTH and what effect cooling during resuscitation has on
the body.
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Suggested mechanisms of MTH exerting neuroprotection include a decrease in cerebral
metabolism, decrease in reactive oxygen species production, decreased cell death mediated
through calcium and glutamate release and possible modulation of inflammatory cascades.
MTH may modulate systemic inflammation post-ROSC and reduce multi-organ failure
(Qureshi, 2008). MTH may have a protective effect on cardiac function post-OHCA
(Yannopoulos, 2009; Yu, 2010). MTH, when commenced intra-arrest, may increase the
likelihood of ROSC, possibly via sympathetic nervous system stimulation.
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Chapter 2
Study Aims and Objectives
2.1 Aims
The aims of the TOPCAT study followed two distinct strands. Firstly, the clinical
resuscitation of OHCA patients in Scotland and secondly, physiological changes occurring
post-OHCA.
Core body temperature is important after OHCA. The progression of core body temperature
after out-of-hospital cardiac arrest and its relation to systemic inflammation and markers of
brain injury remains under investigation.
It was the intention to examine core body temperature immediately after OHCA and
characterise any relationships to markers of systemic inflammation and brain injury.
The primary aim of this study was therefore:
1. To describe the natural pattern of change in core body temperature after OHCA.
2. Establish any relationship between core body temperature, markers if systemic
inflammation (IL-1, 1L-6, IL-8, IL-10, IL-12), brain injury (NSE, SlOOb) and
outcome following OHCA.
Secondary aims were:
OHCA clinical management in Scotland
• To review the literature to establish current optimal management of OHCA patients
in the ED.
• To establish current practice of ED management of OHCA in Scotland.
• To investigate whether improved research-based guidelines on the management of
OHCA patients are required in Scotland.
• To determine whether the presence of a doctor at the scene of OHCA is beneficial.
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• To assess ambulance crews' attitudes towards a doctor attending the scene of
OHCA.
Physiology post-OHCA
• To enrol 36 patients in the pre-hospital setting and determine core body temperature
post-OHCA in the pre-hospital phase.
• To enrol a total of 250 OHCA patients and gather prospective data on core body
temperature, markers of systemic inflammation and brain injury post OHCA on
arrival in the ED.
• To continuously record body temperature on patients surviving to admission to the
1CU and establish whether initial body temperature is related to time-to-reach target
temperature, survival to hospital discharge, neurological outcome and best
neurological performance within 6 months of OHCA.
• To determine the relationship between core body temperature on arrival in the ED
and brain injury markers taken.
• To determine the relationship between core body temperature on arrival in the ED
and markers of systemic inflammation.
• To determine the pattern of change of brain injury and systemic inflammation
markers in the first 5 days post-OHCA.
• To determine the predictive value of brain injury markers in determining outcome
from OHCA in patients receiving therapeutic hypothermia.
2.2 Hypotheses
• Patients post-OHCA are not normothermic in the pre-hospital and ED phases of
resuscitation.
• There is an association between core body temperature post-OHCA and outcome.
• Markers of systemic inflammation (IL-1, IL-6, IL-8, IL-10, IL-12) are significantly
raised in the hours to days post-ROSC following OHCA.
• Markers of systemic inflammation are significantly higher in OHCA patients who do
not survive compared to those who survive to hospital discharge.
• There is a correlation between core body temperature in the early phase post-OHCA
and markers of systemic inflammation.
• Markers of brain injury (NSE/SlOOb) can be used to predict outcome in the context
of therapeutic hypothermia.





The study area covered the Lothians region of south east Scotland, with a population of
approximately 500,000. OHCA patients are attended by crews from the Scottish Ambulance
Service. The majority (>95%) who are not pronounced dead at scene are transported to the
Royal Infirmary of Edinburgh with the remainder being transported to the Western General
Hospital, Edinburgh. We only included patients admitted to a single centre - the Royal
Infirmary of Edinburgh.
3.2 Study Design
The study was designed as a prospective observational study, called the "Temperature Post
Cardiac Arrest" - "TOPCAT" study.
3.3 Patient selection
The Lothians has approximately 450-500 OHCA per annum (Heartstart, 2005). In a 1-year
period from 2005-6 the ED of the Royal Infirmary of Edinburgh received 218 patients post
OHCA. Of these, 50 patients achieved ROSC and survived to be admitted to hospital
(Easterford, 2006). The overall survival-to-discharge rate for OHCA in the Edinburgh area
has historically been consistent with that published for other urban centres at around 4%.
3.4 Study period
The TOPCAT study commenced on the 1st August 2008 and data collection ceased on 28th
February 2010 (total study period: 19 months). The study ran continuously although patients
recruited into the pre-hospital subgroup (see below) were only recruited when the research
doctor was available.
3.5 Sample size
We estimated the ED of the Royal Infirmary of Edinburgh would receive approximately 200
patients post OHCA per year. We predicted a recruitment rate of 80% based on our
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experience of previous studies on critically ill patients in our unit. Over a 19-month period
we would expect to recruit 240-270 patients, with 75 patients expected to survive to reach
admission to hospital.
3.6 Inclusion and exclusion criteria
The inclusion criteria for the TOPCAT study were defined as follows:
• aged 16 years or over
• attending the ED RIE following OHCA
• intubated pre-hospital or on arrival to the ED
• OHCA of presumed non-traumatic aetiology
The exclusion criteria were
• age <16 years
• patient not requiring endotracheal intubation
• OHCA of traumatic aetiology
• Pregnancy
3.7 Patient demographics and data collection
All patients taken to the ED post-OHCA have data collected by the Scottish Ambulance
Service in the standard Utstein format (Jacobs, 2004). On arrival in the Emergency
Department, the OHCA patient was managed according to standard Advanced Life Support
guidelines. Patients were recruited into the study at the discretion of the attending
Emergency Doctor. The patient was assigned a study number and a standard data collection
form completed. The data collection form is shown in Appendix II - Data Collection Form.
All data was pseudo-anonymised.
3.8 Core body temperature measurement
Core body temperature monitoring commenced on arrival in the ED. Oesophageal
temperature (Toes) monitoring is the most practical means of accurately measuring core body
temperature during a resuscitation attempt (Sterz, 2003). An oesophageal temperature probe
was marked at 15cm from the tip and inserted via the nostril or mouth as soon as was
practical during resuscitation. The thermometer tip was therefore 15cm from the nostril and
the position confirmed by laryngoscopy. The probe was linked to a digital recording
thermometer (DataTherm II, RG Medical Diagnostics, USA) with oesophageal temperature
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recorded every 10 minutes to 0.1 °C accuracy. Oesophageal temperature recording continued
for a 24-hour period for patients surviving to 1CU admission. The temperature trace was
downloaded onto a research computer using a direct USB connection and proprietary
software (RG Medical Diagnostics Ltd). We recorded the pattern of change in oesophageal
temperature from either the pre-hospital, see below, or ED phase of the OHCA patient's
journey until target temperature (Ttarg. <34°C) was reached after cooling was commenced in
the ICU. Time taken to reach T,arg after ROSC was recorded, together with time to admission
to the ED and ICU and the time active cooling was commenced. Ordinarily in the Royal
Infirmary of Edinburgh, therapeutic hypothermia is initiated on the ICU. Body surface
cooling (Arctic Sun, Medivance Ltd) is used with automatic temperature feedback control. In
a small proportion of cases cooling is commenced in the ED by placing ice packs on the
patient.
3.9 Missing Data
We anticipated that, despite frequent reminders, oesophageal temperature monitoring and
blood sampling would not be undertaken in a proportion of eligible patients. Where possible,
the remainder of blood samples taken for clinical use were obtained and stored for research
purposes. In cases where oesophageal temperature monitoring was not undertaken, the ICU
clinical chart was obtained and hourly oesophageal temperatures recorded for routine clinical
observation noted. All data, including incomplete sets was used for descriptive analysis.
3.10 Blood sampling, storage and assay
On arrival in the Emergency Department, three tubes of blood were taken from the patient
for research purposes. Two serum gel tubes were filled with approximately 5ml each of
patient blood and one EDTA plasma tube was filled with 5ml of blood. The samples were
immediately centrifuged (either in the hospital laboratory or in the ED) at 3200rpm for 10
minutes. The samples were stored at 4°C for a maximum of 48 hours before being aliquotted
into 2ml sterile containers and frozen at -80°C in the Queen's Medical Research Institute,
Edinburgh, before batch analysis.
Patients surviving to reach admission to the ICU had follow-up blood samples taken at 24,
48 and 72 hours post-arrival in the ED. For patients who survived, a blood sample was taken
at 5 days post-admission. Blood samples were processed in an identical manner to those
from the ED.
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3.11 Human inflammation assay
Human inflammatory markers were analysed using flow cytometry. Flow cytometry is an
analysis tool that detects and count antibodies attached to cells using laser excitation. The
BD™ Cytometric Bead Array (CBA) uses the sensitivity of amplified fluorescence detection
by flow cytometry to measure soluble analytes in a particle-based immunoassay. Each bead
in a BD CBA kit provides a capture surface for a specific protein and is analogous
Multiplexing is the simultaneous assay of many analytes in a single sample. We used the
BD™ Cytometric Bead Array (CBA) to quantitatively measure TNF-a, IL-ip, IL-6, IL-8,
IL-10 and IL12p70. The full protocol for analysis of serum inflammatory markers is given in
Appendix III - Laboratory protocols. Cell surface markers of neutrophil activation were
measured using flow cytometry. The protocol for measuring neutrophil cell surface markers
is given in Appendix III - Laboratory protocols. Blood samples were taken from 16 adult,
healthy volunteers to act as control samples.
3.12 Brain injury markers assay
We used an automated analyser (Diasorin Liaison) to quantify serum levels of NSE and S-
100b.
The method of quantitative determination of NSE and SI00 is a sandwich
chemiluminescence immunoassay. A specific mouse monoclonal antibody is coated on the
magnetic particles (solid phase); another monoclonal antibody is linked to an isoluminol
derivative (isoluminol-antibody conjugate). During the incubation, NSE and SI00 present in
the TOPCAT samples, bind to the solid phase monoclonal antibody and subsequently the
antibody conjugate reacts with NSE/S100 already bound to the solid phase. After incubation,
the unbound material is removed with a wash cycle. Subsequently, the starter reagents are
added and a flash chemiluminescence reaction is thus induced. The light signal, and hence
the amount of isoluminol-antibody conjugate, is measured by a photomultiplier as relative
light units and is indicative of NSE/S100 concentration in the samples. No control samples
were used as the normal serum levels of NSE and SI00b are thought to be negligible
(Oksanen, 2009).
To measure serum GFAP, a proprietary enzyme-linked immunosorbent assay (Biovendor




A subset of patients had oesophageal temperature measurement and blood samples taken
pre-hospital, at the scene of the out-of-hospital cardiac arrest. Pre-hospital patients were only
recruited during the research doctor's on-call periods with the Scottish Ambulance Service.
The aim was to recruit 2 patients per month into the pre-hospital subgroup, giving a total of
36 during the study period. Clinical care of the patient was always first priority with the
research doctor initially assisting the ambulance crew with resuscitation until data sampling
was practical.
3.14 Pre-hospital tasking and response
The research doctor (RL) operated approximately a 1:3 on-call with the Scottish Ambulance
Service (SAS). RL received formal response driver training from the SAS. The driving
course took place over 3 days (August 18-20, 2008). A detailed account of the Response
Driver Training is shown in Appendix IV - Response Driving) The research doctor's car was
fitted with an Automated Vehicle Locator System, which uses satellite tracking technology
to display availability and location in the Emergency Medical Dispatch Centre (EMDC). All
EMDC call handlers and dispatchers were made aware of the study by information sheets
and posters. The research doctor (RL) visited EMDC on a weekly basis to encourage
appropriate tasking.
On receipt of a possible cardiac arrest call an ambulance was immediately dispatched
according to local protocol. The research doctor was then contacted on a designated mobile
phone and given the location details of the suspected OHCA. The research doctor received
training in emergency response driving and had his car fitted with audible and visual
warning systems to allow a fast response as shown in Figure 3.1.
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Figure 3.1. TOPCAT response car and equipment.
A specific motor insurance policy (Towergate MIA, London) covered emergency response
driving. Standard resuscitation equipment, similar to that carried by Scottish Ambulance
Service crews, and a defibrillator (supplied by the British Heart Foundation) was earned by
the research doctor in case he arrived first on scene. The full list of emergency medical
equipment earned by RL is given in Appendix V - Response car equipment.
All SAS crews within the Lothians region were informed about the stud) by means of email
bulletins. At the scene, the research doctor worked with the attending SAS crew, assisting
resuscitation where necessary before starting data collection.
All calls attended by the research doctor were logged and data collected on the time of call,
location, incident details and interventions performed by the doctor on-scene, including
advice given to the attending ambulance crew.
3.15 Pre-hospital data collection
The oesophageal probe was used accordingly to the same protocol described for patients
having temperature monitoring commenced in the Emergency Department. Temperature
monitoring commenced as soon as practical during resuscitation, often before ROSC. The
temperature probe was secured in place for transport to hospital and continued continuously
for 24-hours post-hospital admission or until the patient died.
An intravenous cannula was inserted at the scene and blood taken in the same manner as
described for the Emergency Department samples. The blood samples were immediately
transported back to the hospital for processing and storage as described above.
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3.16 Pre-hospital interaction with Ambulance Crews
All calls that RL received from the EMDC were logged. On arrival at the scene of an OHCA,
RL would assist the attending ambulance crew if required. A log of all advice given and
clinical procedures performed at the OHCA scene was kept. On completion of the episode,
the attending ambulance crew were emailed with a request to anonymously complete an
online survey (SurveyMonkey Ltd) about their experiences working with a pre-hospital
doctor in the field. The survey, with results included, is shown in Appendix VI - Ambulance
crew perceptions of a pre-hospital doctor at the scene of out-of-hospital cardiac arrest.
3.17 Ethics Committee Approval
The study received approval from the national Scottish Medical Research Ethics Committee
(MREC "A") on 26th June 2008 (Ref 07/MRE00/119).
Lothian Research and Development management approval was also obtained on 26th March
2008 (Ref 2008/R/AE/02).
3.18 Informed consent and information sheets
The patient and family information sheets (Version 1.2, Appendix VII - Information sheets)
and patient and family consent forms (Version 1.2, Appendix VIII - consent forms) were
also approved by the MREC.
3.19 Endpoint measures
Patients in the pre-hospital subgroup were either pronounced dead at scene or transported to
the ED.
Patients arriving at hospital were either declared dead in the ED, admitted to the ICU or had
active treatment withdrawn and admitted to a hospital ward for palliation.
Primary endpoint measures were survival to hospital discharge and best cerebral
performance category (CPC) achieved within 6 months post OHCA.
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Table 3.1 Cerebral Performance Category scoring
CPC l.
Good cerebral performance: conscious, alert, able to work, might have mild
neurologic or psychologic deficit.
CPC 2.
Moderate cerebral disability: conscious, sufficient cerebral function for independent
activities of daily life. Able to work in sheltered environment.
CPC 3.
Severe cerebral disability: conscious, dependent on others for daily support because of
impaired brain function. Ranges from ambulatory state to severe dementia or paralysis.
CPC 4.
Coma or vegetative state: any degree of coma without the presence of all brain death
criteria. Unawareness, even if appears awake (vegetative state) without interaction with
environment; may have spontaneous eye opening and sleep/awake cycles. Cerebral
unresponsiveness.
CPC 5.
Brain death: apnea, areflexia, EEG silence, etc.
3.20 Statistical Analysis
Data were entered into a database (Microsoft Access 2007) and analysed using statistical
analysis software (Microsoft Excel 2009, SPSS 16.0).
Continuous data are presented using mean and standard deviation (SD) and interquartile
range (IQR), as appropriate; categorical data are presented using absolute frequencies.
Comparisons between continuous variables were performed using Student's test or Mann-
Whitney U test as appropriate. Categorical data evaluated using chi-square analysis.
Values in the survivor and non-survivor groups were compared at two time points (arrival in
the ED and arrival on the ICU) using an unpaired t-test. Statistical significance was taken at
the 95% level.
54
The primary objective of the study is a descriptive analysis so no formal power calculation
was performed. We determined the sample size required to enable a linear regression
analysis of our data to meet our secondary objectives:
Using the Peduzzi rule ten events per variable would be needed for a linear regression,
equating to a minimum of 60 patients who survive to reach hospital admission over the total
study period. The Emergency Department of the Royal Infirmary of Edinburgh (RIE)
receives approximately 200 patients post OHCA per year. We predicted a recruitment rate of
80% based on our experience of previous studies on critically ill patients in our unit. Over an
18-month period we expected to recruit 261 patients, with 75 patients expected to survive to
reach admission to hospital.
A subset of patients was included in the pre-hospital setting. The lead investigator working a
1 in 3 on-call with the Scottish Ambulance Service would expect to attend 6 OHCA per
month. The aim was to recruit 36 patients over the study period.
To determine if there is a cut-off point that would allow us to distinguish between those who
survive to discharge versus those who die in ICU, receiver operator characteristic (ROC)
curves were produced and the area-under-the curve (AUC) calculated.
Univariate and multiple logistic regression analyses were performed.
Statistical advice, supporting and analysis was facilitated by Ms Catriona Graham, Lead
Statistician, Epidemiology and Statistics Core, Wellcome Trust Clinical Research Facility,
Western General Hospital, Edinburgh.
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Chapter 4
Early In-Hospital Management of Out-of-Hospital
Cardiac Arrest in Scotland: A National Survey
4.1 Introduction
Coronary heart disease is responsible for around 110,000 deaths in the United Kingdom
every year with 75% due to sudden cardiac death (Atwood, 2005). In Scotland, there are
over 3,500 out-of-hospital cardiac arrests (OHCA) annually, with survival to hospital
discharge less than 5% (Heartstart Scotland, 2006).
In the pre-hospital phase effective resuscitation is required in order to obtain return of
spontaneous circulation (ROSC). The only therapy in the post-ROSC phase of OHCA shown
to improve outcome is mild therapeutic hypothermia (MTH) (Hypothermia after cardiac
arrest study group 2002b; Bernard, 2002). This study surveys the use of MTH in Emergency
Departments (ED) and Intensive Care Units (ICU) across Scotland.
In 2002, two prospective, randomised controlled trials of MTH in the post-resuscitation
management of witnessed OHCA were published (Hypothermia after cardiac arrest study
group, 2002a; Bernard, 2002). These papers led to the European Resuscitation Council and
the International Liaison Committee on Resuscitation recommending MTH as standard
therapy for OHCA patients with ventricular fibrillation (VF) as the presenting rhythm who
remain comatose post ROSC (Nolan, 2003). Whether MTH may also benefit patients after
OHCA with non-VF presenting rhythms is unknown.
There is still uncertainty amongst physicians about using MTH (Abella, 2005). Recent
evidence suggests that early achievement of the desired hypothermic temperature is
associated with a better neurological outcome. If target temperature is to be achieved early,
cooling will need to commence in the pre-hospital or ED phase of the OHCA patient's care.
Primary percutaneous coronary intervention (PCI) can be considered after ROSC in the
management of OHCA. PCI is currently regarded as the most effective reperfusion strategy
in ST-elevation myocardial infarction (STEMI) (Keeley, 2003). Whether PCI is beneficial in
56
cases of non-STEMi acute coronary syndrome complicated by cardiac arrest remains under
investigation (Anyfantakis, 2009).
We sought to investigate differences in ED and ICU management of OHCA patients in
Scotland and to establish the degree of consistency in the use of MTH and PCI in the
management of OHCA. We sought to establish possible reasons for variation in clinical
practice and barriers to implementation.
4.2 Methods
A national questionnaire survey was conducted of all Emergency Medicine (EM)
Consultants, EDs and ICUs in Scotland. Each Consultant was emailed with an invitation to
complete a web-based questionnaire. The full survey is shown in Appendix XI - Scottish
Emergency Department Survey. All responses were anonymous and participation was
voluntary.
A telephone survey was conducted of all Scottish Emergency Departments (n=26) and
Intensive Therapy Units (n=22). On receipt of the telephone call, a member of the on-duty
medical team was asked to answer the survey questions. Ethical approval was gained from
the University of Edinburgh Student Projects Committee.
4.3 Results
113 Emergency Medicine Consultants were identified as working in Scotland. Contact email
addresses were available for 87 of these Consultants. 32 (37%) of the contacted EM
Consultants completed the survey. All 26 Scottish EDs and 22 ITUs were contacted by
telephone. The telephone survey was completed by 19 (73%) EDs and 21 (96%) ICUs.
4.4 Emergency Medicine Consultant views on OHCA management
32 EM Consultants responded to the survey. The majority (27; 84%) felt MTH was effective
in the management of OHCA patients and 26 (84%) had experience of using MTH. A large
proportion, (29; 91%) of EM Consultants thought MTH should be commenced earlier (pre¬
hospital or ED setting). 29 (91%) EM Consultants thought it practical to initiate MTH within
the ED.
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21 (67%) of ED Consultants did not think PCI should be used routinely in the early
management of OHCA. The major trigger for PCI referral was reported as an ECG finding
of ST segment elevation.
4.5 Emergency Department management of OHCA
7 (47%) EDs had used cooling before, compared to 19 (91%) ICUs. MTH was more
commonly initiated in ICU than in the ED. (19 (91%) vs. 7 (37%), p<0.05). The majority of
EDs (9; 47%) did not routinely initiating cooling. A protocol for MTH was only present in 4
(21%) EDs, as shown in Table 1.
A protocol for primary PCI use following OHCA was available in 10 (53%) EDs. None of
the district general hospitals that received patients following OHCA had on-site access to
PCI. 59% of university teaching hospitals had on-site access to PCI.
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Table 4.1 Emergency Department management of out-of-hospital cardiac
arrest (OHCA), (n=19)
Ever used MTH in the ED on a patient post OHCA
Yes 7 (37%)
No 12 (63%)
Is it practical to initiate MTH within the ED?
Yes 15 (79%)
No 4 (21%)





ED protocol for MTH use in OHCA patients
Yes 4 (21%)
No 15 (79%)
Method of initiating MTH (if used)
Ice packs 4 (21%)
Surface cooling blankets 2 (11%)
Exposure only 1 (5%)
Cold IV fluids 0 (0%)
Reasons for not initiating MTH in ED
MTH commenced on ICU 8 (42%)
Cooling equipment unavailable 6 (32%)
Insufficient evidence for using cooling 5 (26%)
Protocol in place for PCI following OHCA
Yes 10 (53%)
No 9 (47%)









Availability of PCI facilities
24 hours a day 11 (58%)
Mon-Fri 0900-1700 5 (26%)
Available on request 3 (16%)
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4.6 Intensive Care Unit management of OHCA
The majority of ICUs (19; 91%) had experience of cooling OHCA patients and utilised a
protocol (16; 76%), as shown in Table 2. The majority of OHCA patients admitted to ICU
were cooled, with MTH being used in over 50% of admitted OHCA patients in 14 (67%)
ICUs.
Table 4.2: Intensive Care Unit Management of out-of-hospital cardiac arrest
(OHCA), (n=21)
Ever used MTH in the ICU on a patient post OHCA
Yes 19 (90%)
No 2 (10%)
Proportion of post OHCA patients who have MTH initiated in the ICU
None 2 (10%)
<10% 0 (0%)
10-25 % 2 (10%)
>25 % 17 (80%)
ITU protocol for MTH use in OHCA patients
Yes 17 (81%)
No 4 (19%)
Method of initiating MTH (if used)
Ice packs 13 (62%)
Surface cooling blankets 14 (67%)
Cold IV fluids 8 (38%)
Wet towels and fanning 5 (24%)
Invasive cooling 2 (10%)
How long are patients cooled on ICU for (if applicable)
<6 hours 0 (0%)
6-12 hours 1 (5%)
12-24 hours 2 (10%)
24-48 hours 15 (71%)
>48 hours 1 (5%)
4.7 Discussion
We completed a national survey of Scottish EDs, ICUs and EM Consultants. Compared to
previously published studies, we have found an increase in the use of MTH in both the ED
and ICU setting. A UK survey in 2006 of 98% of all British ICUs found that only 27% had
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ever used MTH (Laver, 2006). Our study reports a 90% MTH experience rate which may
imply an increase in the use of MTH on the ICU for post-OHCA patients. We found the
majority of Scottish ICUs have adopted a cooling protocol but there remains variation in the
cooling techniques used and length of time MTH is maintained, perhaps reflecting the lack
of clinical evidence in these areas.
The consensus from clinical studies supporting early cooling has led ILCOR to recommend
the initiation of MTH as soon after ROSC as possible (Nolan, 2005). If target temperature is
to be achieved early, cooling will almost certainly have to be initiated in the pre-hospital or
ED phase of an OHCA patient's care. 91% of EM Consultants thought it practical to initiate
MTH in the ED. There appears to be a positive attitude towards MTH but our study has
demonstrated a discrepancy in best perceived clinical practice and actual delivered treatment.
None of the surveyed university teaching hospitals routinely used MTH in the ED. The
barriers to implementation most often cited for non-use of MTH were lack of a cooling
protocol, lack of cooling equipment or MTH being initiated in the ICU instead. Studies have
previously reported similar reasons to ours for non-adoption of MTH with the most
commonly cited reasons being: lack of evidence, lack of a protocol, difficulties in
practicality and lack of resources (Abella, 2005; Skulec, 2010). Establishing protocols for
MTH use in the ED and heightened awareness could promote the use of cooling in early
OHCA management.
Early post-ROSC PCI has also been shown to improve survival when used in patients
surviving OHCA. Evidence suggests OHCA STEMI patients are likely to benefit from early
PCI (Anyfantakis, 2009). Whether non-STEMI post-OHCA should have PCI remains
unknown and further research is warranted in order to ensure intervention occurs in the
correct subset of post-OHCA patients. The management of OHCA needs to be co-ordinated
on a regional scale in the form of a cardiac network to ensure patients requiring reperfusion
intervention are transported to the appropriate centre. In our study, none of the district
general hospitals receiving OHCA patients had on-site access to primary PCI. Some
hospitals transferred OHCA patients direct for PCI. The early use of PCI has yet to be widely
accepted and physicians are still unsure of its place in the management of OHCA.
There are several limitations to this survey. Our low sample size may not reflect the opinions
and practice of all physicians in Scotland involved in the care of OHCA patients. The
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telephone survey only interrogated one respondent per department and there is no way of
confirming the answers being provided.
4.8 Conclusion
The use of MTH in Scottish EDs is low. Use of MTH on ICU is increasing. Few EDs
routinely refer OHCA patients for primary PCI and a concerning number of hospitals
receiving patients post-OHCA do not have on-site access to primary PCI facilities. Greater
understanding of the role of MTH and PCI in the early management of OHCA will promote
these promising treatments amongst Emergency and Critical Care physicians.
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Chapter 5
Results - Core body temperature
5.1 Total Study Patients
A total of 240 patients were recruited to the TOPCAT study.
5.2 Excluded Study Patients
Three patients were excluded from the study after being recruited. One patient refused
consent on re-gaining consciousness in ICU. Two patients regained consciousness in the ED,
were extubated and subsequently withdrawn from the study. A total of 237 patients were
included in the final analysis. A summary of patient recruitment is shown in Figure 5.1.
Figure 5.1. Patient recruitment to the TOPCAT study
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5.3 General demographics of recruited patients
A descriptive analysis of baseline characteristics of the patients recruited to the TOPCAT
study is shown in Table 5.1




Age in years, mean ± SD 65.3117
Male sex, n (%) 153 (65)
Details of cardiac arrest
Cause of cardiac arrest presumed cardiac, n (%) 182 (77)
Bystander witnessed cardiac arrest, n(%) 104 (44)
Received bystander CPR, n(%) 115 (49)
First cardiac rhythm VF/VT, n (%) 102 (43)
First cardiac rhythm PEA, n (%) 48(20)
First cardiac rhythm asystole, n(%) 77 (32)
First cardiac rhythm unknown, n(%) 10 (4%)
Time in minutes from 999 call to arrival of first ambulance crew,
median (IQR) 7(4-10)
Adrenaline (mg) given during resuscitation, mean ± SD 4 13.5
Achieved ROSC, n(%) 104 (44)
Time in minutes from call to ROSC, median (IQR) 25 (17-32)
Time in minutes from ROSC to arrival at the ED, median (IQR) 30(23-37)
Outcome
Survived to ICU admission, n(%) 74(31)
Survived to hospital discharge, n(%) 27 (11)
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5.4 Patient outcome
During the study period, 75 patients survived to hospital admission and 27 survived to
hospital discharge. Of those who survived to hospital discharge, the majority had a
favourable neurological outcome, achieving a CPC score of 1 or 2 within 6-months
following discharge, as shown in Table 5.2.
Table 5.2 Best cerebral performance category (CPC) achieved within 6-months
of patients surviving to hospital discharge.
Survivors to
hospital discharge
Best CPC score within 6-months post OHCA (n=27)
CPC 1, n (%) 15(56)
CPC 2, n (%) 5(19)
CPC 3, n (%) 5(19)
CPC 4, n (%) 0
Dead at 6 months 2(7)
Of the patients who achieved ROSC but died in ICU (n=49), the primary cause of death was
severe neurological injury in 28 (57%) patients, multi-organ failure in 14 (29%) isolated
cardiovascular failure in 5 (10%) and sudden in-hospital cardiac arrest in 2 (4%).
5.5 Exclusions from core body temperature analysis
One patient suffered a suspected OHCA from hypothermia (Core temperature 23°C).
Research blood samples were not taken by the attending ED doctor. This patient was
removed from subsequent analysis and died 20 hours after admission.
The cause of OHCA was overwhelming sepsis in one patient who presented to the ED in
cardiac arrest with a core body temperature of 39.5°C. No research blood samples were
taken by the attending ED doctor. This patient was not included in subsequent temperature
analysis.
5.6 Complications of oesophageal temperature monitoring
On arrival in the ED, one patient was noted to have the temperature probe situated next to
the cuff of the endotracheal tube on direct laryngoscopy and the probe was re-sited.
Otherwise no complications from temperature monitoring were observed.
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5.7 Summary of core body temperature analysis
A summary of patient recruitment in relation to oesophageal temperature measurement is
shown in Figure 5.2
Figure 5.2 Summary of oesophageal temperature measurements in TOPCAT
patients
5.8 Pre-hospital oesophageal temperature
A total of 45 patients had oesophageal temperature monitoring pre-hospital. The mean initial
oesophageal temperature on arrival at scene was 33.7°C (95% CI 32.8-34.5).
Patients who achieved ROSC showed a trend towards higher mean pre-hospital oesophageal
temperature compared with patients who failed to achieve ROSC (34.4 vs. 33.4, p=0.15).
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5.9 Emergency Department oesophageal temperature
A total of 171 patients had oesophageal temperature measured on arrival to the ED. Mean
Toes was 34.3°C (95% CI 34.1-34.5) for all patients. Patients who had achieved ROSC and
arrived in the ED with a sustained cardiac output had a mean Toes of 34.6°C (95% CI 34.3-
34.8).
5.10 Intensive Care Unit oesophageal temperature
Patients surviving to reach admission to ICU had a mean Toes of 34.9 (95% CI 34.6-35.2) on
ICU arrival, before cooling was initiated. Patients who survived to reach hospital discharge
had a higher Toes on admission to the ICU than patients who subsequently died on ICU (35.6
vs. 34.4, p=0.0006). This is shown in Figure 5.3 and Table 5.3.
Figure 5.3. Mean Toes of post-ROSC out-of-hospital cardiac arrest patients who
survived to hospital discharge | A ] (n=27) vs. patients who were admitted to ICU but
died in hospital [ ® ] (n=48)
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Table 5.3. Core body temperature post-OHCA in patients who survived to
discharge compared to patients who died in ICU. sd= standard deviation




difference p-valuen mean (sd) n mean (sd)
Core temp pre hospital 8 34.80 (1.36) 7 34.05 (2.37) -0.75 (-1.54, 3.05) 0.478
Core temp in ED 42 34.53 (1.34) 24 34.97 (1.34) +0.45 (-1.34, 0.25) 0.201
Core temp in ICU 38 34.42 (1.20) 25 35.66 (1.33) +1.24 (-1.90, -0.57) 0.001
Patients who survived to hospital discharge appeared to rewarm at a greater rate (mean +0.7°
between ED and ICU) compared to patients who died in ICU (mean: no change between ED
and ICU), as shown in Table 5.3 and Figures 5.4 and Figure 5.5.
Figure 5.4. Emergency Department and Intensive Care Unit admission











Oesophageal temperature of post-OHCA patients
who survived to hospital discharge (n=27). Red line = mean
ED temp ITU temp
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Figure 5.5. Emergency Department and Intensive Care Unit admission
oesophageal temperature of post-OHCA patients admitted to ICU who
subsequently died in hospital (n=48)
Oesophageal temperature of post-OHCA patients admitted




ED temp ITU temp
5.11 Survivors of OHCA versus patients who died in the ICU
There were several significant differences between patients who died in ICU and patients
who survived to hospital discharge, as shown in Table 5.4. When compared to patients who
died in ICU, patients who survived to hospital discharge had a higher incidence of VF/VT as
the presenting cardiac rhythm (48 vs. 85%, p=0.002); higher incidence of arrest of presumed
cardiac cause (67 vs. 96%, p=0.003) and shorter downtime (29 vs. 11 minutes, p=0.0004).
There was no significant difference between survivors and non-survivors in time to ED
arrival (27 vs. 30 minutes, p=0.67) and time to ICU admission (140 vs. 173 minutes,
p=0.96). All patients admitted to ICU were cooled, however, survivors to hospital discharge
took longer to reach target therapeutic temperature (<34°C) than non-survivors (313 vs. 222
mins, p=0.028), as shown in Table 5.4.
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Table 5.4. Differences between post-ROSC out-of-hospital cardiac arrest
patients who survived to hospital discharge (n=27) and those who died in the







Age 1ST yea's, mean ± SD 51 ± IS. 7 50 ±12.3 p=0.71
Male sex, n (%) 29 (60) 19 (70) p=0.45
Details of cardiac arrest
Cause of cardiac arrest presumed cardiac, n (%) 32 (67) 26 (96) p=0.003*
Bystander witnessed cardiac arrest, n(%) 28 (58) 19 (70) p=0.33
Received bystander CPR, n (%) 24 (50) 17 (63) p=0.34
First cardiac rhythm VF/VT, n (%) 23 (48) 23 (85) p=0.002*
First cardiac rhythm PEA, n (%) 5(10) 1(4) p=0.66
First cardiac rhythm asystole, n(%) 20 (42) 1(4) p=0003*
Time in minutes to arrival of first ambulance crew,
' median {/QR}
Time in minutes from call to ROSC,
median (IQR)











Transferred from ED for immediate PCI, n(%) 7(15) 5(19) p=0.74
Transferred from ED for radiological imaging prior to
ICU admission, n(%) 11 (23) 8(30) p=0.58
Transferred from ED direct to ICU, n(%) 30 (63) 14 (52) p=0.47
Temperature data and cooling data
Oesophageal temperature on arrival in ED,
mean (SD) 34.5(1.3) 35.0(1.3) p=0.20
Oesophageal temperature on arrival in ICU,
mean (SD) 34.5(1.2) 35.6(1.3) p=0.0003*
Time in minutes from ROSC to ICU commencement
of cooling, median (IQR) 173(130-216) 140 (88-192) p=0.96
Time in minutes from ROSC to target therapeutic
temperature, median (IQR) 222 (141-303) 313 (220-406) p=0.028*
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5.12 Early in-hospital physiology following OHCA
Aside from the significant difference in Tocs on arrival in the ICU between survivors and
non-survivors several other physiological differences were observed, as shown in Table 5.5.
On admission to ICU, serum hydrogen concentration was significantly lower in survivors
compare to non-survivors (47.4 vs. 78.4 nmol/L, p=0.001) and serum lactate concentration
was lower in survivors (1.6 vs. 5.3 mmol/L, p=0.003). Less adrenaline was given as a
resuscitation drug during the pre-hospital and ED phases of care in survivors compared to
non-survivors (1.4mg vs. 3. lmg, p=0.04)








Mean arterial pressure, mean ± SD 83 (25) 88(17.7) p=0.47
Serum hydrogen concentration (nmol/L), mean± SD 98.1(38) 84.0(39.7) p=0.15
Serum lactate (mmol/L), meant SD 10.1(3.7) 8.5(4.4) p=0.11
Total adrenaline (mg) used during initial
resuscitation, mean ± SD 3.1(3.1) 1.4(3.4) p=0.04
Intensive Care Unit
Mean arterial pressure, mean ± SD 85 (17) 90 (14) p=0.90
Number of patients requiring intropic support at ICU
admission (%) 20 (42%) 6 (22%) p=0.15
Serum hydrogen concentration (nmol/L), meant SD 78.4(32.3) 47.4(6.1) p=0.001
Serum lactate (mmol/L), meant SD 5.3(3.9) 1.6(0.7) p=0.003
5.13 Summary - oesophageal temperature post OHCA
Following OHCA in Edinburgh, all patients have oesophageal temperatures below
normothermia in the pre-hospital phase and on arrival in the Emergency Department.
Patients who achieve ROSC following OHCA and survive to hospital discharge are warmer
on arrival in ICU and take longer to reach target MTH temperatures compared to patients
who die in hospital.
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Chapter 6
Results - Systemic Inflammation & neutrophil activity
post-OHCA
6.1 Markers of systemic inflammation data
Blood samples were taken and analysed for serum inflammatory markers on a total of 14
patients pre-hospital, 76 patients in the ED, 54 patients at 24-hours post-OHCA, 41 patients
at 48-hours post-OHCA, 32 patients at 72-hours post-OHCA and 18 patients 5-days post-
OHCA.
The overall collection of blood samples for serum inflammatory marker analysis is shown in
Figure 6.1.




13 patients who survived to hospital discharge did not have a complete set of blood samples
for serum inflammatory marker assay. This was predominantly from the day-5 sample not
being taken. 21 of the 27 patients who survived to hospital discharge had a complete set of
blood samples apart from the day-5 time point.
Five samples showed an error during laboratory assay and were excluded from subsequent
analysis.
Due to limited assay kit availability, 50 patients who had blood samples taken in the ED but
had never achieved ROSC did not have these samples assayed. The objective was to look for
any pattern in markers of inflammation post-OHCA and we felt analysis of 93 patients who
never achieved ROSC would be sufficient in pilot form.
6.3 lnterleukin-ip
Interleukin-ip did not appear to be significantly raised in post-OHCA patients as compared
to healthy volunteers. The progression of interleukin-lp for all patients post-OHCA is shown
in Figure 6.2. There did not appear to be any significant difference in IL-1(3 levels between
survivors and non-survivors in patients who achieved ROSC, as shown in Figure 6.3.
Figure 6.2 lnterleukin-ip post-OHCA - all patients
PH= pre-hospital; ED= Emergency Department; 24=24 hours post-OHCA; 5D= 5 days post-
OHCA; HV= healthy volunteers. Horizontal line depicts sample mean.
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Figure 6.3 lnterleukin-10 post-OHCA in patients who achieved ROSC
PH= pre-hospital; ED= Emergency Department; 24=24 hours post-OHCA; 5D= 5 days post-





IL-6 was not significantly raised in the pre-hospital phase following OHCA but rose from
ED admission and peaked at 48 hours following ROSC. The progression IL-6 for all patients
post-OHCA is shown in Figure 6.4. Non-survivors showed a non-significant trend towards
higher IL-6 levels at all time points, as shown in Figure 6.5. The area under the ROC curve
for IL-6 to predict in-hospital death for patients who achieved ROSC was 0.757 (95% CI
0.59-0.92).
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Figure 6.4 IL-6 post-OHCA
PH= pre-hospital; ED= Emergency Department; 24-24 hours post-OHCA; 5D= 5 days post-
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Figure 6.5. IL-6 in patients who achieved ROSC following OHCA
Green/S=survived to hospital discharge; Red/NS=non-survivor, died in ICU; PH=pre-
hospital; ED=Emergency Department; 24=24-hours post-ROSC; 5D=5-days post-ROSC.
Error bars- standard error of the mean.
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IL-8 appeared to be significantly raised in patients following OHCA. Increased serum IL-8
was detectable in the pre-hospital and ED phases, with IL-8 reaching peak levels at 24-hours
post-ROSC. The progression of IL-8 for all patients post-OHCA is shown in Figure 6.6. IL-8
levels were significantly higher in non-survivors on arrival at 24-hours (627.2 vs 196.7pg/ml,
p=0.02) and 48-hours (555.1 vs 151.1 p=0.05) post-ROSC. There was a trend towards high
levels of IL-8 measured in the ED in non-survivors compared to survivors (347.1 vs 86.0
pg/ml, p=0.17). IL-8 appeared to return to normal baseline levels at 5 days in survivors but
remained significantly elevated in non-survivors at 5-days (625.1 vs 66.8 pg/ml, p=0.04), as
shown in Figure 6.7.
2 patients showed significantly higher levels of IL-8, accounting for the 5 highest points in
Figure 6.6. The first patient had an OHCA of primary cardiac origin and the second patient
suffered a respiratory arrest from chronic obstructive pulmonary disease, without preceding
infective symptoms. There were no major differences between these patients and the rest of
the study cohort.
Figure 6.6 lnterleukin-8 post-OHCA
PH= pre-hospital; ED- Emergency Department; 24=24 hours post-OHCA; 5D= 5 days post-




Figure 6.7. lnterleukin-8 in patients who achieved ROSC following OHCA
Green/S=survived to hospital discharge; Red/NS=non-survivor, died in ICU; PH=pre-
hospital; ED=Emergency Department; 24=24-hours post-ROSC; 5D=5-days post-ROSC.
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6.6 lnterleukin-10
IL-10 was significantly raised in all patients post-OHCA and remained consistently elevated
in the 5-days following ROSC. The progression of IL-10 for all patients post-OHCA is
shown in Figure 6.8. At the ED time point, no significant difference was observed in the
levels of IL-10 in survivors and non-survivors (27.8 vs 32.1 pg/ml, p=0.84). Non-survivors
had higher levels of IL-10 at 24-hours (70.5 vs 14.2 pg/ml, p=0.01) and 48-hours (63.1 vs
22.2 pg/ml, p=0.05) post-ROSC with a trend towards higher levels at 72-hours and 5-days
post-ROSC, as shown in Figure 6.9.
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Figure 6.8 lnterleukin-10 post-OHCA
PH= pre-hospital; ED= Emergency Department; 24=24 hours post-OHCA; 5D= 5 days post-
OHCA; HV= healthy volunteers. Horizontal line depicts sample mean.
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Figure 6.9. IL-10 in patients who achieved ROSC following OHCA
Green/S=survived to hospital discharge; Red/NS=non-survivor, died in ICU; PH=pre-
hospital; ED=Emergency Department; 24=24-hours post-ROSC; 5D=5-days post-ROSC.




IL-12 levels were mildly elevated from baseline in patients following OHCA, with a peak at
72-hours post-ROSC. The progression of interleukin-10 for all patients post-OHCA is shown
in Figure 6.10. No significant differences in IL-12 level were observed between survivors
and non-survivors, as shown in Figure 6.11.
One patient, who suffered a respiratory and subsequent cardiac arrest following an asthma
attack, accounted for the 3 highest IL-12 values, measured in the ED and at 24- and 48-hours
post-ROSC.
Figure 6.10 IL-12 post-OHCA
PH= pre-hospital; ED= Emergency Department; 24-24 hours post-OHCA; 5D= 5 days post-
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Figure 6.11. lnterleukin-12 in patients who achieved ROSC following OHCA
Green/S=survived to hospital discharge; Red/NS=non-survivor, died in ICU; PH=pre-
hospital; ED=Emergency Department; 24=24-hours post-ROSC; 5D=5-days post-ROSC.
Error bars= standard error of the mean. When the single patient with disproportionately high
IL-12 at 72-hours was removed from analysis, no significant difference was observed
between survivors and non-survivors.
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6.8 Tumour necrosis factor-alpha
Serum levels of TNF-a were mildly raised from ED admission in patients following OHCA.
although levels were not significantly higher than healtin volunteers. The progression of
TNF-a for all patients post-OHCA is shown in Figure 6.12. There did not appear to be any
significant differences in levels of TNF-a between survivors and non-survivors, as shown in
Figure 6.13.
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Figure 6.12 TNF-a post-OHCA
PH= pre-hospital; ED= Emergency Department; 24-24 hours post-OHCA; 5D= 5 days post-
OHCA; HV= healthy volunteers. Horizontal line depicts sample mean.
Figure 6.13. TNF-a in patients who achieved ROSC following OHCA
Green/S=survived to hospital discharge; Red/NS=non-survivor, died in ICU; PH=pre-
hospital; ED=Emergency Department; 24=24-hours post-ROSC; 5D=5-days post-ROSC.




6.9 Markers of neutrophil activation
7 patients, all of whom achieved ROSC, had blood samples taken and processed immediately
for cell surface markers on polymorphonuclear leucocytes, indicating neutrophil activation,
81
including 4 patients with pre-hospital blood sampling. The results of neutrophil activation
markers are shown in Figures 6.14-6.17.
Figure 6.14. CD11b neutrophil expression post-OHCA
PH= pre-hospital; ED= Emergency Department; 24h=24 hours post-OHCA; 5D=5 days
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Figure 6.15. CD62L neutrophil expression post-OHCA
PH= pre-hospital; ED= Emergency Department; 24h=24 hours post-OHCA; 5D=5 days






Figure 6.16. CD64 neutrophil expression post-OHCA
PH= pre-hospital; ED- Emergency Department; 24h=24 hours post-OHCA; 5D=5 days post-





















Figure 6.17. CD88 neutrophil expression post-OHCA
PH- pre-hospital; ED= Emergency Department; 24h=24 hours post-OHCA; 5D=5 days post-
OHCA; HV= healthy volunteers. MCF- mean cell fluorescence. Horizontal line depicts
sample mean.
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6.10 Human neutrophil elastase
Serum human neutrophil elastase (HNE) was assayed in all patients who had VF as the
presenting cardiac rhythm and who achieved ROSC (n=56). When compared to healthy
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volunteers, HNE was raised in all patients and was detectable during CPR and in the
immediate post-ROSC period, remaining elevated in the days following ROSC. This is
shown in Figure 6. IB.
Figure 6.18. Human neutrophil elastase post-OHCA - all patients
PH= pre-hospital; ED= Emergency Department; 24h=24 hours post-OHCA;HV= healthy




Overall, there did not appear to be a significant difference in levels of HNE between
survivors and non-survivors. A small difference was observed in the pre-hospital samples,
with a trend towards higher levels of HNE in tire survivors group, although it should be
remembered that only a small number of pre-hospital samples were collected for HNE assay
(n=I3). HNE levels in survivors and non-survivors are shown in Figure 6.19.
Figure 6.19. Human neutrophil elastase in survivors and non-survivors of VF-
OHCA
Green/S=survived to hospital discharge; Red/NS=non-survivor, died in ICU; PH~pre-
hospital; ED=Emergency Department; 24=24-hours post-ROSC; 5D=5-days post-ROSC.
Error bars= standard error of the mean.
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6.11 Markers of systemic inflammation and cardiovascular indices
Spearman and Pearson correlations were performed between markers of systemic
inflammation and cardiovascular indices. There did not appear to be any significant
correlation between markers of systemic inflammation and core body temperature,
downtime, serum lactate or serum hydrogen ion concentration.
6.12 Summary of inflammation post-OHCA
Inflammatory cytokinaemia and presence of surface markers of neutrophil activation indicate
systemic inflammation is occurring at a very early stage post-OHCA. The inflammatory
response persists for several days following OHCA.
Different elements of the inflammatory response occur at different time points following
OHCA. Significantly high levels of IL-6 and IL-8 are detectable in the early post-ROSC
phase, IL-10 peaks at 24-48 hours post-ROSC and 1L-12 peaks at 72-hours post-ROSC.
There appear to be significant differences in the levels of IL-6, IL-8, IL-10 and IL-12
between OHCA patients who achieved ROSC and survived to hospital discharge and those
who achieved ROSC died in ICU.
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Chapter 7
Results - Brain Injury Markers post-OHCA
7.1 Markers of brain injury samples
Blood samples were taken for analysis of brain injury markers (SI 00b, NSE) on a total of 21
patients pre-hospital, 153 patients in the ED, 56 patients at 24-hours post-OHCA, 42 patients
at 48-hours post-OHCA, 31 patients at 72-hours post-OHCA and 21 patients 5-days post-
OHCA.
Additional separate funding was obtained to perform a limited number of GFAP assays.
GFAP was measured in 38 patients with VF as the initial presenting rhythm who then
achieved ROSC. The overall collection of blood samples for NSE and SI00b analysis is
shown in Figure 7.1.
Figure 7.1 Markers of brain injury samples






OHCA transported to ED, n= 223
Brain injury samples, n= 76
Admitted to ICU for cooling, n=75
Alive at 24 hours post-OHCA.
Brain injury samples, n= 56
Alive at 48 hours post-OHCA
Brain injury samples, n= 42
Alive at 72 hours post-OHCA
Brain injury samples, n= 31
Alive at 5 days post-OHCA
Brain injury samples, n= 21
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21 of the 27 patients who survived to hospital discharge had a complete set of blood samples
apart from the day-5 time point. 13 patients who survived to hospital discharge did not have
a complete set of blood samples for serum markers of brain injury assay. This was
predominantly from the day-5 sample not being taken.
8 samples did not assay correctly on the automated Liaison analyser and were excluded from
subsequent analysis.
7.3 Neuron-specific enolase
NSE was detectable in all patients post-OHCA. Mean serum NSE appeared to reach
maximal levels at 48-hours post OHCA. The progression of NSE post-OHCA for all patients
is shown in Figure 7.2.
Figure 7.2 Neuron-specific enolase post-OHCA for all patients
PH= pre-hospital; ED= Emergency Department; 24=24 hours post-OHCA; 5D= 5 days post-OHCA;


















7.4 Neuron-specific enolase post-OHCA in survivors versus non-
survivors
Post-OHCA patients who survived to hospital discharge had decreasing levels of NSE over
the first 72-hours post-ROSC compared to patients who achieved ROSC but died in ICU, as
shown in Figure 7.3
Figure 7.3. Serum neuron-specific enolase in patients who achieved ROSC
following QHCA
Time of sample
In patients who achieved ROSC, there did not appear to be significant differences between
survivors and non-survivors in the levels of NSE during the pre-hospital or ED phase, as
shown in Figure 7.4. At 24-hours post-ROSC there appeared to be a significant difference in
the serum level of NSE between survivors and non-survivors (21.1 vs 40.4 mcg/L,
p=0.0005). This difference became more marked at 48-hours post-ROSC. At 5-days post-
ROSC there was no difference in NSE levels between survivors and non-survivors.
n
Figure 7.4. Serum neuron-specific enolase in patients who achieved ROSC
following QHCA.
Green S=survived to hospital discharge; Red NS=non-sitrvivor, died in ICU; PH=pre-
hospital; ED=Emergency Department; 24=24-hours post-ROSC; 5D 5-days post-ROSC.





7.5 Neuron specific enolase as a predictive marker of outcome
following OHCA
In order to determine the value ofNSE as a predictive marker between those who die in ICU
and those who survive to discharge ROC curves have been produced and are presented in
Figure 7.5, along with a table summarising the area under curve (AUC). The absolute cut¬
off value to predict mortality with 100% accuracy was 90 pg/L on arrival in the ED and 43.3
pg/L 24-hours post-ROSC.
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Figure 7.5. Receiver operator characteristic curves and area-under-curve for
NSE as a predictor of in-hospital mortality in patients who achieve ROSC
following OHCA

















Lower Bound Upper Bound
ED arrival .581 .074 .279 .436 .726
24 hours .787 .060 .000 .668 .905
48 hours .742 .086 .012 .574 .910
72 hours .750 .104 .040 .546 .954
a Under the nonparametric assumption, b Null hypothesis: true area = 0.5
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7.6 S100b post-OHCA
Serum levels of SI00b post-OHCA appeared to be raised in the immediate period following
OHCA. The progression of SI 00b post-OHCA for all patients is shown in Figure 7.6.
Figure 7.6 S100b post-OHCA for all patients
PH= pre-hospital; ED=Emergency Department; 24=24 hours post-OHCA; 5D= 5 days post-OHCA;
Horizontal line depicts sample mean.
30 n
7.7 S100b post-OHCA in survivors versus non-survivors
Post-OHCA patients who survived to hospital discharge had decreasing levels of SI 00b over
the first 72-hours post-ROSC compared to patients who achieved ROSC but died in 1CU, as
shown in Figure 7.7
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There appeared to be a more marked difference in SI00b levels between survivors and non-
survivors. as shown in Figure 7.8. Whilst there was no significant difference during the pre¬
hospital phase, on arrival in the ED survivors had significantly lower levels of serum SI00
when compared to non-survivors (3.3 vs 6.2 mcg/L, p=0.009). This difference persisted at all
sampling points. The serum level of SI00b in non-survivors decreased from 24-hours to 5-
days following ROSC.
Figure 7.8. Serum S100b in patients who achieved ROSC following OHCA
Green S=survived to hospital discharge; Red NS=non-snrvivor, died in ICU; PH=pre-
hospital; El) - Emergency Department; 24=24-hours post-ROSC; 5D=5-davs post-ROSC.














7.8 S100b on arrival in the ED as a predictive marker of outcome
following OHCA
In order to determine if there is a cut-off point where we can distinguish between those who
die in ICU and those who survive to discharge ROC curves have been produced and are
presented in Figure 7.9 here along with a table summarising the area under curve (AUC).
The absolute cut-off value to predict mortality with 100% accuracy was 15.4 ug/'L on arrival
in the ED and 0.96 pg/L 24-hours post-ROSC.
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Figure 7.9. Receiver operator characteristic curves and area-under-curve for
S100b as a predictor of in-hospital mortality in patients who achieve ROSC
following OHCA
ED arrival 24 hours
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Lower Bound Upper Bound
ED arrival .725 .066 .002 .595 .855
24 hours .902 .041 .000 .822 .982
48 hours .883 .061 .000 .763 1.003
72 hours .857 .071 .002 .717 .997
a Under the nonparametric assumption b Null hypothesis: true area = 0.5
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7.9 Glial Fibrillary Acidic Protein post-OHCA
Only a limited number of GFAP assays were available. GFAP was measured in a total of 38
patients. Only time points up to and including 48-hours were measured.
The results of the GFAP assay for all patients are shown in Figure 7.10. Most of the results
are below the limit of detection of the Biovendor ELISA assay (0.045 ng/ml).
Figure 7.10 GFAP post-OHCA for all patients (n=38)
PH= pre-hospital; ED=Emergency Department; 24=24 hours post-OHCA; 5D= 5 days post-OHCA;










Non-survivors appeared to have detectable levels of GFAP at 24- and 48-hours post-ROSC,
compared to survivors who had levels of GFAP below the limit of detection at all time
points. This is shown in Figure 7.11.
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Figure 7.11. Serum GFAP in patients who achieved ROSC following OHCA
with VF as the initial rhythm
Green S=survived to hospital discharge; RedNS=non-survivor, died in ICU; I'M pre¬











7.10 GFAP as a prognostic marker following OHCA
In this select group of patients, GFAP was poor at predicting in-hospital mortality in patients
who survived to ICU-admission. The AUC-ROC was 0.65 (95% CI 0.44-0.86).
7.11 Summary of brain injury markers post-OHCA
NSE, S-lOOb and GFAP were all raised in patients post-OHCA. Non-survivors showed
significantly raised levels S-100 from the ED and NSE from 24-hours compared with
survivors. S-lOOb measured at 24-hours post-ROSC is better than GFAP or NSE at 24-hours,
or any time point, at predicting in-hospital mortality.
Given the limitations of our sampling points, brain injury markers appear to peak at different
times. S-lOOb peaks within hours of ROSC, whereas NSE peaks, predominantly in non-
survivors, several days post-ROSC. Virtually all patients showed decreasing absolute values




Results - Prognostication following OHCA
8.1 Prognostication on arrival in the ED
Prognostication is important following OHCA to allow rationalisation of on-going treatment,
aid decisions regarding admission to ICU, select patients for novel therapies and more
accurately inform relatives. We chose to evaluate S100, NSE and cytokines as predictive
markers of survival to discharge following OHCA. We took samples on arrival to the ED
and every 24 hours thereafter as these are the routine times for blood sampling in clinical
practice. We evaluated the efficacy of S100, NSE and cytokines as predictive markers using
ROC curves. Figure 8.1 shows the ROC curve to predict in-hospital mortality for both brain
injury markers and markers of systemic inflammation on arrival at the ED. SI 00 and IL-6
have the highest area under the ROC curve, as shown in Table 8.1, although no single
marker predicts in-hospital mortality with sufficient accuracy for clinical use. NB: GFAP
assays were performed after the prognostic modelling was undertaken and are therefore not
included in this chapter.
Figure 8.1 - ROC curve for predicting in-hospital mortality following OHCA on
arrival in the ED
ROC curve predicting in-hospital mortality in OHCA patients who achieved ROSC pre¬
hospital. Markers of brain injury (NSE, S100) and markers of systemic inflammation (ILip,
IL-6, IL-8, IL-10, IL-12, TNF-a) are presented at time point B (arrival in the Emergency
Department).
ROC Curve
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Diagonal segments are produced by ties.
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Table 8.1 AUC-ROC - arrival in ED
Area under the ROC curve for markers of brain injury and markers of systemic inflammation
on arrival in the ED.







Lower Bound Upper Bound
NSE (B) .506 .097 .953 .315 .696
S100 (B) .850 .066 .000 .720 .980
IL-12 (B) .578 .094 .413 .394 .762
TNF-A (B) .574 .095 .438 .387 .760
IL-10 (B) .474 .096 .781 .286 .661
IL-6 (B) .757 .084 .007 .592 .921
IL-1B (B) .671 .090 .072 .494 .848
IL-8 (B) .599 .094 .299 .414 .783
a Under the nonparametric assumption
b Null hypothesis: true area = 0.5
8.2 Prognostication 24-hours post-ROSC
Figure 8.2 shows the ROC curve to predict in-hospital mortality for both brain injury
markers and markers of systemic inflammation at 24-hours post-ROSC. SI 00 has the highest
area under the ROC curve, as shown in Table 8.2.
Figure 8.2 ROC curve for predicting in-hospital mortality following OHCA at
24-hours post-ROSC
ROC curve predicting in-hospital mortality in OHCA patients who achieved ROSC pre¬
hospital. Markers of brain injury (NSE, S100) and markers of systemic inflammation (IL1(3,
IL-6, IL-8, IL-10, IL-12, TNF-a) are presented at time point C (24-hours post-ROSC).










Diagonal segments are produced by ties.
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Table 8.2 Area under the ROC curve for markers of brain injury and
markers of systemic inflammation at 24-hours post-ROSC.







Lower Bound Upper Bound
NSE (C) .782 .062 .001 .660 .904
S100 (C) .901 .041 .000 .820 .982
IL-12 (C) .592 .080 .257 .435 .750
TNF-A (C) .442 .085 .478 .276 .609
IL-10 (C) .736 .070 .004 .599 .873
IL-6 (C) .537 .081 .652 .379 .695
IL-1B (C) .531 .082 .699 .370 .693
IL-8 (C) .735 .069 .004 .599 .870
a Under the nonparametric assumption
b Null hypothesis: true area = 0.5
8.3 Prognostic modelling
In order to perform logistic regression, the serum markers were log transformed and the
results from the univariate analysis used [chi-squared tests for categorical data and two-
sample t-test for continuous data] and included those variables which were statistically
significant and those who were close [p<0.1]. Table 8.3 shows the results of the univariate
analysis.
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Table 8.3. Univariate analysis of factors predicting in-hospital mortality for










Sex - Male 28 (60%) 20 (73%) 0.249
Bystander CPR 24 (51%) 17 (63%) 0.32
Rhythm - VF/VT 22 (47%) 25 (92%) <0.001
34.53 34.97
Core temp ED (1.34) (1.34) -0.45 (-1.34, 0.25) 0.201
Age 60.7 (18.8) 59.5 (12.3) 1.2 (-6.40, 8.81) 0.753
Downtime (mins) 33.5 (17.2) 18.1 (14.7) 15.5 (6.60, 24.38) 0.001
Log (NSE) 3.4 (0.5) 3.2 (0.5) 0.12 (-0.15, 0.38) 0.384
log (S100) 1.5 (1.0) 0.5 (1.4) 1.05 (0.41, 1.69) 0.002
log (IL12) 1.9 (0.9) 2.0 (0.7) -0.13 (-0.69, 0.44) 0.654
log (TNFa) 1.4 (0.4) 1.6 (0.9) -0.24 (-0.82, 0.33) 0.379
log (IL10) 2.2 (1.3) 2.2 (1.4) 0.02 (-0.73, 0.78) 0.949
log (IL6) 4.0 (1.7) 2.9 (1.3) 1.12 (0.31, 1.93) 0.008
log (IL113) 1.2 (0.9) 1.1 (0.8) 0.12 (-0.41, 0.64) 0.654
log (IL8) 4.3 (1.5) 3.7 (0.9) 0.6 (-0.07, 1.28) 0.079
Using only the results available at the time of arrival in the ED the initial model contained
log(SlOO), log(IL8), log (IL6), down time (in minutes) and rhythm (VF/VT versus the rest).
After removing a single variable and re-running the model and repeating this until the only
variables remaining were statistically significant a predictive model was developed From
the patients admitted to ICU, as downtime increases and also log (SI00) so did the odds of
death in ICU [odds ratio (95% CI), 1.06 (1.01, 1.12), 3.43 (1.50, 7.82) per unit increase in
downtime and log(S100) respectively].
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Chapter 9
Results - Pre-hospital Resuscitation
9.1 Pre-hospital OHCA calls
Survival from OHCA is dependent on prompt intervention by pre-hospital emergency
medical services (Atwood, 2005). In Scotland, this role is performed by the Scottish
Ambulance Service (SAS). The SAS aims to be on-scene within 8 minutes of receiving a
possible OHCA-call. The quality of resuscitation delivered by ambulance crews will
influence survival. Transthoracic impedance (TTI) measurement is a useful tool in the
assessment of the quality of pre-hospital resuscitation by ambulance crews (Olasveengen,
2007; Steelier, 2008c). The TTI signal is already recorded through the pads of the
defibrillator used by the SAS (LIFEPAK 12) without the need for any further equipment to
be placed on the patient. Both chest compressions and ventilations result in identifiable
changes in the TTI trace. Analysing the trace using proprietary software (Codestat, Physio
Control) allows a variety of resuscitation metrics including the hands-on-the chest time,
compression rate and time-to-shock intervals to be accurately measured.
During the study period the Scottish Ambulance Service responded to 414 cardiac arrest
calls within the study region.
The research doctor (RL) was called by the Emergency Medical Dispatch Centre (EMDC)
180 times. Details of the time of call and initial triage code is shown in Appendix X - "Log
of calls to TOPCAT from EMDC". On 40 occasions RL was stood down en-route to-scene
or the call was not appropriate to attend. RL attended the scene on 140 occasions. Full
resuscitation was attempted in 47 cases.
9.2 Clinical interventions performed by the research doctor
The primary aim of the doctor being on-scene was to collect temperature data and blood
samples. However, clinical care of the patient was the first priority. The research doctor gave
advice regarding resuscitation technique or decisions to move the patient in 25 (44%) cases
where resuscitation was attempted. The commonest directions to ambulance crew were to
increase the proportion of time performing chest compressions, decrease compression rate
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and use the defibrillator in manual mode to reduce the interval to deliver a shock. In 10 cases
the ambulance crew wanted to extricate the patient before ROSC was achieved. Advice was
given to continue resuscitation at-scene and ROSC was achieved in 7 of these cases.
In 16 cases the attending ambulance crew requested the doctor to intubate the patient and in
40 attempted-resuscitation cases the doctor was requested to gain intravenous access.
9.3 Quality of cardiopulmonary resuscitation performed by ambulance
crews
The quality of pre-hospital cardiopulmonary resuscitation performed by ambulance crews, as
witnessed by the research doctor, was found to be variable. Clinical interventions not
previously shown to improve outcome from OHCA (endotracheal intubation, intravenous
cannulation and resuscitation drug administration) were frequently performed by ambulance
crews in preference to performing good quality cardiopulmonary resuscitation. The quality
of pre-hospital CPR was measured in several cases by downloading the trans-thoracic
impedance trace from the Lifepak 12 defibrillator and using proprietary software (Codestat,
Physio Control) to analyse CPR.
Having a doctor on-scene influenced the ambulance crews' CPR performance in several
cases. Figure 9.1 shows a report generated by Codestat software demonstrating the effect of
a having a doctor on-scene of a particular cardiac arrest case (Patient number 179).
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Figure 9.1 Effect of having a doctor on-scene at the OHCA (witnessed
collapse, 72 year old male in ventricular fibrillation)
Vertical numbers represent report time line (in minutes) from placing of defibrillator pads on
patient. Each red line represents a single chest compression. A red triangle shows a DC
shock. The compression rate of each minute and compression rate of each minute are
shown.
The ambulance crew arrive and place defibrillator pads on the patient at Minute=0. Few
chest compressions are performed in the first 3 minutes of resuscitation. The defibrillator is
used in semi-automatic advisory mode to deliver a shock with a prolonged off-the-chest
interval (>2 minutes). The research doctor arrives on scene at minute 5 and gives the
attending ambulance crew advice on resuscitation technique. Subsequent to minute 5, the
compression ratio increases, the compression rate decreases and the time off the chest to
deliver a shock is markedly reduced.
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84 - 55 - 123 57 -
100 - 100 - 126 125 -
100 - 100 - 129 129 -
100 - 39 - 129 113 -
85 - 72 - 125 87 -
100 - 100 - 116 114 -
100 - 100 - 108 109 -
100 - 100 - 116 115 -
100 - 94 - 115 107 -
9.4 Acceptance of a doctor on-scene of OHCA
After a resuscitation attempt at which the research doctor was on-scene, 60 ambulance
members were sent an email inviting them to complete an online questionnaire. 47 (78%)
responses were received. The full survey results are shown in Appendix VI - "Ambulance
crew perceptions of a pre-hospital doctor at the scene of out-of-hospital cardiac arrest".
All (100%) of ambulance crews felt the doctor had integrated well with the pre-hospital
team.
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9.5 The effect of a pre-hospital doctor on ambulance crew performance
42 (89%) ambulance staff felt reassured by the doctor's presence. 16 (34%) ambulance staff
felt their own clinical performance improved after the doctor arrived on-scene. 2 (4%)
ambulance staff felt the doctor hindered their usual clinical work. 44 (94%) ambulance staff
felt the doctor gave them useful feedback during or after the resuscitation attempt.
Several of the surveyed ambulance crews made comments on the value of having a pre¬
hospital doctor on-scene for education, performing clinical interventions and decision
making - as shown in Appendix VI.
9.6 Outcome
The research doctor was on-scene for 47 OHCA cases where full resuscitation was
attempted. ROSC was achieved in 24 (51%) of cases compared to when the research doctor
was not present 87 of 189 (46%) achieved ROSC (p=0.62).
There was a trend towards higher survival to discharge when the research doctor was present
(8/47 (17%) vs. 19/189 (10.0%), p=0.20).
9.7 Summary - Pre-hospital doctor at OHCA-scene
The quality of pre-hospital resuscitation performed by ambulance crews was found to be
variable. The pre-hospital doctor frequently intervened during resuscitation to perform
clinical and non-clinical intervention. A pre-hospital doctor on-scene of an OHCA is




10.1 Core body temperature following OHCA - study findings
In this study we found that oesophageal temperature follows a predictable pattern in the first
few minutes and hours after OHCA. Patients cooled quickly in the pre-hospital phase and
remained cool in transit to the ED. Thereafter, patients destined to survive to discharge
appeared to re-warm faster before cooling was commenced and took longer to reach target
temperature. Patients maintained oesophageal temperature close to the target range for MTH
throughout the pre-hospital phase without specific intervention to lower temperature.
Possible explanations for this finding are given below.
Several studies have previously noted episodes of hyperthermia occurring in patients
following cardiac arrest (Kamarainen, 2009; Uray, 2008) but our study reports a correlation
between early changes in oesophageal temperature within the normothermic range and
patient survival. The reason for this observation remains uncertain. In line with previous
studies (Kamarainen, 2008a; Uray, 2008), we noted a significant difference in the time
between collapse and ROSC between survivors and non-survivors. Longer collapse-ROSC
times are likely to be associated with greater neurological injury and impairment of central
mechanisms of body temperature control.
10.2 Core body temperature post-OHCA - comparison to published
literature
Our study has demonstrated that patients remain cool (Mean=33.7°C, 95% CI 32.8-34.5) in
the pre-hospital phase of OHCA. Transfer-to-hospital times in the City of Edinburgh are
generally short (<15 minutes) with total pre-hospital time usually <60 minutes. Patients post-
OHCA may have little time to re-warm during the pre-hospital phase.
Animal evidence has shown that a delay in initiating cooling negates the beneficial effect of
MTH after cardiac arrest (Carroll, 1992; Coimbra, 1994; Kuboyama, 1993), yet there is
currently limited human evidence to support immediate cooling. For early MTH to be
achieved in human cardiac arrest, cooling would need to begin in the pre-hospital phase. To
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date, no human trials have shown pre-hospital cooling per se improves survival from OHCA
(Kamarainen, 2009; Kim, 2009), although pre-hospital intra-nasal cooling has recently been
shown to be safe and effective at inducing hypothermia (Castren, 2010) and further clinical
trials are on-going.
Despite the paucity of clinical evidence demonstrating benefit (Kamarainen, 2009; Kim,
2007), some ambulance services have adopted methods of initiating hypothermia in the pre¬
hospital phase (Suffoletto, 2008). Cooling at the scene or during transport requires additional
equipment, resources and monitoring and may distract from the basic practice of maintaining
a patent airway, ventilation and adequate circulation. Further research is currently underway
to establish whether pre-hospital cooling really confers additional benefit. A recently
published study from Australia failed to demonstrate survival benefit by cooling pre-hospital
with cold saline (Bernard, 2010), although intra-arrest evaporative nasal cooling looks
promising in the pre-hospital setting (Band, 2008; Castren, 2010).
10.3 Core body temperature post-OHCA - possible mechansims
The reason for OHCA survivors re-warming quickly post-ROSC and being more difficult to
cool remains uncertain. Patients who survive to hospital discharge may have better cardiac
function following ROSC and less hypothalamic damage, leading to a higher oesophageal
temperature as a function of greater cardiac output and intact thermoregulation. Several
(n=28) non-survivors had severe neurological injury as their eventual cause of death and all
remained hypothermic after ROSC. Animals studies have shown that ischaemic brain injury
can result in hypothalamic damage and body temperature lability (He, 1999).
The temperature gradient between the brain and the rest of the body may be important.
Measuring absolute brain temperature is technically difficult (Axelrod, 2006). Whilst we
measured oesophageal temperature, known to be an accurate measurement of central blood
temperature (Shiraki, 1986), the absolute brain temperature may be different. Further
research is warranted, possibly using high-resolution neuro-imaging, to quantity the
relationship between absolute brain and body temperature, especially during cooling.
Body temperature lability - episodes of both hyperpyrexia and spontaneous hypothermia -
have recently been shown to be adversely linked to outcome in patients following in-hospital
cardiac arrest (Suffoletto, 2009). The mechanism for this is unknown though there are
similarities to the temperature dysregulation found in severe sepsis (Adrie, 2004). In sepsis,
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development of spontaneous hypothermia is associated with greater neurological injury
(Clemmer, 1992) although animal work suggests that controlled MTH may improve
outcomes (Taniguchi, 2003).
10.4 Core body temperature monitoring - study limitations
This study should be interpreted in the context of certain limitations. Whilst we observed
several statistically significant results, data was collected from a relatively small number of
patients in a single centre. We did, however, achieve a high degree of data capture on all
patients enrolled in the study. Body temperature was recorded using oesophageal probes with
instructions given to insert the probe to I5cm from the nostril. It could be argued that,
placing these probes in the field or in the ED may have resulted in probes not being inserted
to adequate length and sitting in the posterior nasopharynx. This may have altered
temperature recordings slightly, however there was strong pre-hospital agreement in
temperature in all patients. The oesophagus is an accurate site to measure body temperature,
second only to the pulmonary artery, and is more robust than other techniques commonly
used in our setting (e.g. tympanic membrane temperature using an infrared probe) (Axelrod,
2006; Craig, 2002). Oesophageal temperature monitoring is also the most practical means of
accurately measuring body temperature during the pre-hospital phase of patient care.
10.5 Therapeutic hypothermia - future research
Several questions regarding the use of MTH remain unanswered (Nolan, 2008). The
optimum time, or time window, following OHCA when cooling should commence remains
under investigation. Recent studies have explored the possibility of initiating cooling during
CPR (Castren, 2010), with initial results being promising. The optimal timing for initiating
MTH after OHCA is unclear. There is limited animal evidence suggesting that early
initiation of cooling is beneficial (Kuboyama, 1993; Sterz, 1991; Zhao, 2008). There is no
direct human clinical evidence to support the immediate initiation of cooling, although
retrospective analysis has indicated a possible benefit to patients cooled shortly after ROSC
(Wolff, 2009). Several studies have examined the possibility of pre-hospital cooling
(Kamarainen, 2008a; Kamarainen, 2008b) but prospective randomised clinical trials have, so
far, failed to demonstrate any survival benefit (Kamarainen, 2009; Kim, 2007). Further
human clinical studies are required to establish whether such early cooling confers outcome
benefit.
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The optimum therapeutic target temperature has yet to be established. The TOPCAT study
has demonstrated patients re-warm post-ROSC, possibly due to restoration of circulation but
also possibly driven by a pro-inflammatory response. It is possible that maintaining
normothermia alone post-ROSC may be sufficient to prevent pro-inflammatory reperfusion
injury and may confer equal benefit in terms of outcome.
The maintenance and re-warming phases remain under investigation, although we have not
specifically examined these in the TOPCAT study.
In our study, cooling was initiated approximately 2 hours after ROSC, on arrival on the ICU.
If MTH is not commenced in patients following OHCA, many patients develop a mild
pyrexia commencing around 8 hours after ROSC (The Hypothermia after Cardiac Arrest
Study Group, 2002). Hyperthermia following OHCA has previously been associated with
poor outcome (Zeiner, 2001). Episodes of pyrexia are correlated with poorer neurological
outcome in focal ischaemic brain injury, and measures are taken to actively keep these
patients normothermic (Hajat, 2000). Pyrexia after OHCA may reflect a pro-inflammatory
cytokine-mediated response to the whole body ischemia-reperfusion insult during
resuscitation (Takino, 1991). It is postulated that this inflammatory response may cause
multi-organ injury and, in particular, exacerbate neurological injury. Because the mechanism
of the benefit accrued from MTH is uncertain it is difficult to build a physiological rationale
for the optimum target temperature for therapeutic hypothermia. It is unclear whether it is
tissue cooling per se, (with reduction in oxygen demand and modulation of tissue injury
pathways) improves outcome, or whether the attenuation of specific elements in the
inflammatory response to OHCA is also crucially important. It is possible that maintenance
of normothermia with immune-modulation and other strategies for neuroprotection post-
ROSC could provide similar benefits to whole body cooling (Bouch, 2008).
It is uncertain whether cooling the brain, heart, whole body or all three is important when
using MTH. It is unclear whether cooling with surface techniques, intra-nasally or with cold
intravenous fluids differentially cools different organs, possible affecting outcome. An
understanding of these concepts will be needed to optimise MTH as a therapy for post-
OHCA patients.
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10.6 Core Body Temperature - Conclusion
Following OHCA all patients have oesophageal temperatures below normal in the pre¬
hospital phase and on arrival in the ED. Patients who achieve ROSC following OHCA and
survive to hospital discharge are wanner on arrival in ICU and take longer to reach target
MTH temperatures compared to patients who die in hospital. The reason for the robust
association between oesophageal temperature and survival from OHCA remain unclear and
further research is warranted to clarify this relationship.
10.7 Inflammation post-OHCA - findings
We have shown that serum inflammatory markers are raised in OHCA patients post-ROSC.
Both pro- and anti-inflammatory cytokine production was up-regulated post-OHCA,
indicating global activation of the inflammatory cascade. Serum levels of lL-6, IL-8, IL-IO
and IL-12 differ between survivors and non-survivors and have different rates of
progression. TNF-a and IL-ip are also raised but no difference was observed between
survivors and non-survivors. The fact we did not identify specific peaks of TNF-a and IL-ip
may be a reflection of the timing of blood sampling and cytokine clearance. A peak level
occurring in the first 12-hours post-ROSC may remain undetected by sampling at 24-hours.
IL-8 has previously been shown to peak at 12-hours post-ROSC (Ito, 2001), however we
chose 24-hours to coincide with routine clinical sampling. Similar to previous studies (Shyu,
1997), we did not find a correlation between cardiovascular status post-ROSC and the
magnitude of the post-ROSC inflammatory response.
The early (pre-hospital, ED and 24-hour) level of 1L-6 observed in patients in the TOPCAT
study was comparable to patients in septic shock (Adrie, 2004), indicating a significant level
of cytokinaemia. IL-6 is known to propagate a pro-inflammatory response and also acts on
the thermocentres of the hypothalamus resulting in pyrexia. Interestingly, one human study
has suggested MTH leads to increased IL-6 production and whilst still conferring therapeutic
benefit (Diestel, 2008). Clearly, more research is warranted to examine the role and effect of
individual cytokines.
We have shown that neutrophil activation post-OHCA occurs earlier than described in some
other previous studies (Adrie, 2004), with neutrophil activation being detectable in the CPR-
phase of resuscitation.
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There have been previous suggestions that catecholamines, both endogenous and exogenous,
play a role in leucocyte activation and propagation (Springer, 1995). We did not observe a
difference in serum elastase levels in patients who had varying quantities of adrenaline
administered during resuscitation. We found survivors of OHCA had less adrenaline
administered during resuscitation than non-survivors. This is likely to reflect the shortened
resuscitation period as adrenaline has recently been shown not to improve survival OHCA in
humans (Olasveengen, 2009a).
10.8 The role of systemic inflammation post-OHCA
Cytokinaemia is present after OHCA, both in survivors and non-survivors. There were
significant differences in levels of IL-8 and IL-10 in survivors and non-survivors of OHCA,
however no global correlation was observed between systemic inflammation and core body
temperature. There are two possible explanations for these findings. Firstly, amelioration of
the systemic inflammatory response mediated by cytokines is not required for the therapeutic
benefit of hypothermia. Secondly, the inflammatory response and post-ROSC reperfusion
cascades occurring in the brain may differ from those in the rest of the body.
Neutrophils are activated and increase in number during cardiopulmonary resuscitation, as
shown by the increased cell surface marker expression and increased serum levels of human
neutrophil elastase. In animal models leucocytes are thought to play a role in early
microcirculatory reperfusion failure through leucocyte adherence and sticking (Bottiger,
2002). Neutrophils, activated by the cytokine cascade, can then migrate across the blood-
brain barrier leading to further brain injury (Schmid-Schonbein, 1993). Human studies have
shown similar results to ours, with neutrophil activation indicated through increased levels of
neutrophil elastase, complement split products and soluble intercellular adhesion molecules
present post-resuscitation (Bottiger, 2002; Lechleitner, 1993; Mussack, 2001).
The systemic inflammatory response following OHCA may be different from the response
observed in other proinflammatory conditions such as sepsis or stroke. In bacterial infection,
inflammatory cytokines may cause circulatory failure by increasing capillary permeability,
vasodilation, mitochondrial dysfunction and disseminated intravascular coagulation
(Richards, 2005). Secondary neutrophil activation following stroke can lead to secondary
neurological injury (Bhardwaj, 2003).
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Following cardiac arrest, cerebral ischaemia results in a complex cascade of events, triggered
by hypoxia and depletion of energy stores, leading to cellular depolarisation and calcium
influx that result in excitotoxic cell death. The magnitude of cerebral injury is dependent on
the time between onset of cerebral ischaemia and restoration of circulation and the duration
and severity of ischaemic injury (Harukuni, 2006). Post-ischaemic inflammation plays a role
in brain ischaemia (Kriz, 2009). Following the onset of cerebral ischaemia, cytokines act on
the vascular endothelium to increase the expression of intercellular adhesion molecule-1, E-
selectin and P-selectin, which promotes neutrophil adherence and accumulation (Huang,
2006). We have demonstrated that neutrophil activity in the serum is increased in the
immediate stage following OHCA. Expression of these integrins, together with structural
changes in the basal lamina and extracellular matrix results in the migration of neutrophils
across the endothelium. Activated neutrophils bind to endothelial ligands, migrating to the
area of tissue injury. Neutrophil adhesion is a critical step in vascular endothelial injury,
resulting in increased microvascular permeability and thrombosis (Homer-Vanniasinkam,
1997). Secondary inflammatory cascades occur leading to further cerebral ischaemia.
Reducing the brain temperature below 34°C can reduce inflammatory cell infiltrate and
reduce concentrations of a variety of inflammatory mediators such as reactive oxygen
species, nitric oxide and inflammatory cytokines (Yenari MA, 2005). However, serum levels
of inflammatory cytokines measured in the acute phase of ischaemic stroke do not correlate
with lesion size or outcome (Intiso, 2004; Sanchez-Moreno, 2004). It is possible, therefore,
that the beneficial effect of therapeutic hypothermia maybe related to restricted modulation
of inflammation in the brain.
A previous study has demonstrated that, despite cooling, post-OHCA patients had a
significant rise in IL-6 levels during the hypothermic period (Fries, 2009). In the setting of
acute ischaemic stroke, IL-6 is associated with neurological deterioration (Vila, 2000).
TNF-a has also been implicated in secondary brain injury following OHCA but it remains
unclear whether cytokines per se lead to brain injury or whether they act as a catalyst for
other cellular responses, such as neutrophil migration, which ultimately cause brain injury.
MTH has previously been shown to result in lower levels of TNF-a after OHCA (Fries,
2009). Using specifically targeted therapies, such as infliximab for TNF-a, could alleviate
the adverse effect of pro-inflammatory mediators. Infliximab has been shown to reduce
myocardial dysfunction following cardiac arrest in a swine model (Niemann, 2010). Other
targeted anti-cytokine therapies using monoclonal antibodies have been shown to reduce
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tissue injury following reperfusion in animal models (Sekido, 1993). Targeted anti¬
inflammatory therapy could prevent brain injury if the precise mechanisms of the reperfusion
syndrome were better understood.
10.9 Cytokines post-OHCA - comparison of our findings with published
literature
Previous studies have demonstrated a measurable inflammatory response in the hours
following ROSC (Adrie, 2002; Adrie, 2004; Ito, 2001; Zacharia, 2009) and animal models
have shown that MTH reduces cytokine release from the brain following cardiac arrest
(Meybohm, 2010b). We have demonstrated that a systemic inflammatory response is
occurring in the immediate post-ROSC phase, with cytokinaemia and neutrophil activation
occurring in the pre-hospital phase. The systemic inflammatory response appears greater in
patients that do not survive. However, no definite evidence exists to show that the systemic
inflammatory response observed post-ROSC causes secondary neurologic or systemic injury
(Adrie, 2002; Grunenfelder, 2000). The magnitude of the inflammatory response is likely to
be related to the severity and duration of global ischaemia and reperfusion.
Cardiac arrest leads to whole body ischaemia. The effect of hypoperfusion on organs other
than the brain is important. Gut ischaemia can lead to translocation of exotoxins through
sites of gut wall ischaemia and elevated endotoxin levels have been described within 2 days
following successful resuscitation (Adrie, 2002). Bacteraemia from the gut may also
contribute to systemic inflammation (Cerchiari, 1993). In addition, gastric aspiration is
common in cardiac arrest and even when minimal, can give rise to a systemic inflammatory
response (Gaussorgues, 1988).
Animal studies of proinflammatory cytokines post-OHCA have shown 1L-6 and TNF-a to
rise within one hour of ROSC but to return to normal levels within 24 hours (Sipos, 2010).
The same study found that different levels of hypothermia did not unequally influence the
amount of circulating proinflammatory cytokines. However, IL-10 mRNA levels were found
to have prognostic power for survival. We have seen very similar results in our human study.
Therapeutic hypothermia is believed to decrease the inflammatory response (Fries, 2009).
An in vitro study demonstrated that moderate hypothermia reduced the inflammatory
response of stimulated microglia cells, shown by a reduction in inflammatory cytokine
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production and reduced expression of adhesion molecules (Schmitt, 2007). A previous study
has also shown hypothermia decreases some proinflammatory cytokines but increased IL-6
production from stimulated endothelial cells (Diestel, 2008). Our findings are consistent with
the hypothesis that MTH modulates the inflammatory response following OHCA but it
remains under investigation whether a reduction in inflammatory response has beneficial
effects in terms of survival and neurological outcome.
10.10 Inflammation post out-of-hospital cardiac arrest - future research
A major difficulty in evaluating systemic inflammation post-OHCA is determining whether
it is a marker of therapeutic efficacy, potential therapeutic target or not related to post-ROSC
brain injury.
An animal model is required to test hypotheses on elements of the inflammatory process
after cardiac arrest. The impact of modifying leucocyte activity and cytokinaemia following
cardiac arrest needs to be evaluated. A previous animal study demonstrated improved
neurological outcome in dogs treated with a simple anti-inflammatory (Ibuprofen) following
cardiac arrest (Kuhn, 1986). An animal model could be used to label neutrophils during
cardiac arrest, track their migration and activity and observe the outcome of modifying
neutrophil activity. An animal model of depleted neutrophils and other leucocytes would
determine whether these cells are firstly involved in secondary brain injury following cardiac
arrest and, secondly, whether therapeutic hypothermia exerts neuroprotection by altering
neutrophil activity. Similarly, the pro-inflammatory response could be pharmacologically
manipulated and the effect on outcome observed.
If ROSC is achieved following OHCA, the effect of whole body ischemia and reperfusion
leads to a state known as the "post-resuscitation syndrome". This is characterized by
hyperthermia, hypotension and multiple organ failure and is a likely consequence of whole-
body ischaemia/reperfusion injury that occurs following ROSC (Adrie, 2004; Nolan, 2008).
The effect of the reperfusion syndrome may be more detrimental than the initial primary
ischaemic insult (Ar'Rajab, 1996), particularly leading to secondary brain injury. Although
reperfusion is essential for survival, it may exacerbate cerebral injury and thus presents a
treatment paradox (Safar, 2002).
A targeted approach to post-ROSC resuscitation care is required, combining therapeutic
hypothermia with haemodynamic optimization (Gaieski, 2009; Sunde, 2007). The exact
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elements of the post-resuscitation syndrome that are detrimental are unknown, but the
inflammatory response has been suggested as having harmful secondary effects. Greater
understanding of the post-resuscitation syndrome is crucial if targeted protective therapies
are to evolve.
10.11 Brain injury markers post-OHCA
Serological markers of brain injury are a potential means of prognostication following
OHCA. Studies have demonstrated the difficultly in using early markers of brain injury to
predict outcome (Song, 2010). We found S-100 to be superior to NSE and GFAP in
predicting outcome from OHCA in the context of patients treated with MTH. Our results are
consistent with previously published studies, evaluating SI00 prior to the use of MTH
(Hachimi-Idrissi, 2002; Martens, 1996; Rosen, 1998). We found the cut-off value for poor
outcome to be 0.96 pg/L at 24-hours post-ROSC which is in-keeping with other studies
(Shinozaki, 2009b).
This is one of the few studies to evaluate GFAP as a predictive neurological marker
following OHCA, but we found it to be poor compared with S-100. A previous study found
when serum GFAP was present in the serum at >0.1ng/dL in the context of MTH when
measured at 48-hours post-ROSC, poor outcome was accurately predicted. However, GFAP
levels measured at 12 or 24 hours post-ROSC were not significantly associated with outcome
(Kaneko, 2009).
Our failure to show any correlation between core body temperature and serum markers of
neurological injury may be multi-factorial. A gradient may exist between brain temperature
and the oesophageal suggest there is a gradient between brain and body temperature is
indicative of neurological injury, or neurological injury is prevented by the cooling process
of MTH and not related to core body temperature prior to cooling being initiated.
10.12 Pre-hospital resuscitation practice
During the TOPCAT study, the quality of pre-hospital resuscitation was noted, by direct
observation and analysis of defibrillator downloads to be variable. The commonest observed
findings were poorly performed chest compressions, inappropriate early tracheal intubation
and intravenous cannulation, and use of the defibrillator in semi-automatic mode. Several
recent studies have reported the adverse physiological consequences of poor resuscitation
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technique (Frenneaux, 2003) and have demonstrated that quality of pre-hospital CPR
influences outcome from OHCA (Christenson, 2009a; Garza, 2009).
Chest compressions aim to provide adequate perfusion to the vital organs during cardiac
arrest. Periods during which chest compressions are not performed result in lack of blood
flow - defined as no blood flow time (NBT). Recent clinical evidence shows increased NBT
during CPR is associated with poor outcome (Christenson, 2009b).
A variety of factors influence the delivery of effective chest compressions. Tracheal
intubation and obtaining intravenous access for subsequent drug delivery interrupt chest
compressions, but no high level evidence exists to show that either intervention improves
survival from OHCA in humans (Kramer-Johansen, 2006; Olasveengen, 2009a). Automated
rhythm analysis will often take longer than manual rhythm interpretation by a trained
healthcare professional, resulting in increased delay-to-shock times when ambulance
defibrillators are used in automatic mode (Kramer-Johansen, 2007a; Yu, 2002). Calculating
the NBT has important implications for resuscitation training, optimising the quality of
resuscitation and clinical outcome after OHCA (Steelier, 2008b).
There have been calls for regular monitoring of CPR quality and for uniform reporting of
CPR variables (Kramer-Johansen, 2007b). Ambulance crews receive initial training in
performing CPR pre-hospital but receive variable training updates. Individual crews are
likely to encounter few OHCA and skill retention can be problematic (Perkins, 2009). There
is a need to monitor compliance of CPR performed by ambulance crews in accordance with
current international resuscitation guidelines (Olasveengen, 2007), as previous investigation
of pre-hospital practice has demonstrated poor compliance with recommended chest
compression depth and rate, compounded by pauses in delivery of chest compressions
(Steen, 2008; Wik, 2005). Determining the quality of pre-hospital resuscitation performed by
ambulance crews in the field is technically difficult, but crucial if pre-hospital care of OHCA
patients is to improve (Olasveengen, 2009b).
The results from our survey of ambulance personnel suggest they value the presence of an
experienced clinician at the scene of OHCA, particularly for education, feedback and to aid
clinical decision making. The pre-hospital physician/paramedic model is widely employed in
continental Europe and Scandinavia. The TOPCAT study has shown that resuscitation
practice can be changed with simple advice and guidance.
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10.13 Pre-hospital resuscitation future research
Towards the end of the TOPCAT study period (November 2009), a pilot study was launched
with the aim of improving pre-hospital resuscitation practice by ambulance crews.
Transthoracic impedance (TTI) measurement is a useful tool in the assessment of the quality
of pre-hospital resuscitation by ambulance crews (Olasveengen, 2007; Stecher, 2008a). The
TTI signal is already recorded through the pads of many models of external defibrillator
without the need for any further equipment to be placed on the patient. Both chest
compressions and ventilations result in identifiable changes in the TTI trace.
Logging and analysis of TTI data from ambulance defibrillators after OHCA does not yet
occur routinely in the United Kingdom. The ICECAP (Informed Continuous Education of
Cardiac Arrest for Ambulance Personnel) pilot study is the first of its kind in the UK to
implement a data network to collect defibrillator TTI data via telemetry from ambulances in
the City of Edinburgh, Scotland. Following each resuscitation attempt, the attending
ambulance crew selected the respective case and instructed the defibrillator to transmit the
data. After receipt of the TTI trace, CODESTAT software was used to calculate the no-flow
ratio, compression rate and time interval to administer defibrillatory shocks. A resuscitation
report was generated that was printed and sent as part of feedback and training to the
attending ambulance crew.
From the initial 58 TTI traces received, the mean ratio of chest compressions was 73% (95%
CI 69-77%), the mean chest compression rate was 128 (95% CI 122-134). There were 19
resuscitation attempts where at least once shock was administered from the defibrillator. The
mean time interval to deliver to deliver a shock was 27 seconds (95% CI 22-32s)
The ICECAP pilot study has started a monthly resuscitation class at Edinburgh City
ambulance station and, together with feeding back the resuscitation reports, aims to achieve a




The TOPCAT study has investigated the physiological response to OHCA and current
resuscitation practice in Scotland.
The physiological response to OHCA has been characterised in relation to oesophageal
temperature, systemic inflammation and serum markers of brain injury. Following OHCA all
patients have oesophageal temperatures below normal in the pre-hospital phase and on
arrival in the ED. Patients who achieve ROSC following OHCA and survive to hospital
discharge are warmer on arrival in 1CU and take longer to reach target MTH temperatures
compared to patients who die in hospital. The mechanisms of action underlying oesophageal
temperature and survival from OHCA remain unclear and further research is warranted to
clarify this relationship.
A systemic inflammatory response occurs earlier in the post-ROSC phase than previously
described. Further research is warranted to clarify the mechanism of action of therapeutic
hypothermia post-OHCA and the role of the systemic inflammatory response in determining
survival. SI00b is a more reliable predictor of outcome following OHCA than NSE or
GFAP. The TOPCAT study has generated several testable hypotheses for future work.
The quality of pre-hospital and in-hospital resuscitation in Scotland have been examined.
MTH is commonly used in Scottish ICUs but rarely commenced in the ED. The quality of
pre-hospital resuscitation is variable and practice can be improved. We have demonstrated
the value of a second tier, experienced pre-hospital response to OHCA calls. Following the
TOPCAT study, initiatives have been launched aiming to improve the quality of pre-hospital
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Introduction: Out-of-hospital cardiac arrest (OHCA) is a significant cause of death and severe neurological
disability. The only post return of spontaneous circulation (ROSC) therapy shown to increase survival is
mild therapeutic hypothermia (MTII).Thc relationship between esophageal temperature post OIICA and
outcome is still poorly defined.
Methods: Prospective observational study of all OIICA patients admitted to a single centre for a 14-month
period (1/08/2008 to 31/09/2000). Esophageal temperature was measured in the Emergency Department
and Intensive Care Unit (ICU). Selected patients had pre-hospital temperature monitoring. Time taken to
reach target temperature after ROSC was recorded, together with time to admission to the Emergency
Department and ICU.
Results: 164 OHCA patients were included in the study. 105 (6105!;) were pronounced dead in the Emer
gency Department. 59 (36.0%) were admitted to ICU for cooling; 40 (24.4%) died in ICU and 19 (11.6%)
survived to hospital discharge. Patients who achieved ROSC and had esophageal temperature measured
pre-hospital (n-29) had a mean pre-hospital temperature of 33.9°C (95% CI 33.2-34.5). All patients
arriving in the ED post OHCA had a relatively low esophageal temperature (34.3 C, 95% CI 34.1-34.6).
Patients surviving to hospital discharge were warmer on admission to ICU than patients who died in
hospital (35.7°C vs 313"C, p ' 0.05). Patients surviving to hospital discharge also took longer to reach
Turg than non-survivors (2 h 48min vs 1 h 32 min, p<0.05).
Conclusions: Following OIICA all patients have esophageal temperatures below normal in the pre-hospital
phase and on arrival in the Emergency Department. Patients who achieve ROSC following OHCA and sur¬
vive to hospital discharge aie wauutti on arrival in ICU and take luugei tu leach target MTH ternpeiatuies
compared to patients who die in hospital. The mechanisms of action underlying esophageal temperature
and survival from OIICA remain unclear and further research is warranted to clarify this relationship.
© 2010 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Out-of-hospital cardiac arrest (OHCA) is a significant cause of
death and severe neurological disability across Europe. Resuscita¬
tion is attempted in 66 per 100,000 population annually.1 Despite
efforts to optimise early access to advanced cardiac life support,
survival rates from OHCA remain low, with survival to hospital dis¬
charge rates varying from less than 5% to over 10%.2'3 Good quality
* A Spanish translated version of the abstract of this article appears as Appendix
in the final online version at dni:10 1016/j resuscitation 2010 03 017
* Corresponding author. Tel.:+44 0131 242 1338/7967731172:
fax: +44 131 242 1339.
E-mail address: richardlyon@doctors.org.uk (R.M. Lyon).
cardiopulmonary resuscitation and prompt defibrillation are key
interventions to achieve return of spontaneous circulation (ROSC)
and neurologically intact survival. Following ROSC the aim is to
limit further brain injury and minimise subsequent morbidity and
mortality. The only post-ROSC therapy shown to increase survival
and improve neurological outcome following OHCA is mild thera¬
peutic hypothermia (MTH).
In 2002 two prospective randomised trials found that induc¬
ing MTH (32-34 °C) after OHCA could increase survival and reduce
neurological morbidity.4'5 Both trials had similar recruitment critc
ria and included patients with ROSC who remained intubated and
ventilated after OHCA due to ventricular fibrillation (VF) of pre¬
sumed cardiac aetiology. Despite the uniformity of study groups,
the implementation of MTH differed significantly between the two
trials.
0300-9572/$ - see front matter © 2010 Elsevier Ireland Ltd. All rights reserved,
doi: 10.1016/j.resuscitation.2010.03.017
Author's persona! copy
R.M. Lyon et al. / Resuscitation 81 (2010) 867-871
Survived to hospital discharge
n=19
(CPC 1,2 n=16, CPC 3,4 n=3)
Died in hospital
n=40
Fig. 1. Patient flow diagram.
In 2003, the Advanced Life Support Task Force of the Interna¬
tional Liaison Committee on Resuscitation (ILCOR) published an
advisory statement indicating that further research was required
to establish the optimum target temperature, optimal duration of
hypothermia, rates of cooling and re-warming and an understand¬
ing of the mechanism of MTH.6 This call for further research was
reiterated by ILCOR in 2007.7 To generate explanatory hypothe¬
ses answering some of these important clinical questions baseline
observational data is required. Establishing the pattern of change
of body temperature after OHCA will inform decisions about the
most effective time to commence cooling and may enhance under¬
standing of the mechanisms of MTH.
This prospective study aims to describe the natural progression
of esophageal temperature following OHCA from the pre-hospital
phase until arrival on the Intensive Care Unit (ICU) and observe any
relationship between esophageal temperature, outcome and time
to reach target temperature.
2. Methods
We prospectively collected data on OHCA in the Edinburgh area
(population approximately 500,000) over a 14-month period (1 st of
August 2008 to 31st September 2009). OHCA patients transported
to the Emergency Department (ED) of a single university teaching
hospital (Royal Infirmary of Edinburgh) were enrolled in the study.
Inclusion criteria were adult cardiac arrest of non-traumatic cause,
unwitnessed by ambulance personnel and who remained comatose
after ROSC. The study was approved by the Scottish national med¬
ical research ethics committee.
The Scottish Ambulance Service routinely collect Utstein tem¬
plate data on all OHCA patients. Time of emergency call, ambulance
dispatch and on-scene times are recorded automatically by the
ambulance service computer system with the aid of real-time satel¬
lite positioning. Ambulance records were matched with the ED and
ICU patient notes. Patients were followed up to the point of dis¬
charge from the admitting hospital or death. Cerebral Performance
Category8 was noted at the point of hospital discharge.
For a proportion of the OHCA episodes studied, a research doctor
(RL) attended the scene with an ambulance crew. For these patients
esophageal temperature (Tes) measurement was commenced in the
field. All other OHCA patients had esophageal temperature mea¬
suring commenced on arrival in the ED. Esophageal temperature
monitoring is the most practical means of accurately measuring
core body temperature during the pre-hospital phase of patient
care. An esophageal temperature probe was marked at 15 cm from
the tip and inserted as soon as practical during the resuscitation.
The thermometer tip was therefore 15 cm from the nostril and
the position confirmed by laryngoscopy. The probe was linked to
a digital recording thermometer (DataTherm II) with esophageal
temperature recorded every lOmin to 0.1 C accuracy. Esophageal
temperature recording continued for a 24-h period.
We recorded the pattern of change in esophageal temperature
from either the pre-hospital or ED phase of the OHCA patient's jour¬
ney until target temperature (Ttarg. <34°C) was reached in the ICU.
Time taken to reach Ttarg. after ROSC was recorded, together with
time to admission to the ED and ICU and the time active cooling
was commenced.
The study was approved by the Scottish National Research Ethics
Committee. Consent from the next-of-kin was sought until the
patient was able to give informed consent. If the patient did not
survive, permission was granted from the Ethics Committee to use
the research data.
In the receiving hospital, cooling is routinely initiated after
admission to the ICU. Body surface cooling (Arctic Sun, Medivance
Ltd) is used with automatic temperature feedback control. In a small
proportion of cases cooling is commenced in the ED by placing ice
packs on the patient. Patients who had active cooling initiated in
the ED were excluded from the time point at which cooling was
commenced. Data were entered into a database (Microsoft Access
2007) and analysed using statistical analysis software (Microsoft
R.M. Lyon et al. / Resuscitation 81 (20)0) 867-871 869
Table 1
Out-of-hospital cardiac arrest (OHCA) patient demographics. CPR: cardiopulmonary
resuscitation; VF: ventricular fibrillation; PEA: pulseless electrical activity; NS: not
significant; ROSC: return of spontaneous circulation; and IQR: interquartile range.
Table 2























































Excel 2009, SPSS 16.0). Values in the survivor and non-survivor
groups were compared at two time points (arrival in the ED and
arrival on the ICU) using an unpaired t-test. Statistical significance
was taken at the 95% level.
3. Results
During the study period 183 OHCA patients were transported
to the ED. Of these, 29 patients had pre-hospital esophageal
temperature measurements performed. Four patients had cooling
commenced in the ED, either ice packs or cold IV fluid and were
excluded after cooling commenced as they could not be compared
to the rest of the study cohort. Two patients were excluded as
they were not comatose on arrival. ED temperature data was not
available for 12 patients, all of whom subsequently died in the ED.
Temperature data was available to all patients admitted to ICU. One
patient refused consent after discharge from ICU. Patient enrol¬
ment into the study is shown in Fig. 1. A total of 164 patients were
enrolled into the study and all were followed up until hospital dis¬
charge or death. On arrival in the ED, one patient was noted to have
the temperature probe situated next to the cuff of the endotracheal
tube on direct laryngoscopy and the probe was re-sited. Otherwise
no complications from temperature monitoring were observed.
105 (64.0%) patients were pronounced dead in the ED. 59 (35.6%)
patients enrolled in the ED survived to admission to ICU and were
eligible for inclusion. 19(11.7%) enrolled patients survived to hos¬
pital discharge. 40 (25.0%) patients admitted to ICU subsequently
died in hospital. Patient demographics and resuscitation details of
survivors and non-survivors are shown in Table 1.
Patients who achieved ROSC and had esophageal temperature
measured pre-hospital (n = 29) had a mean esophageal tempera¬
ture of 33.9°C (95% CI 33.2-34.5). All eligible patients arriving in
the ED post OHCA (n = 164) also had a relatively low esophageal
temperature (Table 2) but there was no significant difference in
(ED). Tcs: esophageal temperature and ICU; Intensive Care Unit.
Mean on Standard 95% CI of mean
arrival ED deviation
All patients 34.3 1.59 34.1-34.6
(n = 164)
Died in ED 34.1 1.70 33.8-34.5
(n = 105)
Survived to ICU 34.4 1.37 34.0-34.9
admission
(n = 59)




ED esophageal temperature between patients who died in hospital
(n = 40) and patients surviving to hospital discharge (n = 19).
The majority ofsurvivors had a favourable Cerebral Performance
Score (CPC) at hospital discharge (CPC 1; ri = 8, CPC 2: n = 8). Three
survivors had poor neurological outcome at hospital discharge (CPC
3; n = 2, CPC 4: n = 1). 16 non-survivors who were admitted to ICU
had severe, isolated, ischaemic brain injury (including three with
brain stem death). All of these patients arrived in the ED cool (mean
Tes 34.5 C; 95% CI 33.7-35.3) and did not appear to re-warm prior to
ICU admission (mean ICU admission Tes 34.2 C; 95% CI 33.6-34.8).
Patients surviving to hospital discharge were warmer on admis¬
sion to ICU than patients who survived to ICU admission but
subsequently died in hospital. There was no significant difference
from the time of ROSC to ICU admission in survivors and non-
survivors (3 h 18 min vs 3 h 38 min, p = 0.71). Patients surviving to
hospital discharge also took longer to reach T^g (<34 C) once cool¬
ing was commenced (Table 3). The progression of Tes post-ROSC is
shown in Fig. 2.
4. Discussion
In this single centre observational study, we found that
esophageal temperature follows a predictable pattern in the
first few minutes and hours after OHCA. Patients in our study
cooled quickly in the pre-hospital phase and remained cool in
transit to the ED. Thereafter, patients destined to survive to
discharge appeared to re-warm faster before cooling was com¬
menced and took longer to reach target temperature, a finding
not yet described in the literature. Esophageal temperature on
arrival in the ED was 34.4 C (range = 30.5-36.6 °C) - compara¬
ble to the target temperature reached in a recent pre-hospital
pilot study of the feasibility of cooling post OHCA9 and also
previously published studies.1011 Patients in our study main¬
tained esophageal temperature close to the target range for
MTH throughout the pre-hospital phase without specific inter¬
vention to lower temperature. Despite the paucity of clinical
evidence demonstrating benefit,9-11 some ambulance services have
adopted methods of initiating hypothermia in the pre-hospital
phase.12 Cooling at the scene or during transport requires addi¬
tional equipment, resources and monitoring and may distract
from the basic practice of maintaining a patent airway, ventilation
Table 3
Esophageal temperature on admission to the Intensive Care Unit (ICU) and time to reach target temperature. Tes: esophageal temperature; ROSC: return of spontaneous
circulation; and TU(&: target therapeutic hypothermia of <34°C.
Died in hospital Survived to hospital discharge p-value
Mean T„ on arrival ICU 34.3 (95% CI 33.9-34.8) 35.7(95% CI 35.2-36.3) 0.0008
Mean time from ROSC to arrival on ICU 159 min (95% CI 137-183) 169 min (95% CI 140-198) 0.60
Mean time from ROSC to (<34 LC) 219min (95% CI 165-271) 320 min (95% CI 266-374) 0.019
Mean time from arrival ICU to Tta,s 96min (95% CI 56-136) 168 min (95% CI 118-217) 0.028
Author's personal copy
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Fig. 2. Mean Tes of out-of-hospital cardiac arrest patients who achieved return of
spontaneous circulation (ROSC) and survived to hospital discharge (triangles; n = 19)
and patients who achieved ROSC. survived to Intensive Care Unit admission but died
in hospital (dots; n = 40). Error bars represent standard error of the mean.
and adequate circulation. Further research is currently underway
to establish whether pre hospital cooling really confers addi
tional benefit. A North American study of outcome from cardiac
arrest when cold IV fluids are infused in the pre hospital setting
is currently recruiting (http://www.ClinicalTrials.gov/identifier
NCT003D1<169).
Several studies have previously noted episodes of hyperther
mia occurring in patients following cardiac arrest but our study
reports a correlation between early changes in esophageal tern
perature within the normothermic range and patient survival. The
reason for this observation remains uncertain. We noted a signif¬
icant difference in the time between collapse and ROSC between
survivors non survivors. Longer collapse ROSC times arc likely to
be associated with greater neurological injury and impairment of
central mechanisms of body temperature control.
Patients who survive to hospital discharge may have better
cardiac function following ROSC and less hypothalamic damage,
leading to a higher esophageal temperature as a function of greater
cardiac output and intact thermoregulation. Several (n = 16) non-
survivors had severe neurological injury as their eventual cause of
death and all remained hypothermic after ROSC.
Body temperature lability - episodes of both hyperpyrexia
and spontaneous hypothermia - have recently been shown to be
adversely linked to outcome in patients following in-hospital car¬
diac arrest.13 The mechanism for this is unknown though there
are similarities to the temperature dysregulation found in severe
sepsis.14 In sepsis, development of spontaneous hypothermia is
associated with greater neurological injury15 although animal work
suggests that controlled MTH may improve outcomes.16
The optimal timing for initiating MTH after OHCA is unclear.
There is limited animal evidence suggesting that early initiation
of cooling is beneficial.17"19 There is no direct clinical evidence to
support the immediate initiation of cooling, although retrospec¬
tive analysis has indicated a possible benefit lu patients cuuled
shortly after ROSC.?n Several studies have examined the possibil¬
ity of pie-hospital Cuuliiig71,27 but piospecLive landuinised clinical
trials have, so far, failed to demonstrate any survival benefit.9,11 A
temperature rise >38 °C is often seen in patients following OHCA
but it is unclear whether this bears any causal relationship to sur¬
vival oi neuiological outcome, and the leasori for this pyrexia is
unknown.
In our study, cooling was initiated approximately 2h after
ROSC, on arrival on the ICU. If MTH is not commenced in patients
following OIICA, many patients develop a mild pyrexia com
mencing around 8h after ROSC.4 Hyperthermia following OHCA
has previously been associated with poor outcome.23 Episodes
of pyrexia are correlated with poorer neurological outcome in
focal ischacmic brain injury, and measures arc taken to actively
keep these patients normothermic.24 Pyrexia after OHCA may
reflect a pro inflammatory cytokine mediated response to the
whole body ischaemia repcrfusion insult during resuscitation.25
It is postulated that this inflammatory response may cause
multi-organ injury and, that in particular, exacerbate neuro¬
logical injury. Because the mechanism of the benefit accrued
from MTH is uncertain it is difficult to build a physiological
rationale for the optimum target temperature for therapeu¬
tic hypothermia. It is unclear whether it is tissue cooling per
so (with reduction in oxygen demand and modulation of tis
sue injury pathways) that improves outcome, or whether the
attenuation of specific elements in the inflammatory response
to OHCA is also crucially important. It is possible that main¬
tenance of normothermia with immune-modulation and other
strategics for neuroprotection post-ROSC could provide similar
benefits to whole body cooling.26 Further research is warranted
to determine the mechanism by which MTH confers neurologi
cal protection and the optimum modality, timing and duration of
cooling.
Our study should be interpreted in the context of certain limi
tations. Whilst wc observed several statistically significant results,
our data was collected from a relatively small number of patients
in a single centre. We did, however, achieve a high degree of data
capture on all patients enrolled in the study. Body temperature was
recorded using esophageal probes with instructions given to insert
the probe to 15 cm from the nostril. Flacing these probes in the field
or in the ED may have resulted in probes not being inserted to ade
quatc length and sitting in the posterior nasopharynx. This may
have altered temperature recordings slightly, however there vcas
strong pre hospital agreement in temperature in all patients. The
esophagus is an accurate site to measure body temperature, sec
ond only to the pulmonary artery, and is more robust than other
techniques commonly used in our setting (e.g. tympanic membrane
temperature using an infrared probe).27,28 Esophageal temperature
monitoring is also the most practical means of accurately measur
ing body temperature during the pre hospital phase of patient care.
5. Conclusion
Following OHCA all patients have esophageal temperatures
below normal in the pre hospital phase and on arrival in the ED.
Tatients who achieve ROSC following OIICA and survive to hos¬
pital discharge are warmer on arrival in ICU and take longer to
reach target MTI1 temperatures compared to patients who die in
hospital. The mechanisms of action underlying esophageal temper
ature and survival from OHCA remain unclear and further research
is warranted to clarify this relationship.
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ABSTRACT
Out-of-hospital cardiac arrest (OHCA) is a leading cause
of mortality and severe neurological disability. Recent
literature suggests that mild therapeutic hypothermia
(MTH) can improve survival and neurological outcome in
some groups of comatose patients after cardiac arrest
but uncertainty exists over the best way to implement
this treatment. This review examines the evidence for
the efficacy and mode of implementation of MTH after
OHCA, particularly in the Emergency Department setting.
A literature search was performed and all systematic
reviews; human and animal randomised and non-
randomised trials were screened for inclusion. Specific
emphasis was placed on MTH being commenced in the
prehospital and Emergency Department setting.
Outcome measures were: time to reach target
temperature, in-hospital mortality, neurological outcome
at hospital discharge and complications of therapeutic
hypothermia. Two systematic reviews found that MTH
improved outcome after OHCA. Five human randomised
controlled trials were identified. Two trials commenced
cooling prehospital. One showed a favourable outcome
but the other failed to show survival benefit. The other
three trials only commenced cooling after the patient
arrived in hospital and all showed improved survival for
patients treated with MTH after OHCA. Evidence from
animal and non-randomised studies suggests cooling
should be commenced as early as possible after return of
spontaneous circulation. Cold intravenous fluid was
reported as a safe, effective means of cooling in the
emergency setting. MTH improves patient outcome after
OHCA. There is some evidence to suggest cooling should
be commenced early. Cold intravenous crystalloid
infusion may be the preferred cooling method in the
Emergency Department.
INTRODUCTION
Out-of-hospital cardiac arrest (OHCA) is a leading
cause of morbidity and mortality in the developed
world. Resuscitation is attempted in 66 per 100000
population across Europe every year. Of those that
survive to leave hospital, >50% are left with
permanent neurological sequelae.1 The first clinical
intervention in the postresuscitation phase of
OHCA shown to decrease mortality and improve
neurological outcome is mild therapeutic hypo¬
thermia (MTH).2 3 MTH was used in patients with
OHCA as early as 1950, but cooling was largely
abandoned due to complications. The concept of
preserving the brain in the field, protecting it from
hypoxia until the patient could be transported to
hospital for spontaneous circulation to be restored
or placed on cardiopulmonary bypass, was first
suggested by Peter Safar in 1984.4 5 In the 1990s, a
number of encouraging animal studies showed
benefit, and several pilot human studies were
conducted.6 7 In 2002, two randomised trials
demonstrated the benefit of cooling survivors of
witnessed OHCA who had ventricular fibrillation
(VF) as the presenting rhythm.2 3 This led to the
International Liaison Committee on Resuscitation,
the American Heart Association and the European
Resuscitation Council recommending MTH in the
management of unconscious patients following
OHCA.8 9 Despite these recommendations, the
use of MTH is not yet routine.10 Since 2002, further
trials have explored the use of MTH for non-VF
OHCA, traumatic cardiac arrests and in paediatric
patients.
The optimum initiation, method and duration
of cooling are unclear.11 Animal research suggests
that cooling early after return of spontaneous
circulation (ROSC) is associated with improved
neurological outcome,12 13 but human studies
show that delayed cooling also yields favourable
results.3 12 14
Both invasive and non-invasive cooling methods
have been developed, and whole-body and brain-
only cooling methods have been trialled. The
majority of cooling techniques have been trialled in
critical care settings with few methods specifically
evaluated in the Emergency Department (ED).15
While MTH initiated in the ED may reduce the
time taken to reach target temperature, prehospital
cooling poses logistical and technical challenges.
Patients arriving at hospital after OHCA may
require in-hospital transfer for imaging or cardiac
intervention prior to ICU (intensive care unit)
admission. Cooling techniques intended for early
deployment must therefore combine efficacy with
ease of use.
While some ambulance services and EDs have
adopted MTH as a routine treatment for patients
after OHCA, it is unclear whether the available
evidence supports this practice.
This paper aims to review and discuss key
elements of the published literature on using MTH
in the emergency setting and is not intended to
provide a definite statement in the form of
a systematic review.
We reviewed the published literature to answer
the following:
1. In comatose patients after OHCA, does MTH
improve neurological outcome?
2. Is there an optimal time and place for
commencing MTH?
3. In patients after OHCA considered for MTH,
what methods of cooling are available for use
within the ED?
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METHODS
A literature review was performed by a single investigator. All
short-listed studies were assessed by the other two authors for
quality and to ensure the inclusion criteria were met. Search
terms included 'therapeutic hypothermia', 'hypothermia',
'cardiac arrest', 'heart arrest', 'out-of-hospital cardiac arrest' and
'cardiopulmonary resuscitation'. Outcome parameters included
in-hospital mortality, 6-month mortality and favourable neuro¬
logical outcome (defined as independent living) within
6 months.
Inclusion criteria were studies commencing cooling early
post-ROSC. For human studies we included those commencing
cooling prehospital or in the ED. For animal studies we
included cooling before, during or immediately after cardiac
arrest. Specific exclusion criteria included non-cardiac arrest
conditions—for example, myocardial infarction, cerebrovas¬
cular accident and traumatic brain injury. In contrast to
previous published systematic reviews,16 17 this review specifi¬
cally examines MTH use in the prehospital and ED setting. We
found the number of randomised controlled trials (RCTs) on the
use of MTH after OHCA to be small; therefore, all RCTs were
screened for inclusion, regardless of the timing of initiation of
cooling.
We included literature searches from Ovid Medline
1950—2009, the Cochrane Library, EMBASE 1988—2009, Google
scholar and citation tracking. The search sought to identify
studies that evaluated the use of MTH following OHCA using
the search criteria above. Finally, a Web of Science citation search
was performed on all included studies. Reference lists of all
available primary studies and review articles were obtained to
identify potentially relevant citations. Previously published
systematic review articles were sought, looking for particular
relevance to using MTH in the prehospital and ED setting. After
a generalised search, limits were applied for 'trials'.
Human trials were assessed using the Jadad system18 to assess




One thousand and sixty-two papers were screened for inclusion.
These were subdivided into animal studies, non-randomised
studies, randomised trials and systematic reviews. Two
systematic reviews and five randomised clinical trials were
identified. Five animal trials comparing timing of cooling initi¬
ation were included.
Animal studies
The first animal studies using hypothermia after cardiac arrest
were reported in the 1950s. In the early 1960s, Peter Safar
observed that dogs that were mildly hypothermic at the initia¬
tion of experimental cardiac arrest had a better neurological
outcome than dogs that were normothermic.19
A summary of selected animal studies is shown in table 1.
These particularly relate to early cooling and the potential effect
this may have on outcome.
The discovery of the neuroprotective effects of mild to
moderate hypothermia led to the investigation of resuscitative
hypothermia in several animal models. Dogs treated with
immediate mild (34°C) or moderate (30°C) hypothermia showed
improved functional and histological outcome. Dogs treated
with deep hypothermia (15°C), however, showed no improve¬
ment in neurological function and had more severe cerebral
histological changes compared with mild or moderate hypo¬
thermia groups.13 23 In the same model, delaying the onset of
cooling until 15 min postreperfusion was not associated with
the same improvement in functional outcome but did improve
histological damage. MTH was not associated with any signif¬
icant side effects in these studies.
More recently a trend towards better outcomes after earlier
initiation of therapeutic hypothermia (<15 min post-ROSC) has
been demonstrated.20 22 Kuboyama and colleagues demonstrated
that survival without neurological deficit can still be achieved
after 40 min of VF cardiac arrest in dogs when intra-arrest
hypothermia is instigated using cold intravascular fluids.
However, a delay in cooling after the induction of VF was
Table 1 Animal models of therapeutic hypothermia after out-of-hospital cardiac arrest
Study (year) Animal model
Cooling method + target
temperature Duration of cooling Outcome Comments
Sterz 30 dogs. 10 min VF arrest model.
RCT of cooling during CPR vs
early post-ROSC cooling vs
normothermia
Kuboyama20 2 2 dogs, induced VF for 12.5 min.
Prospective RCT of normothermia
vs immediate hypothermia vs
delayed (15 min after reperfusion)
cooling
Nozari21 27 dogs. VF cardiac arrest model




Abella22 3 0 mice. Potassium-induced
arrest. Prospective RCT of intra-
arrest cooling vs delayed
(20 min) postarrest cooling vs
normothermia
Zhao'2 45 mice. Potassium-induced
cardiac arrest for 8 min.
Prospective RCT of normothermia
vs intra-arrest cooling vs





















when cooling started during CPR
or immediately after R0SC
Immediate cooling showed trend
towards better functional
outcome compared with delayed
cooling and associated with
lower histological damage scores
Mild or moderate hypothermia
during prolonged CPR improved
survival and functional outcome
Intra-arrest cooling showed
better survival to 72 h than
delayed cooling or normothermia
Animals treated with
hypothermia, even in prolonged
ischaemia group showed




External CPR and resuscitation
drugs used as per human practice
Functional outcome did not reach
statistical significance
Invasive techniques used; not




Early intra-arrest cooling possible
only in prehospital setting. Intra-
arrest cooling may be useful for
haemodynamic resuscitation
CPR, cardiopulmonary resuscitation; RCT, randomised controlled trial; VF, ventricular fibrillation; R0SC, return of spontaneous circulation.
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associated with an increased mortality and poorer neurological
outcomes.20 Nozari showed that early intra-arrest cooling in
dogs with 60 min of VF resulted in a favourable neurological
outcome.21 However, when cooling was delayed until 20 min
after onset of VF, seven of eight dogs did not survive. Abella and
colleagues showed that mice cooled 20 min after cardiac arrest
showed a higher mortality than mice cooled just prior to
resuscitation from an 8 min period of cardiac arrest. Zhao
demonstrated in a randomised, controlled, murine model that
delaying resuscitation to institute therapeutic hypothermia still
resulted in a favourable neurological outcome.12
The animal studies reviewed suggest that cooling should
commence with a minimum of delay after cardiac arrest and
should continue for at least 24 h to confer lasting neuro¬
protection.
Non-randomised trials
The first reported human studies using therapeutic hypothermia
were reported in 1958.24 Since then >20 non-randomised studies
have been published. The target temperature has consistently
been 32—34°C using a variety of cooling techniques. Reported
favourable neurological outcome rates vary from 25% to 68%. A
summary of non-randomised trials is shown in table 2.
hi 1997, Beniaid and colleagues conducted a pilot 3tudy
comparing patients treated with MTH, induced by the appli¬
cation of ice packs, with normothermic controls. They demon¬
strated improved outcome in the treatment group, without
significant complications.6 Yanagawa cooled 13 patients who
had survived initial resuscitation.7 Cooling to 33°C commenced
on arrival at the ED (time to target temperature of 5.5 h post-
ROSC) and was maintained for 48 h before slowly rewarming at
1°C pti day.
Further studies adopted progressively more sophisticated
means of inducing therapeutic hypothermia. A study using cold
air surface cooling in the ED by Zeiner and colleagues was
successful in lowering core body temperature.25 Despite non¬
significant results, these studies supported the evidence that
MTH was a safe clinical intervention and could improve
outcome after OHCA.
Cooling modalities are summarised in table 3. Methods of
initiating prehospital cooling have been investigated, with cold
fluids and ice packs being the modalities of choice.28 29 Other
methods of cooling, including body surface cooling with ice and
cold blankets, helmet devices, endovascular cooling catheters,
haemofiltration and coronary bypass, have been studied. None
of these combines efficacy with ease of use. A key finding is that
infusion of up to 2 litres of cold (4°C) intravenous fluid (0.9%
saline or Ringer's lactate) in the immediate post-ROSC phase is
an effective and safe method of cooling and is not associated
with significant complications or cardiovascular instability.
Whatever the cooling technique employed the degree of hypo¬
thermia induced is important, and Merchant and colleagues
have demonstrated that overcooling is a significant risk and
careful core body temperature monitoring is mandatory.30 The
risks of overcooling include infection, coagulopathy and cardiac
arrhythmias.
Randomised trials
Five randomised clinical trials of therapeutic hypothermia post-
IHCA have been published.2 3 32-34 These are summarised in
table 4. The first clinical trial of therapeutic hypothermia,
published in 2001,32 enrolled 30 patients following OHCA with
asystole or pulseless electrical activity (PEA) as the initial cardiac
rhythm. Sixteen patients were cooled to 34°C for a maximum of
4 h with a helmet cooling device and then allowed to rewarm
passively. Two of the patients treated with MTH survived with
a favourable neurological outcome compared with no patients in
the normothermia group.
In 2002, two prospective, RCTs of MTH in the post-
resuscitation management of witnessed OHCA were published.2 3
Table 2 Non-randomised studies
Initial cardiac Cooling method + target
Study Year rhythm temperature T,„g (min) Duration of cooling Outcomes
Bernard6 1997 Any Ice packs 74 12 h No significant side effects. Increased
(n=22) 33°C survival and better neurological outcome
compared with historical controls
Yanagawa7 1998 Any Cooling blanket 414 48 h Cooling associated with increased rates of
(n=13) 33—34°C pneumonia. Higher survival and recovery
rates in hypothermia group
Zeiner25 2000 Any Cold air 276 >24 h No major complications in first 24 h. Mild
(n=27) resuscitative hypothermia shown to be
safe and feasible
Felberg26 2001 Any Cooling blanket 378 24 h No major complications. Cooling methods
(n=9) found to be slow and imprecise.
Favourable neurological outcome
demonstrated
Bernard27 2003 Any Cold fluids (30 ml/kg 4°C ASAP Rapid drop in core body temperature from
(n=22) Ringer's), ice 35.5 to 33.8°C, improved BP and renal
function. No cases of pulmonary oedema
Kim28 2005 Any Cold fluids (2 litres of 4°C ASAP 24 h Fluid infusion did not alter ejection
(n=17) saline) fraction, central venous pressure or
pulmonary pressures
Busch29 2006 Any Sports ice packs and water- 450 12-24h Cooling rates found to be slow. Higher
|n=27) soaked towels placed
prehospital
in-hospital survival rates in cooled
patients
Merchant30 2006 Any Cooling blanket 360 12-24 h Majority of cases showed unintentional
(n=32) overcooling to <32°C
Kliegel31 2007 Any Cold fluids (4°C saline 30 ml/kg/h) 60 24 h Majority reached <34°C in <60 min
(n=20)
ASAP, as soon as possible; BP, blood pressure; Ttarg, time to target temperature.
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Table 3 Cooling methods
Invasive techniques Non-invasive techniques
Cold intravenous fluid infusion Ice packs
Extracorporeal cooling blood circuit Cooling blankets (water/air filled!
Cardiopulmonary bypass Cooling helmets (water/air filled!
Femoral—carotid bypass Cold water immersion




Both of these studies recruited a highly selective cohort of
patients, with 92% of patients initially assessed for eligibility
excluded.
Recruitment criteria for both trials were similar and included
ROSC in patients who remained intubated and ventilated after
OHCA due to VF of presumed cardiac aetiology.
The European trial cooled 136 patients to a core temperature of
32—34°C using a mattress cover that delivered cold air. The aim
was to reach target temperature within 4 h of ROSC, maintain it
for 24 h and then allow passive rewarming to occur. The study
showed the number needed to treat (NNT)=6 (RR 1.40, 95% CI
1.08 to 1.81) for a favourable neurological outcome when MTH
was used. The overall mortality at 6 months was reduced from
55% in the normothermia group to 41% in the MTH group,
NNT=7 (RR 40.74, 95% CI 0.58 to 0.95).
In the Australian study cooling was initiated prehospital
by applying ice packs to the head and torso. The target
temperature (33°C) was maintained for 12 h posthospital
admission before patients were actively rewarmed after 18 h.
Forty-three patients were cooled; 21 (49%) had a favourable
neurological outcome of living at home or within a rehabilitation
facility (RR 1.85, 95% CI 0.97 to 3.49, NNT=4). Mortality was
reduced from 68% to 51% in the hypothermia group (RR 0.76,
95% CI 0.52 to 1.10, NNT=6). These findings led to the Euro¬
pean Resuscitation Council, in association with the Interna¬
tional Liaison Committee on Resuscitation and the American
Heart Association, recommending MTH as standard treatment
for OHCA victims that achieve ROSC following a VF arrest.8
A randomised trial33 of inducing MTH by isovolumic
haemofiltration in patients after OHCA showed an increased
survival benefit, but it was unclear whether this was conferred
by the hypothermic or filtration processes. This technique is not
suitable for use in the emergency and prehospital environment.
A recent clinical pilot study explored the benefit of cooling
patients immediately after OHCA using intravenous cold saline
administered by paramedics in the field.34 An infusion of
500—2000 ml of 0.9% saline at 4°C was administered. Subse¬
quent in-hospital cooling was at the discretion of the attending
physician. Sixty-three patients were treated with prehospital
hypothermia. Only 78% of patients in the hypothermia group
received further cooling. Prehospital cooling led to a significantly
lower temperature on arrival at hospital (34.7°C vs 35.7°C,
p<0.0001). There was no significant difference in survival to
hospital discharge in the hypothermia versus normothermia
groups (33% vs 29%, p=0.70). Subgroup analysis of patients
with VF as the initial cardiac rhythm showed a trend towards
increased survival to hospital discharge but there was a trend
towards increased mortality in the cooling group where the
initial cardiac rhythm was PEA or asystole.
Systematic reviews
Two systematic reviews matched our inclusion criteria. Cheung
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representing 436 patients.17 Inclusion criteria were adults with
primary OHCA who remained comatose after ROSC. The clin¬
ical trials ranged from score 1 to 3 on the Jadad scale and A—C
on the Cochrane grade score. The combined data showed that
MTH decreased in-hospital mortality (RR 0.75, 95% CI 0.62 to
0,84). The review concluded that MTH had an NMT of 5 to
improve neurological outcome and an NNT of 7 to save a life.
However, the review failed to draw conclusions on the optimum
cooling method, rate or duration of cooling. No evidence of
treatment-limiting side effects was reported.
A meta-analysis16 of three trials has shown that patients
treated with hypothermia show an increased rate of survival
with favourable neurological outcome (RR 1.68, 95% CI 1.29 to
2.07). The calculated 95% CI for the NNT to result in a patient
being discharged from hospital with a favourable neurological
outcome ranged from 4 to 13.
DISCUSSION
There is strong evidence to support the use of MTH in comatose
patients after OHCA whose initial cardiac rhythm was VF. The
evidence supporting MTH use in other presenting cardiac
rhythms is less clear and further studies are required. Despite
animal studies demonstrating the benefit of immediate cooling,
either during cardiopulmonary resuscitation (CPR) or immedi¬
ately post-ROSC,12 20 22 the existing evidence from human
studies is less clear.14 Practically, initiating cooling in the
prehospital environment is challenging; however, several studies
have shown that initiating cooling in the ED is feasible and
effective.27 28 31 The different cooling modalities are shown in
table 3. The use of ice packs is a simple, but relatively slow,
means of cooling. A bolus of cold intravenous fluids combines
efficacy with ease of use and is not associated with significant
unwanted side effects. This is probably the cooling method of
choice for the ED. Intravenous fluids can be stored in a refriger¬
ator within the ED and administered to patients following
OHCA shortly after arrival in hospital. Initiating cooling in
the ED is likely to shorten the time to target temperature,
particularly if the patient requires coronary intervention or
radiological imaging prior to ICU admission. Cooling with cold
intravenous fluids can continue during transfer or during clinical
procedures.
The three phases of therapeutic hypothermia are induction,
maintenance and rewarming. For all phases, accurate core body
temperature measurement is essential to ensure accurate cooling
and prevent overcooling. For rapid induction, oesophageal or
central venous temperature should be measured, as probes in the
bladder or rectum do not reflect core body temperature accu¬
rately.35 Overcooling is common.30 After induction, therapeutic
hypothermia can be maintained on the ICU with body surface
cooling techniques with accurate feedback mechanisms, or
invasive, endovascular cooling techniques. In order to prevent
shivering, paralysis and sedation are required. The optimum
length of time for which MTH should be maintained remains
unknown,11 36 but previous studies have used maintenance
periods of 12—48 h.2 ' The optimum means, whether active or
passive, and rate of warming are unknown, and further research is
required to improve the induction, maintenance and rewarming
phases.
Despite strong evidence suggesting benefit, uptake of thera¬
peutic hypothermia in routine clinical practice has been slow.10 37
Lack of awareness, fear of a novel treatment and unknown side
effects, as well as lack of equipment, have been cited as barriers to
MTH implementation.38
CONCLUSION
The use of MTH in patients who remain comatose after OHCA
improves survival and neurological outcome. The optimal time
of initiation, cooling method and target temperature have yet to
be established. Cooling is feasible within the ED, and cold
intravenous crystalloid infusion is effective, simple and safe.
Wider awareness among ED medical staff may increase the early
use of therapeutic hypothermia in patients after OHCA.
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Outcome from OHCA is primarily determined by
prehospital events and meaningful clinical OHCA
research must include data recorded in this setting.
There is little evidence on which to base the practice of
prehospital resuscitation and research in this area
presents huge challenges but is required if survival from
OHCA is to improve. This short report aims to provide
a practical guide to performing prehospital research on
OHCA, based on lessons learned from the Temperature
Post Cardiac Arrest (TOPCAT) research; an observational
study into OHCA.
BACKGROUND
Out-of-hospital cardiac arrest (OHCA) remains one
of the leading causes of mortality across Europe.1
In the 1970s academic clinicians brought out-of-
hospital cardiac arrest (OHCA) research into the
prehospital arena, dramatically improving
survival.2 3 Recent publications have highlighted
the requirement for out-of-hospital clinical research
if basic science is to translate into clinical benefit.4
This report presents a practical description of some
of the challenges involved in United Kingdom
prehospital research based on experiences with the
Scottish Temperature Post Cardiac Arrest
(TOPCAT) study.
in brief, TOPCAT is a prospective observational
study of patients with OHCA during the prehospital
phase of resuscitation, while in the Emergency
Department, and through to the Intensive Care
Unit. Measurements include core body temperature
and serum markers of systemic inflammation and
brain injury. So far, 137 patients have been enrolled
from OHCA resuscitation events involving approx¬
imately 160 different ambulance service personnel
(see Table 1).
PLANNING A PREHOSPITAL STUDY
Ethical approval and consent
The ethical considerations relating to prehospital
research are challenging.5 Patients in cardiac arrest
are unconscious, and in Scotland, the Adults with
Incapacity Act strictly governs research involving
these individuals. Ethical approval from a national
Research Ethics Committee (REC) is required
before undertaking research involving this patient
group. For the TOPCAT study the REC agreed that
consent should be sought from the participant's
next-of-kin at the earliest opportunity. Should the
patient recover sufficiently, retrospective, informed
consent is sought from them. This approach of
waiving initial consent is being more widely
adopted to facilitate research involving incapaci¬
tated adults in an emergency setting 6
Coordinating across agencies
For prehospital research to be successful, coopera¬
tion between members of the research team,
Emergency Medical Dispatch Centre (EMDC),
Emergency Medical Services (EMS) personnel,
Emergency Department and Intensive Care Unit is
vital. All EMS personnel likely to be involved in the
study need to be informed and aware of the
research protocol.5 7 Although EMS personnel may
not be responsible for data collection on-scene,
interaction between all members of the clinical and
research team ensures optimum patient care and
data collection.
Collecting prehospital data
Prehospital research requires excellent relations
with the local ambulance service. EMS in the
United Kingdom do not routinely task a preho¬
spital doctor to OHCA but in the present study, an
Emergency Medicine Specialty Registrar performs
the field research. In order to gather data it may be
necessary to perform clinical interventions not
routinely carried out by EMS such as oesophageal
temperature probe insertion or jugular vein
cannulation to obtain enough blood for subsequent
analysis. Blood samples are promptly transported
back to the hospital, being kept cool with dispos¬
able chemical cooling packs.
Dispatch
In order to allow EMDC to track the registrar's
location and availability to respond the TOPCAT
research, the registrar's car is fitted with a compat¬
ible satellite transponder. On receipt of a possible
cardiac arrest call, EMDC first dispatches an ambu¬
lance response then contacts the research registrar
on a mobile phone, which is switched on only
during on-call periods. A marked response car
equipped with audible and visual warning systems is
used, which has the authorisation of the local police.
Training, insurance and liability
The research registrar received formal response
driver training from the Scottish Ambulance
Service but such training is available from the
police or commercial sources. A specific insurance
policy is required to cover emergency driving. This
is available through several motor insurance brokers
adding approximately 10% to the regular car
insurance policy (eg, Towergate MIA, London).
Emerg Med J 2010;27:637-638. doi: 10.1136/emj.2009.087395 637
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Table 1 Summary of prehospital activity for the temperature post
cardiac arrest (TOPCAT) study (1/08/08—1/10/09)
Total Emergency Medical Dispatch Centre calls to TOPCAT to date 137
Calls attended 106
Cardiac arrest with attempted resuscitation 55
Mean response time ambulance 7.4 min
Mean research doctor response time 10.4 min
On-scene data recorded by the EMS crew and research doctor
are correlated with electronic data from EMDC. Ambulance and
doctor response, together with on-scene times are automatically
recorded via the tracking systems, which update every 13 s.
On arrival at the scene, the research registrar may be requested
to assist the attending EMS crew. Clinical care of the patient
always remains a priority and data collection only commences
when life-saving interventions have been performed. Although no
additional medical equipment is carried by the research registrar,
he frequently assists with endotracheal intubation, intravenous
cannulation and provides reassurance and encouragement.
Only through novel, prehospital research studies involving
close collaboration between clinical researchers and frontline
EMS crews is outcome from OHCA likely to be improved.
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102 Short report
Early in-hospital management of out-of-hospital cardiac
arrest in Scotland: a national survey
Richard M. Lyona, John Shepherdb and Gareth R. Cleggc
Guidelines recommend the use of mild therapeutic
hypothermia (MTH) and percutaneous coronary
intervention (PCI) in the early post-resuscitation
management of select out-of-hospital cardiac arrest
(OHCA) cases. This study aims to assess the current use
of MTH and PCI in Scottish Emergency Departments
(ED) and Intensive Care Units (ICU). We conducted a
questionnaire survey of all the Scottish Emergency
Medicine Consultants, EDs and ICUs. MTH was more
commonly initiated in ICU than in the ED (19; 91 vs. 7;
37%, P<0.05). Only a minority two (11%) EDs routinely
referred OHCA patients for early PCI and only three
(16%) EDs receiving patients after OHCA had on-site
access to PCI facilities. The use of MTH after OHCA
appears to be widespread, although it is infrequently
initiated in the ED. The utilization of PCI in OHCA
management has yet to be widely established.
Increased awareness may increase the use of promising
therapies such as MTH and PCI following OHCA to
save lives. European Journal of Emergency Medicine
18:102-104 © 2011 Wolters Kluwer Health | Lippincott
Williams & Wilkins.
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Introduction
Coronary heart disease is responsible for around 110000
deaths in the UK every year with 75% because of sudden
cardiac death [1]. In Scotland, there are over 3500 out-of-
hospital cardiac arrests (OHCA) annually, with survival to
hospital discharge less than 5% [2].
In the pre-hospital phase effective resuscitation is
required to obtain the return of spontaneous circulation
(ROSC). The only therapy in the post-ROSC phase of
OHCA shown to improve outcome is mild therapeutic
hypothermia (MTH) [3,4]. This study surveys the use of
MTH in Emergency Departments (ED) and Intensive
Care Units (ICU) across Scotland.
In 2002, two prospective, randomized controlled trials of
MTH in the post-resuscitation management of witnessed
OHCA were published [3,4]. These papers led to the
European Resuscitation Council and the International
Liaison Committee on Resuscitation recommending MTH
as standard therapy for OHCA patients with ventricular
fibrillation as the presenting rhythm who remain coma¬
tose post-ROSC [5], Whether MTH may also benefit
patients after OHCA with non-ventricular fibrillation
presenting rhythms is unknown.
There is still uncertainty amongst physicians about using
MTH [6]. Recent evidence suggests that early achieve¬
ment of the desired hypothermic temperature is associated
with a better neurological outcome. If target temperature
is to be achieved early, cooling will need to commence in
the pre-hospital or ED phase of the OHCA patient's care.
0969-9546 (c) 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Primary percutaneous coronary intervention (PCI) can be
considered after ROSC in the management of OHCA.
PCI is currently regarded as the most effective reper-
fusion strategy in ST-elevation myocardial infarction
(STEMI) \1\. Whether PCI is beneficial in cases of non-
STEMI acute coronary syndrome complicated by cardiac
arrest remains under investigation [8],
We sought to investigate the differences in ED and ICU
management of OHCA patients in Scotland and to
establish the degree of consistency in the use of MTH
and PCI in the management of OHCA. We sought to
establish possible reasons for variation in clinical practice
and barriers to implementation.
Methods
A national questionnaire survey was conducted of all
emergency medicine (EM) consultants, EDs and ICUs in
Scotland. Each consultant was e-mailed with an invitation
to complete a web-based questionnaire. All responses were
anonymous and participation was voluntary.
A telephone survey was conducted of all Scottish EDs
(« = 26) and Intensive Care Units {n = 22). On receipt
of the telephone call, a member of the on-duty medical
team was asked to answer the survey questions. Ethical
approval was gained from the University of Edinburgh
Student Projects Committee.
Results
One hundred and thirteen EM consultants were identi¬
fied as working in Scotland. Contact e-mail addresses
DOI: 10.1097/MEJ.0b013e32833cfc40
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were available for 87 of these consultants. Thirty-two
(37%) of the contacted EM consultants completed the
survey. All 26 Scottish EDs and 22 Intensive Care Units
were contacted by telephone. The telephone survey was
completed by 19 (73%) EDs and 21 (96%) ICUs.
Emergency medicine consultant views on OHCA
management
Thirty-two EM consultants responded to the survey. The
majority (27; 84%) felt MTH was effective in the manage¬
ment of OHCA patients and 26 (84%) had experience of
using MTH. A large proportion, (29; 91%) of EM consultants
thought MTH should be commenced earlier (pre-hospital or
ED setting). Twenty-nine (91%) EM consultants thought it
practical to initiate MTH within the ED.
Twenty-one (67%) of ED consultants did not think PCI
should be used routinely in the early management of
OHCA. The major trigger for PCI referral was reported
as an ECG finding of ST-segment elevation.
Emergency Department management of OHCA
Seven (47%) EDs had used cooling before, compared
to 19 (91%) ICUs. MTH was more commonly initiated
Table 1 Emergency Department management of OHCA (n = 19)
Ever used MTH in the ED on a patient post-OHCA?
Yes 7 (37%)
No 12 (63%)
Is it practical to initiate MTH within the ED?
Yes 15 (79o/o)
No 4 (21o/o)
Proportion of post-OHCA patients who have MTH initiated in the ED
None 14 (74o/o)
< 10% 3 (16o/o)
10-25% 1 (50/0)
>25% 1 (50/0)
ED protocol for MTH use in OHCA patients
Yes 4 (21o/o)
No 15 (79o/o)
Method of initiating MTH (if used)
Ice packs 4 (21o/o)
Surface cooling blankets 2 (11o/o)
Exposure only 1 (5o/o)
Cold IV fluids 0 (Oo/o)
Reasons for not initiating MTH in ED
MTH commenced on ICU 8 (42o/o)
Cooling equipment unavailable 6 (32o/o)
Insufficient evidence for using cooling 5 (26%)
Protocol in place for PCI following OHCA
Yes 10 (53o/o)
No 9 (47o/o)
What proportion of post-OHCA patients go for PCI from the ED?
None 4 (21o/o)
< 10% 11 (58%)
10-25% 2 (11o/o)
>25% 0 (Oo/o)




Availability of PCI facilities
24 h a day 11 (58%)
Monday-Friday 09:00-17:00 5 (26%)
Available on request 3 (1 60/0)
ED, Emergency Department; ICU, Intensive Care Unit; MTH, mild therapeutic
hypothermia; OHCA, out-of-hospital cardiac arrest; PCI, percutaneous coronary
intervention.
in ICU than in the ED. [19 (91%) vs. seven (37%),
/><0.05]. The majority of EDs (nine; 47%) did not
routinely initiate cooling. A protocol for MTH was only
present in four (21%) EDs, as shown in Table 1.
A protocol for primary PCI use following OHCA was
available in 10 (53%) EDs. None of the district general
hospitals that received patients following OHCA had
on-site access to PCI. Fifty-nine percent of university
teaching hospitals had on-site access to PCI.
Intensive Care Unit management of OHCA
The majority of ICUs (19; 91%) had experience of cooling
OHCA patients and utilized a protocol (16; 76%), as shown
in Table 2. The majority of OHCA patients admitted to
ICU were cooled with MTH being used in over 50% of
admitted OHCA patients in 14 (67%) ICUs.
Discussion
This study reports on a national survey of Scottish EDs,
ICUs and EM consultants. Compared to studies pub¬
lished earlier, we have found an increase in the use of
MTH in both the ED and ICU setting. A UK survey in
2006 of 98% of all British ICUs found that only 27% had
ever used MTH [9], Our study reports a 90% MTH
experience rate which may imply an increase in the use of
MTH on the ICU for post-OHCA patients. We found the
majority of Scottish ICUs have adopted a cooling protocol
but there remains a variation in the cooling techniques used
and in the length of time MTH is maintained, perhaps
reflecting the lack of clinical evidence in these areas.
The consensus from clinical studies supporting early
cooling has led the International Liaison Committee on
Resuscitation to recommend the initiation of MTH as
soon as possible after ROSC [10]. If target temperature is
Table 2 Intensive Care Unit management of OHCA (n = 21)
Ever used MTH in the ICU on a patient post-OHCA?
Yes 19 (90%)
No 2 (10%)
Proportion of post-OHCA patients who have MTH initiated in the ICU
None 2 (10%)
< 10% 0 (0%)
10-25% 2 (10%)
>25% 17(80%)
ICU protocol for MTH use in OHCA patients
Yes 17(81%)
No 4 (19%)
Method of initiating MTH (if used)
Ice packs 13 (62%)
Surface cooling blankets 14 (67%)
Cold IV fluids 8 (38%)
Wet towels and fanning 5 (24%)
Invasive cooling 2 (10%)
How long are patients cooled on ICU for? (if applicable)
<6 h 0(0%)
6-12 h 1 (5%)
12-24 h 2(10%)
24-48 h 15(71%)
>48 h 1 (5%)
ICU, Intensive Care Unit; MTH, mild therapeutic hypothermia; OHCA, out-of-
hospital cardiac arrest; PCI, percutaneous coronary intervention.
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to be achieved early, cooling will almost certainly have to
be initiated in the pre-hospital or ED phase of an OI ICA
patient's care. Ninety-one percent of EM consultants
thought it practical to initiate MTH in the ED. There
appears to be a positive attitude towards MTH but our
study has shown a discrepancy in best perceived clinical
practice and actual delivered treatment.
None of the surveyed university teaching hospitals
routinely used MTH in the ED. The barriers to imple¬
mentation most often cited for non-use of MTH were
lack of a cooling protocol, lack of cooling equipment or
MTH being initiated in the IGU instead. Studies have
earlier reported similar reasons to our non-adoption of
MTH with the most commonly cited reasons being: lack
of evidence, lack of a protocol, difficulties in practicality
and lack of resources [6], Establishing protocols for MTH
use in the ED and heightened awareness could promote
the use of cooling in the early OHCA management.
Early post-ROSC PCI has also been shown to improve the
survival when used in patients surviving OHCA. Evidence
suggests OHCA STEMI patients are likely to benefit
from early PCI [8]. Whether non-STEMI post-OHCA
should have PCI remains unknown and further research is
warranted to ensure that the intervention occurs in the
correct subset of post-OHCA patients. The management
of OHCA needs to be coordinated on a regional scale in
the form of a cardiac network to ensure patients requiring
reperfusion intervention are transported to the appro¬
priate centre. In our study, none of the district general
hospitals receiving OHCA patients had on-site access to
primary PCI. Some hospitals transferred OHCA patients
direct for PCI. The early use of PCI has yet to be widely
accepted and physicians are still unsure of its place in the
management of OHCA.
There are several limitations to this study. Our low-
sample size may not reflect the opinions and practice of
all physicians in Scotland involved in the care of OHCA
patients. The telephone survey only interrogated one res¬
pondent per department and there is no way of confirm¬
ing the answers being provided.
Conclusion
We have shown that the use of MTH in Scottish EDs is
low. Use of MTH on ICU is increasing. Few EDs routinely
refer OHCA patients for primary PCI and a concerning
number of hospitals receiving patients post-OHCA do
not have on-site access to primary PCI facilities. Greater
understanding of the role of MTH and PCI in the early
management of OHCA will promote these promising treat¬
ments amongst emergency and critical care physicians.
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Abstract
Out-of-hospital cardiac arrest (OHCA) is a leading cause of prehospital mortality
and serious neurological morbidity. Survival from OHCA almost entirely depends
on prehospital intervention by ambulance personnel. Recent evidence has
shown the importance of good quality cardio-pulmonary resuscitation (CPR) in
improving outcome from OHCA. Recent studies have suggested that intubation,
intravenous cannulation and drug administration may distract from basic CPR
and be associated with poor outcomes following OHCA. This article reviews the
latest evidence on prehospital OHCA management and presents the case for a
'back to basics' approach.
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Out-of-hospital cardiac arrest (OHCA) is amajor cause of mortality and morbidityin the UK nd presents the commonest
immediate life-threatening medical emergency
ambulance crews face (Cobb et al, 1996). Survival
from OHCA is almost entirely dependent on the
prehospital resuscitation attempt, but overall
survival to discharge remains poor (<10%). Out-of-
hospital cardiac arrest presents unique challenges
for ambulance personnel and survival is almost
entirely dependent on the prehospital interventions
performed.
The challenge of cardiac arrest
Rapid access to the scene is critical and ambulance
response time targets are largely based on OHCA
research. At-scene, a number of complex tasks
need to be undertaken, often with a limited amount
of space, poor lighting or distressed bystanders.
The initial actions of the on-scene ambulance crew
will often determine whether the OHCA patient
survives. Extrication of OHCA patients can be
challenging—continuing effective resuscitation
while carrying a patient on a stretcher is almost
impossible and performing chest compressions in
a moving ambulance poses significant risks to Lhe
ambulance crew.
In recent years, resuscitation research has
highlighted the need to focus on the fundamentals
of resuscitation, namely CPR and defibrillation,
and has brought into question advanced airway
management and resuscitation drug administration.
Improving cardiac arrest survival
This year marks the 50th anniversary of modern
cardio-pulmonary resuscitation (Kouwenhoven et
al, I960). The 'chain of survival' still remains vital
for a successful resuscitation outcome, with early
access, early CPR, prompt defibrillation and early
advanced care, including therapeutic hypothermia,
being key for survival.
The only three therapeutic interventions proven to
improve survival from OHCA are good quality CPR,
prompt defibrillation and therapeutic hypothermia.
Modern paramedics are taught advanced airway
skills, intravenous cannulation and can administer
a range of intravenous drugs. However, with an
increasing number of paramedics, skills atrophy is
a risk and even paramedics operating in densely
populated regions are only likely to encounter a
small number of OHCA per year.
Most ambulance services measure return of
spontaneous circulation (ROSC) as a key performance
indicator, but recent studies have shown that ROSC is
not necessarily associated with survival to hospital to
discharge, which is the meaningful clinical outcome
measure for OHCA (Olasveengen et al, 2009a).
Ambulance services striving to improve survival from
OHCA need to measure survival to hospital discharge
in addition to ROSC rates.
Cardiac compressions and
defibrillation
Cardiopulmonary resuscitation is vital to maintain
cerebral and cardiac perfusion until ROSC can
be achieved. Studies suggest that immediate
bystander CPR doubles the chances of survival
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to discharge compared to delaying CPR until
emergency medical assistance arrives (Gallagher
et al, 1995)- The quality of CPR delivered by
ambulance personnel is vital. Studies have reported
the adverse physiological consequences of poor
resuscitation technique and have demonstrated that
quality of CPR influences the outcome from OHCA
(Frenneaux, 2003).
Chest compressions aim to provide adequate
perfusion to the vital organs, including the heart,
during cardiac arrest. A short period of just a few
seconds off the chest leads to inrra-oardinc pressure
changes—the right ventricle dilates and the left
ventricle is compressed, leading to a cardiac state
where even in the presence of ventricular fibrillation,
a defibrillatory shock will not be effective.
Tracheal intubation, establishing intravenous access
and extrication all interrupt chest compressions.
Neither endotracheal intubation nor administration
of resuscitation drugs have been definitively shown
to improve survival from OHCA (Olasveengen et
al, 2007). Recent" evidence suggests an increased
hands off chest' during CPR is associated with poor
outcome (Christenson et al, 2009).
Cardiac rhythm recognition can be performed by
trained healthcare professionals, including many
ambulance crews, or automated cardiac rhythm
recognition can be used. Automated rhythm
analysis will often take longer than an experienced
health professional, resulting in increased delay-
to-shock times and decreased chance of successful
defibrillation (Yu et al, 2002; Kramer-Johansen et
al, 2007).
There is a need to monitor compliance of CPR
performed by ambulance crews in accordance
with current international resuscitation guidelines
(Olasveengen et al, 2007) as previous studies have
demonstrated poor compliance with recommended
chest compression depth, rate and pauses in
chest compressions (Wik et al. 2005; Steen and
Kramer-Johansen, 2008). There have been calls for
regular monitoring of CPR quality and for uniform
reporting of CPR variables (Kramer-Johansen et
al, 2007a). Determining the quality of prehospital
resuscitation performed by ambulance crews in the
field is technically difficult, but crucial if prehospital
care of OHCA patients is to improve (Olasveengen
et al, 2009b).
Currently, there is research ongoing in Scotland
evaluating the role of resuscitation downloads
and paramedic feedback in auditing prehospital
resuscitation quality and assessing whether survival
can be improved using trans-thoracic impedance
analysis technology, as shown in the Appendix.
Resuscitation drugs
Advanced life support practice has recommended
Figure 1. Out-of-hospital cardiac arrest survival is almost entirely
dependent on the prehospital interventions performed.
the use of adrenaline, atropine and amiodarone,
despite only animal studies suggesting survival
benefit. For decades, ambulance personnel have
been administering drugs without this practice
being critically evaluated in a randomized trial. A
group from Oslo in Norway recently undertook
such a trial (Olasveengen, 2009a). Despite the
challenges of conducting prehospital research, over
900 patients with OHCA were included in the trial.
Patients were randomized to standard resuscitation
care (including intubation, defibrillation and
intravenous drugs) or a protocol that omitted
the use of drugs. The study found no significant
difference in survival to hospital discharge
between the two groups (10.5% in standard care
vs 9.2% in the no drugs group, p=0.6l). There
was no difference in the quality of CPR between
the two groups. These results question the value
of administering drugs during resuscitation from
sudden cardiac arrest.
Airway and ventilation
The introduction of paramedic practice by
ambulance services aimed to bring advanced life
support to the patient including tracheal intubation.
Paramedic intubation in the UK is usually limited
to patients who do not require drug assisted
intubation—the majority of these have had an
OHCA.
The most appropriate advanced airway
intervention in OHCA is unknown. Tracheal
intubation without anaesthetic drugs for OHCA is
not associated with increased survival rates (Murray
et al, 2002), yet tracheal intubation is currently a
core skill on the paramedic syllabus.
There is a significant complication rate
associated with prehospital tracheal intubation by
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Figure 2. Animal model (murine) showing the effect of increasing
the time interval from cessation of chest compressions to
delivering a defibrillator shock. In this model, when the 'hands
off' time was 20 seconds or greater, no animals survived
(Redrawn from: Wu et at, 2002).
Box 1. Improving resuscitation practice
• Resuscitation training, including practical training, is required at least every
six months
• Survival to hospital discharge rates should be reported in addition to return
of spontaneous circulation following OHCA
• The quality of prehospital resuscitation should be audited in addition to
ambulance response time.
paramedics and other airway strategies have been
suggested. Supraglottic airway devices are well
established in anaesthetic practice and have been
used successfully in OHCA patients (Sasada and
Gabbott, 1994). Supraglottic airways have recently
been recommended by the Joint Royal College
Ambulance Liaison Committee (JRCALC).
A recent study from southeast Scotland
demonstrated surveyed prehospital tracheal
intubation in 628 patients (Lyon et al, 2010).
Successful endotracheal intubation was achieved
in three or fewer attempts in 573 (91.2%) of these
patients. In 55 patients, tracheal intubation was
associated with a signilicant problem, mainly
unrecognized oesophageal intubation.
One hundred and ten of 628 patients who
underwent prehospital tracheal intubation survived
to hospital admission from the ED. 55 patients who
did not undergo prehospital tracheal intubation
survived to hospital admission. Survival to
admission was higher in patients who did not have
prehospital intubation performed (33.1 vs 17.5%,
p<0.0001). The LMA was not used on any patients.
Repeated attempts at laryngoscopy or inability to
intubate the trachea compromises oxygenation and
ventilation, extends on-scene times and increases
the risk of aspiration. Advanced airway skills
used by paramedics confer no increased survival
compared to patients attended by ambulance
technicians with basic airway skills (Guly et al,
1995).
Most clinicians rely on a combination of direct
vision and auscultation to confirm tracheal
tube position. Capnography is the most reliable
method of confirming tracheal tube placement
in the prehospital setting, but requires a specific
electronic monitor. A number of simple devices are
available to confirm tracheal placement including
the Ambucheck™ device and colorimetry. Many
UK ambulances are not equipped with any such
device. In patients in cardiac arrest, the delivery of
carbon dioxide in the pulmonary circulation can be
variable. Capnography can therefore be unreliable
in confirming tube position in these patients and
should therefore be used in conjunction with other
confirmatory techniques.
In this study, prehospital tracheal intubation
was associated with decreased rates of survival
to admission. The reasons for this are likely to be
multi-factorial. Tracheal intubation may distract
from providing good quality basic life support,
defibrillation and delay on scene times. Tracheal
intubation and ventilation with oxygen will result
in an inspired oxygen concentration of close to
100%. Ventilating cardiac arrest patients with 100%
oxygen may increase oxidative stress and reactive
oxygen species production which can contribute to
neuronal cell death (Kramer-Johansen et al, 2007a).
A number of studies have examined the use
of the laryngeal mask airway (LMA) in OHCA
(Olasveengen et al, 2007; Steen and Kramer-
Johansen, 2008). The LMA has a number of
potential benefits—the need for relatively little
training or ongoing competency requirements, ease
of insertion and less risk of incorrect placement.
Using an LMA in OHCA has few complications
and has not been shown to negatively impact
on survival when compared to basic airway
management (Steen and Kramer-Johansen, 2008).
The 2008 JRCALC guidelines include a
recommendation that the use of supraglottic airway
devices should be considered by ambulance crews.
Currently, however, there is little guidance for
paramedics on when to use an LMA or intubate the
patient and availability of LMAs varies across UK
ambulance services.
A study from Arizona has shown that by delaying
intubation and focusing on early continuous
chest compressions and defibrillation, survival
to discharge after sudden cardiac arrest tripledl9
and this finding has been replicated by other
emergency medical services (Garza et al, 2009).





Ambulance paramedic training teaches advanced
skills, including advanced airway management,
cannulation and drug administration. These newly
acquired skills, when eagerly put into practice for
the first time, can distract from the basic elements
of CPR. While advanced clinical intervention
may be required in some cases, accurate clinical
decision-making is required to ensure interventions
are performed appropriately and paramedic training
should address this. For example, the decision on
when to move a patient from the OHCA scene,
particularly if the patient has a shockable cardiac
rhythm, can have far-reaching consequences as CPR
on the move is invariably ineffective.
On completion of paramedic certification, there
can be minimal on-going training and regular
assessment of resuscitation skills. Research has
shown that skill decay is present in even the most
experienced paramedics and practical training,
theoretical updates and assessment should be
performed at least every six months (Perkins and
Mancini, 2009).
Therapeutic hypothermia
Cooling patients to 32-34°C for 24-hours after
a witnessed VF OHCA has been shown to
dramatically improve survival (Bernard et al, 2002;
The Hypothermia After Cardiac Arrest Study Group,
2002) and has been recommended as standard
treatment in the management of these patients.
However, a key question on when to commence
therapeutic hypothermia remains unanswered—
when to start cooling. Previous studies have shown
tlie beneficial effect of therapeutic hypothermia
persists even when cooling is commenced several
hours after the OHCA (The Hypothermia after
Cardiac Arrest Study Group, 2002).
Cooling post-OHCA patients in the prehospital
phase requires additional equipment and to-date,
no studies have demonstrated that early cooling,
in the prehospital phase by ambulance personnel,
confers additional survival benefit (Kim et al, 2009;
Bernard et al, 2010). Ambulance personnel should,
therefore, concentrate on good quality basic
resuscitation to achieve ROSC at-seene and ensure
a rapid subsequent transfer to hospital, where
cooling can commence.
Conclusion
The latest evidence from resuscitation research
suggests a 'back to basics' approach is required
with a focus on high quality CPR and prompt
defibrillation. There is no evidence to support early
intubation during resuscitation following OHCA and
Key points
• Chest compression fraction is associated with outcome from out-of-hospital
cardiac arrest (OHCA).
• Resuscitation should maintain a high 'hands-on-the-chest' time with minimal
interruptions for defibrillation.
• Early intubation may be associated with a worse outcome from OHCA.
• Trial data suggest resuscitation drugs do not improve the survival to
discharge rate from OHCA.
recent studies question the value of intravenous
drug administration during OHCA. Good quality
basic prehospital resuscitation, with an emphasis on
'hands on the chest', will save lives.
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S T R A C T
Background: Out of hospital cardiac arrest (01ICA) is a leading cause of pre-hospital mortality. Chest com
pressions performed during cardiopulmonary resuscitation aim to provide adequate perfusion to the vital
organs during cardiac arrest. Poor resuscitation technique and the quality of pre hospital CPR influences
outcome from OHCA. Transthoracic impedance (TTI) measurement is a useful tool in the assessment of the
quality of pre hospital resuscitation by ambulance crews but TTI telemetry has not yet been performed
in the United Kingdom. We describe a pilot study to implement a data netwoi k to collect dcfibi hiatus TTI
data via telemetry from ambulances.
Methods: Prospective, observational pilot study over a 5 month period. Modems were fitted to 10 defib
rillators on ambulances based in Edinburgh. TTI data was sent to a receiving computer after resuscitation
attempts for OHCA.
Results: 58 TTI traces were transmitted during the pilot period. Compliance with the telemetry system
was high. The mean ratio of chest compressions was 73% (95% CI 69 77%), the mean chest compression
rate was 128 (95% CI 122 131). The mean time interval from chest compression interruption to shock
delivery was 27 s (95% CI 22-32 s).
Conclusion: Trans thoracic impedance analysis is an effective means of recording important measures of
resuscitation quality including the hands on the chest time, compression rate and defibrillation interval
time. TTI data transmission via telemetry is straightforward, efficient and allows resuscitation data to be
captured and analysed from a large geographical area. Further research is warranted on the impact of
post-resuscitation reporting on the quality of resuscitation delivered by ambulance crews.
© 2010 Published by Elsevier Ireland Ltd.
1. Background
Out-of-hospital cardiac arrest (OHCA) is one of the leading
causes of mortality and serious neurological disability in Europe.
Cardiopulmonary resuscitation (CPR) is vital to maintain cere¬
bral and cardiac perfusion until return of spontaneous circulation
(ROSC) can be achieved.
Several recent studies have reported the adverse physiological
consequences of poor resuscitation technique1 and have demon¬
strated that quality of pre-hospital CPR influences outcome from
OHCA.2'3
Chest compressions aim to provide adequate perfusion to the
vital organs during cardiac arrest. Periods during which chest com
pressions are not performed result in lack of blood flow - defined as
* Corresponding author. Tel.: +44 0131 242 1338: fax: +440131 242 1339.
E-mail address: richardlyon@doctors.org.uk (R.M. Lyon).
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no blood flow time (NBT). Recent clinical evidence shows increased
NBT during CPR is associated with poor outcome.2
A variety of factors influence the delivery of effective chest com¬
pressions. Tracheal intubation and obtaining intravenous access
for subsequent drug delivery interrupt chest compressions, but
no high level evidence exists to show that cither intervention
improves survival from OHCA in humans.4'5 Automated rhythm
analysis will often take longer than manual rhythm interprota
tion by a trained healthcare professional, resulting in increased
delay-to-shock times when ambulance defibrillators are used in
automatic mode.6'7
Calculating the NBT has important implications for resuscita¬
tion training, optimising the quality of resuscitation and clinical
outcome after OHCA.8
There have been calls for regular monitoring of CPR quality
and for uniform reporting of CPR variables.9 Ambulance crews
receive initial training in performing CPR pre-hospital but receive
variable training updates. Individual crews are likely to encounter
PleaS* t il* Hii> article in press as: Lyou RM, et <tl. Resuscitation quality assurance for Out-tif-hospiUl cardiac arrest - Setting-up an ambulance
defibrillator telemetry network. Resuscitation (2010), doi:l 0.1016/j.resuscitation.2010.09.007
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few OHCA and skill retention can be problematic. There is a need
to monitor compliance of CPR performed by ambulance crews in
accordance with current international resuscitation guidelines,10
as previous investigation of pre hospital practice has demon¬
strated poor compliance with recommended chest compression
depth and rate, compounded by pauses in delivery of chest
compressions.11'12
Determining the quality of pre-hospital resuscitation performed
by ambulance crews in the field is technically difficult, but crucial
if pre-hospital care of OHCA patients is to improve.13
Transthoracic impedance (TTI) measurement is a useful tool
in the assessment of the quality of pre-hospital resuscitation by
ambulance crews.8,10 The TTI signal is already recorded through
the pads of many models of external defibrillator without the need
for any further equipment to be placed on the patient. Both chest
compressions and ventilations result in identifiable changes in the
TTI trace. Analysing the trace allows a variety of resuscitation met¬
rics including the hands-on-the chest time, compression rate and
time-to-shock intervals to be accurately measured.
Analysing the TTI trace from individual defibrillators following
a resuscitation attempt requires the data to be downloaded to a
computer, before analysis with software can occur. Data can be
downloaded from the defibrillator using a direct cable connection
or transmitted wirelessly via telemetry. The former requires the
defibrillator to be taken to a download station post-resuscitation,
is labour intensive, may delay ambulance crews returning to clinical
duties and may result in a poor data capture rate. Sending the TTI
data via telemetry allows more convenient data transmission post-
resuscitation, which can be achieved directly from the ambulance
and allows remote data access.
Logging and analysis of TTI data from ambulance defibrillators
after OHCA does not yet occur routinely in the United Kingdom.
We describe a pilot study to implement a data network to collect
defibrillator TTI data via telemetry from ambulances in the City of
Edinburgh, Scotland.
2. Methods
Ambulance crews in Scotland currently use the LIFEPAK 12
(Physio Control) defibrillator and transmit 12-lead electrocardio¬
graph (ECG) data to Cardiology units using a low bandwidth
telemetry system. The data file containing the TTI trace for each
OHCA event was found to be significantly larger (500 kb - 3.5 MB)
than a 12-lead ECG and transmitting such a large data file via
telemetry was initially found to be problematic. Attempting to con¬
nect the defibrillator to a mobile telephone for data transmission
via the existing Bluetooth system resulted in frequent signal fallout
and unacceptably long (>20 min) data transmission times.
In our pilot project general packet radio service (GPRS) modems
were fitted to 40 defibrillators on ambulances based at Edinburgh
City Ambulance Station. This enabled faster, reliable data transmis¬
sion. The modems were housed in a sealed case attached to the rear
of the defibrillator and connected via serial cable. Operation of the
modem was automatic and did not require any intervention by the
ambulance crews.
Ambulance crews were informed via email and posters of the
need to transmit the TTI trace following a resuscitation attempt and
a sticker with detailed instructions was placed on each defibrillator
as a reminder.
Following each resuscitation attempt, the attending ambulance
crew selected the respective case and instructed the defibrillator
to transmit the data. The TTI trace was typically transmitted in
under 2 min using this technology. A choice of two different receiv¬
ing targets was pre-configured on the defibrillator menu allowing
transmission of a resuscitation attempt after OHCA or a 12-lead ECG
in patients with suspected myocardial infarction as per the existing
local protocol.
The TTI data packets are sent via GPRS and world-wide web to
a LIFENET Server (Physio-Control). The LIFENET server then directs
the data packet securely onwards to a receiving computer or mul¬
tiple receiving destinations. No patient data is held on the server.
To receive the TTI data, a computer with a permanent broadband
internet connection is required. The data packet is stored and anal¬
ysed using proprietary software (CODESTAT, Physio Control). The
system can be configured to send an email notification to the study
team on receipt of a TTI trace. The LIFENET system is a subscription
service. The cost will vary depending on local mobile telephone
operators but the approximate monthly cost is £30 per ambulance
and £375 per hospital.
Importantly, we chose not to include patient-identifiable data
in the transmission. Clinical data were matched probabilistically to
the date and time of transmission and the individual defibrillator.
After receipt of the TTI trace, CODESTAT software was used to
calculate the no-flow ratio, compression rate and time interval to
administer defibrillatory shocks. A resuscitation report was gener¬
ated that was printed and sent as part of feedback and training to
the attending ambulance crew.
3. Results
During the initial pilot study period (1/11/2009 to 1/4/2010) 58
TTI traces were transmitted following OHCA. We found compliance
with the system amongst ambulance crews to be high with many
positive comments received on the usefulness of receiving post-
resuscitation reports.
In two cases (3%), ambulance crews reported being initially
unable to send the TTI data packet but when the ambulance moved
location the data was sent successfully, indicating a region with
poor GPRS signal as the likely cause of the failure.
All TTI traces were received and analysed on a single computer.
During the study period, a hard drive error on the receiving com¬
puter resulted in permanent loss ofdata for 18 traces. Subsequently,
a data back-up system was installed to protect against hardware
failure.
From the initial 58 TTI traces received, the mean ratio of chest
compressions was 73% (95% CI 69-77%), the mean chest compres¬
sion rate was 128 (95% CI 122-134). There were 19 resuscitation
attempts where at least once shock was administered from the
defibrillator. The mean time interval from chest compression inter¬
ruption to shock delivery was 27 s (95% CI 22-32 s)
4. Discussion
This is the first study to describe TTI telemetry in the United
Kingdom. We found establishing a telemetry network to be an
effective, time-efficient means of pre-hospital resuscitation data
collection. Using GPRS technology to transmit TTI traces proved to
be a reliable, rapid means of transmitting data to a remote computer
for analysis. Data security and back-up is important to prevent loss
of data in the event of a hardware failure.
Previous studies have highlighted the need to collect data on and
monitor the quality of CPR performed by ambulance crews but few
studies have described the methodology for collecting such data.
Initial TTI data collected in our region has demonstrated the need
to improve pre-hospital resuscitation practice.
A limitation of this pilot study was that we did not identify all
OHCA cases attended by the modem-equipped ambulances during
the study period to measure overall ambulance crew compliance
with transmitting the traces.
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5. Conclusion
Evaluating quality of pre-hospital resuscitation practice is
important to assure quality and to improve outcomes from
OHCA. TTI analysis is an effective means of recording impor¬
tant measures of resuscitation quality including the hands-
on-the-chest time, compression rate and defibrillation interval
time. TTI data transmission via telemetry is straightforward,
efficient and allows resuscitation data to be captured and
analysed from a large geographical area. Further research
is warranted on the impact of post-resuscitation report¬
ing on the quality of resuscitation delivered by ambulance
crews.
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Appendix II - TOPCAT Data collection form
TOPCAT Data Collection Form
PATIENT DETAILS -
Emergency Dept episode number imn
Date QDGIGMII3 '
Sex (circle) male female
Study number (to be completed by Investigator) L
Lead Resuscitation care provider 1 F I I 1
Study number (to be completed by Investigator)
INITIAL ASSESSMENT
In cardiac arrest on arrival to resuscitation (circle) No Yes
If in arrest, presenting rhythm (circle) VF/ Pulseless VT /PEA/ Asystole / Agonal
GCS on arrival eO mO vG
Intubated pre-hospital (circle) No Yes
ET tube in correct position on arrival in the ED (circle) No Yes
Intubated/re-intubated in ED (circle) No Yes Bagged/ventilated in ED (circle) No
Chest compressions performed (circle) No Yes
If yes (circle): Manual LUCAS device
Defibrillated in ED (circle) No Yes
Number of DC shocks given L _TG
Adrenaline given in ED (circle) r No Yes
Yes
Total in number of Mini-jets (mg)
Any return of spontaneous circulation (ROSC) (circle) No Yes
Time of first ROSC [ H | H 1.[mTG
Any queries please contact Richard Lyon, bleep # 6461
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Temperature First tympanic temperature recording in °C 1 1 I.I 1 °C 1
First oesophageal temperature recording °C L J I.I I °C 1
I
Was the patient actively cooled in the ED? (circle) No Yes □
Method (circle): ice packs cooling blanket cold saline 1 D
Earliest gas result (circle): arterial venous 1 □
pn?l 1 II IkPA pm? 1 1 II IkPA H+l 1 1 II 1 mmnl 1 |
Rirarh 1 II 1 mmnl lactate 1 1 1
1
1
1 DISPOSAL 1 I
1 fc
Hate left the PH 1 D | D |/| M | M |J Y | Y | Time let! the PH 1 H | H |.| M M] 1




Dale of death I J ^ l/l M |'r. I/I ' I 1 Time of death | H | H |.| M Ml
y














Systemic inflammatory markers - laboratory protocol
All samples were stored at -80°C. Before analysis, samples were thawed to +4°C. Markers
of systemic inflammation were measured in serum.
Materials included in the CBA kit
Human Inflammatory Cytokines Capture Beads (A 1-6)
Wash buffer - 260ml bottle of phosphate buffered saline solution containing protein and
detergent.
Assay diluent - a single, 30ml bottled of a buffered protein solution used to reconstitute and
dilute the Human Inflammatory Cytokines Standards and to dilute test samples.
Serum Enhancement Buffer - A single, 10ml bottle of a buffered protein solution used to
dilute mixed capture beads.
Human Inflammatory Cytokines PE detection Reagent (B)
Human Inflammatory Cytokines Standards (C)
PE Positive Control Detector
FITC Positive Control Detector
Materials required but not provided in kit
A flow cytometer equipped with a 488nm laser capable of detecting and distinguishing
fluorescence emissions at 576 and 670 nm.





Neuron Specific Enolase Assay
Liaison NSE kit
A fully automated Liaison analyser (Diasorin, Italy) was used with an NSE module (Ref
314561) to assay for NSE in the TOPCAT serum samples.
Materials provided in the NSE kit:





Tracer conjugate (14ml): anti-NSE tracer, labelled with isoluminol, monoclonal
(mouse)
Materials required but not provided:
Liaison Module (Ref 319130)
Liaison Starter Kit (Ref 319102)
Liaison Light Check (Ref 319101)
Liaison Wash/System Liquid (Ref 319100)
Liaison Waste Bags (Ref 450003)
Assay procedure
The Liaison Automated Analyser was configured according to the Analyser
Operator's Manual. Liaison Calibration Solution was used to calibrate the NSE high and low
levels. The Analyser operation was as follows:
25 pi TOPCAT serum sample
+ 20pl Coated magnetic particles
+ lOOpl Tracer conjugate





A fully automated Liaison analyser (Diasorin, Italy) was used with an SI00 module (Ref
314701) to assay for SI00 in the TOPCAT serum samples.
Materials provided in the NSE kit:
Magnetic particle suspension (2.3ml): magnetic particles coated with anti-SlOO,
monoclonal (mouse)
Assay buffer (14ml)
Tracer conjugate (23ml): anti-SlOO tracer, labelled with isoluminol
Materials required but not provided:
Liaison Module (Ref 319130)
Liaison Starter Kit (Ref 319102)
Liaison Light Check (Ref 319101)
Liaison Wash/System Liquid (Ref 319100)
Liaison Waste Bags (Ref 450003)
Liaison SI00 calibration (low/high) (Ref 319117)
Assay procedure
The Liaison Automated Analyser was configured according to the Analyser
Operator's Manual. Liaison SI00 Calibration Solution was used to calibrate the SI00 high
and low levels. The Analyser operation was as follows:
100 pi TOPCAT serum sample
+ 20pl Coated magnetic particles
+ lOOpl Assay buffer
10 min Incubation followed by a wash cycle
+ 200pl Tracer conjugate




All samples were stored at -80°C. Before analysis, samples were thawed to +4°C. GFAP was
measured in serum.
ELISA protocol:
1. Samples were diluted 3x
2. A standard dilution curve was used (25ng/ml-0.25ng/ml)
3. lOOpl of diluted Standards, Quality Controls, Standard Diluent and samples were
pipetted, in duplicate, in wells pre-coated with polyclonal anti-human GFAP anti¬
body.
4. The plate was incubated at 25°C for 2 hours, shaking at 300rpm on an orbital plate
shaker.
5. The wells were washed 3-times
6. lOOpl of Biotin Labelled Antibody solution was added to each well.
7. The plate was incubated at 25°C for 1 hour, shaking at 300rpm on an orbital plate
shaker.
8. The wells were washed 3-times
9. lOOpl of substrate solution was added into each well and the plate protected from
light.
10. The plate was incubated for 15-miutes.
11. The colour development was stopped by adding lOOpl of Stop Solution.
12. The absorbance of each well was determined using a microplate reader set to 450nm.
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Neutrophil cell surface marker detection
Whole blood was stained for CDllb, CD64 and L-selectin (CD62L), using fluorophore
conjugated murine monoclonal antibodies (Invitrogen, Paisley, UK). The fluorophores were
R-phycoerythrin (RPE), tri-colour (TC) and fluorescein isothiocyanate (F1TC) respectively.
Murine IgGl conjugated to the relevant fluorophore was used as an isotype control.
Antibody, or isotype control, was added to 50pl whole blood and incubated at 4°C for 30
minutes. The leucocytes were then fixed and erythrocytes lysed by the addition of 450pl of
FACSlyse (BD Bioscience, Oxford, UK). Fixed cells were then analysed on a FACScan
flow cytometer (BD Bioscience), and neutrophils gated by forward and side scatter
characteristics. Previous confirmation of these gate positions was obtained using CD 16 and
CD 14 stains to identify neutrophils and monocytes respectively (data not shown). Expression
of the cell surface marker was measured as geometric mean fluorescence, using the arbitrary




Details of 3-day response driver training course.
Day 1 Cockpit drill
Introductory drive




Introduction to the driving system
Steering
Day 2 Driving system (rural)
Corners and bends
Box overtaking




The Law, exemptions, non-exemptions
Day 3 Emergency Driving
Route planning
Red mist
Arriving at the scene






WILLIAM BRACKENRIDGE *u<Hon.> use
KEVIN DORAN
BETTER DRIVING COURSE
18™ -20th AUGUST 2008
Dr Richard Lyon







As part of the 'Topcat' study in to core temperature of pre-hospital
cardiac arrests, the Scottish Ambulance Service agreed to provide an
intensive driving awareness course to Or Richard Lyon, SpReg who is
leading the study.
This course was predominately conducted in the car Dr Lyon will be
using for the study.
The course, provided over three days, covered an introduction to
systematic driving, heightened observations and hazard awareness. It
was split in to three parts
Part 1: Urban driving
Part 2: Rural driving and skid avoidance.
Part 3: Emergency driving.
Report
Initially, Dr Lyon, presented as a competent driver who displayed a few
bad habits that had developed over his years of driving. These included
resting his foot on the clutch pedal and over use of the indicators.
He adapted his driving style quickty to include a systematic approach to
the presented hazards. To achieve this, he developed his observation
skills to obtain a greater all round view from the vehicle.
His existing steering technique was effective, but he adopted 'three
pressure' braking which led to consistently smooth stopping
procedures.
Whilst negotiating rural routes, Dr Lyon was introduced to cornering
techniques. This improved his ability to read corners, using limit points
and subsequently to maintain progress through corners without
overuse of the brakes.
In addition, on day two, he attended a 2-hour skid avoidance course at
Knockhill that covered cadence braking and how to correct all types of
skids.
During the course, he was briefed about the exemptions and non-
exemptions he can claim whilst conducting an emergency drive. He had
the opportunity to attend emergency calls, which required driving on
both urban and rural routes. This highlighted many teaching points with
regard to the actions of other motorists.





The course also covered correct procedures to adopt on arrival at the
scene and what to do if he was the first person on scene.
Conclusion
At the completion of the three days, Dr Lyon was using advanced
observation skills to produce effective driving plans. This led to smooth,
systematic drives being demonstrated with the emphasis on safety.
Neil Proven
Divisional Training Officer








Oropharyngeal airways size 2,3,4
Nasopharyngeal airways sizes 6,7
Hudson mask with reservoir
Nebulizer mask
Bag-valve-mask with 02 tubing
Laryngoscope with size 4 blade
Magill's forceps
Endotracheal tubes sizes 6,7,8,9











































"D" size oxygen cylinder
Phillips FR2 semi-automatic defibrillator




Ambulance crew perceptions of a pre-hospital doctor
at the scene of out-of-hospital cardiac arrest
Question 1.
In the ambulance service, what is your primary role?























Have you worked with a doctor in the field before? (tick all that apply)





















At your recent call at which the TOPCAT doctor was present, was the emergency


















Please rate the following statements relating to your
doctor. Please answer all statements.


























































































Overall, how do you rate the usefulness of having a doctor present at the call you were attending?






















If you found it useful having a doctor at the call you were attending please briefly
say why.
Dr Lyons gave better understanding of unfolding events and has a far greater knoweledge
from which to take from.
Ability to make clinical decissions without our protocols in the best interest of patient and
family.
finding it difficult to cannulate pt,doctor cannulated pts neck to very good effect, doctor
explained the importance of not stopping cpr ,and the statistics of stopping very breifly.the
importance of core temp.
good to have someone with hospital intervention performance at the scene
I have had several experiences of this Doctor attending & have found each occassion to be
beneficial not only to the patient but to myself & colleagues in way of learning different
techniques & more specialised treatments or considerations.
Although the clinical procedures carried out during the incident were the same as we
usually do, I feel that much more time was taken at the incident. We, as ambulance
personnel, have a tendancy to 'load and go1 so the patient can receive more definitive
treatment by Doctors in the hospital environment. However, this incident taught me to allow
myself time to carry out the skills I have. It also made me reconsider my CPR technique
and that the quality, along with the time factor can be of GREAT benefit to the patient.
Giving us guidance in performing better cpr than we are currently taught to do.
expert advice and feedback on CPR technique.
Obese patient with a difficult airway, unable to intubate,
doctor able to gain i/v access and intubate patient
The patient was very large and the doctor assisted in getting a venflon in while working in a
confined space.
It was useful because although it would have been futile to have transported our patient to
hospital, we had no reason not to according to our JRCALC guidelines. Having a Doctor
present to make that decision was very useful and the patiend was PLE'd on scene.
He was able to interprate to ECG during the arrest and advise us on the best time to move.
Having any extra medical professional is always helpful, even more so when that person is
an expert in their field.
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Always helpful to have greater medical expertise present at a cardiac arrest. Instead of
simply following a set protocol there was opportunity for applying knowledge and learning
during the event how to improve outcome for the patient.
Question 7.
Did the doctor perform any interventions that were outwith your usual protocol?
Answer Options ResponsePercent Response Count
No
Yes










Number Yes (please give details)
1 temperature monitoring
Administered Bicarb IV
2 Inserted Nasal thermometer
3 central line
4 administer drugs that paramedics/technicians don't carry.
stept out of paramedic guidlines for resusitation of astmatic arrest.ie 1,1000 im
5 epinepherin and admin salbutamol.
Giving the patient drugs I am not authorised to use. Although a paramedic was
present to administer certain drugs, doctors have a far wider range than the
6 ambulance service.









14 Central IV line
Doctor was willing to PLE patient at the scene, making it easier on the family as the
patient had been in Cardiac Arrest for some time, when we would have had to
15 transport within our protocols.
Central line cannulation
16 core temperature monitoring
17 Gave more fluids than would be usual at this type of arrest
18 administration of 8 x 500ml saline fluid IV for hypovolaemia
19 cessation of resuscitation outside normal Sas parameters
20 canulated, intubated patient and administered cardiac drugs and fluids
21 CANULATION AND ADMINISTRATION OF DRUGS
22 A central line (IV) was in place.
A central line was in place, I have never seen this before and have just recently asked
23 paramedics if they are able to do this.
cannulated pts neck to very good effect, return of spontanious pulse after small
24 amount of cardiac drugs.pt made resp. effort enroute to hosp.
25 central line
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A Line. Drug administration outwith Paramedic guide lines.
IV access was gained through the neck
cpr during shock load up and straight after delivering a shock when
a patient has an output.
Higher emphasis on compressions, less on breaths. Greater use of manual mode on
defibrillator
LMA. Paramedics are given training on the use of LMAs but we currently do not carry
them.
doctor able to gain i/v access and intubate patient
Central Line
Simply encouraging more chest compressions - at every opportunity and in particular
while the defib was charging before shocking.
Question 8.
Do you feel a skilled doctor working in the pre-hospital environment is


















If you feel a doctor can be beneficial in the field, please indicate in which cases. (Please tick all
that apply)





















In dispatching a doctor to the scene, would you prefer (please tick all that apply)
Answer Options ResponsePercent Response Count
Direct dispatch by Control
































Unable to tick more than one strongly agree box on the survey.
The incident i was at Dr Lyons was very useful at the scene due to the nature of the
job. A 22 year old female in cardiac arrest due to suspected OD.
The survey is very limited in its questioning and not all answers can be answered with
a yes or no reply.In certain situations the experianced paramedic having worked with
medic one or in the resuss room knowes what needs to be done in respect to drugs
and treatment but has not got the authority or drugs to do what needs to be done
I think it will always be useful to have someone whose medical experience can bring
increased patient care, as long as that presence does not hinder the safe removal and
transportation of patient to a hospital environment.
Doctotrs would be more beneficial if there were no paramedics available.it would also
depend on the sevrity of the case.
All though a doctor can somtimes be useful, I think it has to be remembered that
paramedics are highly trained and very skillful in their own field. Although we are not
doctors and hopefully no one ever tries to act like one, we do a very good job on our
own and are not afraid to request help when required, medic one, for example. If
doctors were to become a permanant feature in the out of hospital arena, ambulance
crews would be relegated to taxi drivers, again.
I think it should also be noted that as pro drivers, our skills are developed after our
course has finished. Just completing an emergency driving course does not make you
a safe and competent driver and you really do need to be driving every day at speed,
to develop.
As I said, when requested by ourselves, doctors in the field are a great help, often
saving a life that would otherwise have been compromised if not lost. All I ask is that
you let paramedics and technicians do their job while doctors do their's in hospitals
and together the patient receives the best treatment from call to discharge.
Most GP's on scene are happy to take a 'back seat' and assist when requested. It is
useful to have a pre hospital specialist on scene, but in the majority of cases there
may be no need.
It is very difficult to ascertain the severity of a call on the phone, which would make it
in-appropriate to dispatch a doctor to all apparent 'emergencies'. There is no easy way
around this. In genuine cases a doctor could be beneficial if dispatched by control, as
the time delay incurred waiting while on scene could prove detrimental to the patient's
overall care, although there is no way to differentiate between real and apparent
'emergencies' from the initial call. So dispatch in ALL cases may not prove a good use
of a valuable resourse.
edinburgh would greatly benefit from a joint paramedic and physician rapid repsonse
vehicle
Dr Lyon is a credit to his profession,and works extremely well with the paramedics in
the field.
Dr R Lyon is a very welcome clinical complement in my experiences of pre-hospital
care within Edinburgh
I have answered Question 8 as cardiac arrest as this is my remit. I feel that a doctors'
presence at all the named incidents must be an advantage
1) - The Doctor gave simple advice to Amb staff in relation to 'getting right back on to
CPR' following a shock where there is a general Amb case of waiting a few seconds to
look at the Defib Screen first.
2) - Can Paramedics place a central line as I have never seen it done before?
I would like to commend Dr Richard Lyons for not only his impressive knowledge &
practical skills, but also for his ability to enter any enviroment & enhance the ongoing
patient assessment/ treatment as part of the team. He is also to be commended for
the time he takes with feedback, suggestions & advice when asked. My only
suggestion to improve the service Dr Lyons brings to the pre-hospital setting would be
for him to carry copious amounts of chocolate & orange Lucozade for the tired
Paramedics.
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I think the Topcat study is a great asset to Edinburgh. I feel I will benefit from the skills
and experience a doctor bring to the calls. I will improve my skills at arrest because of
15 this study. I look forward to taking part and find out more.
The only problem experienced related to who was ultimately 'in charge' of the scene. It
was a fantastic learning experience to have a Topcat dr present and certainly
improved treatment of the patient but logistics became awkward when ambulance staff
were not sure of whether to proceed with basic scene control without checking first
with the dr. This lead to an element of confusion that might be resolved simply by
clarifying to all ambulance staff that once the dr is on scene the dr is ultimately in
charge of all patient care. Otherwise, the scene can become confused and with no-
one certain of their role.
Many thanks for all the Topcat feedback to ambulance staff - much appreciated both




PATIENT INFORMATION SHEET FOR TOPCAT STUDY
We appreciate this is a distressing time for you and your family. You are taking
part in a research study after your heart stopped. You are being asked whether
you want to remain in the study. Thank you for reading this information please
read it carefully and take time to discuss it with your relatives.
What is the purpose of this study and why am I participating?
If the heart is restarted after a heart attack, cooling the body (therapeutic hypothermia) helps prevent
brain damage and increases survival. The best method of therapeutic hypothermia is not known. We
aim to gather information on your natural temperature after cardiac arrest and see what effect this has
on vital chemical pathways in your body. This study involves collecting information only and does not
alter your care in any way.
You have already been entered into the study after your cardiac arrest. We are
asking whether you want to help us with this research and continue in the study. If
you do NOT want to participate, you can be withdrawn from the study AT ANY
TIME. You don't have to give a reason for not wanting to participate and this will not
alter your care now or at any stage in the future.
We plan to look at body temperature and chemical pathways in the following ways:
1) Simple blood tests taken before you arrived in hospital, during your
stay in the Emergency Department and on up to three further
occasions depending on your length of stay in hospital. When
possible, blood tests will occur at the same time as routine clinical
tests.
2) A small, soft, plastic thermometer placed in the back of the throat to
measure body temperature for up to 24 hours.
There are no unwanted side effects of having the thermometer and you will not
have been aware of it.
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With your agreement, we will telephone you 6 months after your discharge from
hospital to ask you a few questions about your health.
If you do decide that you would want to continue to take part in this study we
will ask you to sign a consent form. You will receive a copy of this information
sheet and consent form.
All samples and other information collected about you during the course of this
study will be kept strictly confidential and have your name and address
removed so that they cannot be identified. Information will only be used by
individuals directly involved in the research project. We also plan to store the
samples and information that we gather at the Centre for Inflammation
Research in the University of Edinburgh for possible use in future projects
looking into heart diseases. We may wish to test the samples for genetic material
after they have been anonymised but you can ask for this test not to occur if you
wish. We will obtain formal ethical permission before conducting any further
testing on the blood samples.
The study has been approved by the Local Research Ethics Committee.
Further information can be obtained from: Richard Lyon
Specialty Registrar in Emergency Medicine
Royal Infirmary, Edinburgh
0131 2421338
Thank you for your help
Dr Richard Lyon
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RELATIVE INFORMATION SHEET FOR TOPCAT STUDY
We appreciate that this is a distressing time for you and your family. Your
relative is taking part in a research study after their heart stopped. You are
being invited to consider whether your relative would agree to take part. Thank
you for reading this information, please read it carefully and take time to discuss it
with your relatives.
What is the purpose of this study and why is my relative participating?
If the heart is restarted after a heart attack, cooling the body (therapeutic hypothermia) helps prevent
brain damage and increases survival. The best method of therapeutic hypothermia is not known. We
aim to gather information on the patients' temperature after cardiac arrest and see what effect this has
on vital chemical pathways in the body. This study involves collecting information only and does not
alter your relatives care in any way.
Your relative has already been provisionally entered into the study after their cardiac
arrest. We have taken blood samples which have been frozen and not yet analysed.
Your relatives' care has been not been affected in any way. We are asking you to
consider whether your relative would want to help us with this research. If you feel
they would NOT want to participate, they can we withdrawn AT ANY TIME. You
don't have to give a reason for not wanting your relative to participate and this will
not alter your relative's care, or your care, now or at any stage in the future.
In this study, we plan to look at body temperature and chemical pathways in the
following ways:
1) Simple blood tests taken before your relative arrived in hospital,
during their stay in the Emergency Department and on up to three
further occasions depending on their length of stay in hospital. When
possible, blood tests will occur at the same time as routine clinical
tests.
2) A small, soft, plastic thermometer placed at the back of the throat to
measure body temperature for up to 24 hours.
There are no unwanted side effects of having the thermometer and your relative
will not be aware of it.
With your agreement, we will telephone your relative 6 months after their
discharge from hospital to ask them a few questions about their health.
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If you do decide that your relative would want to take part in this study we will
ask you to sign a consent form. You will receive a copy of this information sheet
and consent form to take away with you.
All samples and other information collected about your relative during the
course of this study will be kept strictly confidential and have the name and
address removed so that they cannot be identified. Information will only be used
by individuals directly involved in the research project. We also plan to store
the anonymous samples and information that we gather at the Centre for
Inflammation Research at the University of Edinburgh, for possible use in
future related research projects. We may wish to test the samples for genetic
material after they have been anonymised but you can ask for this test not to
occur if you wish. We will obtain formal ethical permission before conducting
any further testing on the blood samples.
The study has been for approved by the Local Research Ethics Committee.
Further information can be obtained from:
Medicin
Thank you for your help
Richard Lyon








RELATIVE CONSENT FORM FOR TOPCAT STUDY
Principal Researcher: Dr Richard Lyon, Specialty Registrar in Emergency Medicine, Edinburgh.
I have read the information sheet for the above study. (
I have had the opportunity to ask questions about the study and to discuss it with family and friends. (
understand the purpose of the study and how my relative will be involved.
I understand, and accept, that if my relative continues to takes part in the study they may not gain direct personal
benefit from it. C
I understand that all information collected in the study will be held in confidence and that, if published or presented,
all my relative's personal details will be removed. C
I give permission for the researchers to have access to my relative's medical notes and other routine NHS data
sources when this is relevant to my relative taking part in the research. C
agree that my relative may be telephoned after discharge from hospital
I agree that the samples my relative provides and the information gathered from them may be stored by Dr Richard
Lyon in the Centre for Inflammation Research at Edinburgh University for possible use in future projects.
o
I agree that the genetic material in the samples my relative gives may be studied after all personal details have been
removed. O
I confirm that I agree to my relative continuing to take part in the study, and I understand that I can request that they
be withdrawn from it, at any time and for any reason without their medical care or legal rights being affected.
O
agree for my relative to take part in the above study.
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Patient taking part in study Date: / /
Person taking consent:
Relative of study participant.
Name:
Are you nearest relative, next- Yes, state relation:
of-kin or welfare guardian? No; no nearer relative is
Date: / /







RELATIVE CONSENT FORM FOR TOPCAT STUDY
Principal Researcher: Dr Richard Lyon, Specialty Registrar in Emergency Medicine, Edinburgh.
I have read the information sheet for the above study.
I have had the opportunity to ask questions about the study and to discuss it with family and friends. O
understand the purpose of the study and how my relative will be involved.
understand, and accept, that if my relative continues to takes part in the study they may not gain direct personal
benefit from it.
I understand that all information collected in the study will be held in confidence and that, if published or presented,
all my relative's personal details will be removed.





sources when this is relevant to my relative taking part in the research.
I agree that my relative may be telephoned after discharge from hospital Q
I agree that the samples my relative provides and the information gathered from them may be stored by Dr Richard
Lyon in the Centre for Inflammation Research at Edinburgh University for possible use in future projects. O
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I agree that the genetic material in the samples my relative gives may be studied after all personal details have been
removed. O
I confirm that I agree to my relative continuing to take part in the study, and I understand that I can request that they
be withdrawn from it, at any time and for any reason without their medical care or legal rights being affected.
O
agree for my relative to take part in the above study.
Patient taking part in study Date: / /.
Person taking consent:
Relative of study participant.
Name:
Are you nearest relative, next- Yes, state relation:
of-kin or welfare guardian? No; no nearer relative is
Date: / /.









OHCA management - Scottish Emergency
Department survey
Questionnaire














4. What type of hospital so you primarily work in?
O Teaching Hospital
O District General Hospital
O Community Hospital
5. How large is the hospital?
O 0-50 beds
O 50 - 250 beds
O 250 - 500 beds
O 500-750 beds
O 750- 1000 beds
O 1000+ beds
6. How often do you admit patients following out-of-hospital cardiac arrest (OHCA)?
O Never
O Under 5 per year
O 5-10 per year
O 10-20 per year
O 20-50 per year
O 50+ per year
7. Does your hospital have access to primary PCI (Percutaneous Coronary
Intervention) facilities?
O Yes, on-site access
O Yes, off-site access
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O No
8. When are these facilities available? (select all that apply)
O 24 hours/day
O 9-5 Mondays to Fridays
O Weekends
O Upon emergency request
O Facilities not available
9. Does your hospital have a protocol for the use of immediate PCI in OHCA patients?
O Yes
O No




o 25 - 50%
o 50 - 75%
o 75 - 90%
o > 90%
11. When are these patients sent for primary PCI?
O Prior to ED (Emergency Department) admission
O Upon transfer from ED to ITU (Intensive Therapy Unit)
O Shortly after admission onto ITU
O After discharge from ITU
O N/A (Not applicable)




13. What ECG features would trigger the decision to send the patient for immediate
PCI? (select all that apply)
O Persistent ST elevation
O New LBBB
O Any ischaemic changes
O Decision not made on ECG features
O Other (please specify)
14. What Clinical features would trigger the decision to send the patient for immediate
PCI? (select all that apply)
O Persistent hypotension
O Signs of LVF (left ventricular failure)
O High ionotrope requirement
O Absence of an obvious non-cardiac cause
O Decision not made on clinical features
O Other (please specify)
15. If PCI is not routinely used in OHCA patients, what reasons best describe why?
(select all that apply)
O N/A
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O Facilities not available
O No protocol for use
O Insufficient evidence to support use
O Difficulties in interpreting ECG changes
O Unfavourable outcomes observed
O Too few patients seen
O Other (please specify)
16. Have you ever used Therapeutic Hypothermia (TH) in the Emergency Department,
in a patient following out-of hospital cardiac arrest (OHCA)?
O Yes
O No
17. In what proportion of post-OHCA patients do you use TH, in the Emergency
Department?
O None
O None, MTH initiated in the ITU
O <10%
O 10-25%
O 25 - 50%
O 50 - 75%
O 75 - 90%
O > 90%






19. Do you think it is practical to initiate MTH in the Emergency Department?
O Yes
O No
20. Is there a protocol in place in your hospital for MTH use in OHCA patients?
O Yes, in the ED
O Yes, in the ITU
O No
21. Where is MTH currently commenced in your hospital?
O Pre-hospital (ambulance)
O Emergency Department
O Intensive Therapy Unit
O TH not currently in use
22. Where do you think MTH should ideally be commenced?
O Pre-hospital (ambulance)
O Emergency Department
O Intensive Therapy Unit
O None
23. What method of cooling do you use? (select all that apply)
O Ice packs
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O Cold intravenous fluids
O Cooling blankets
O Intravenous cooling catheter
O Cooling helmet
O Lavage (pleural, peritoneal or gastric)
O Wet towels + fanning
O N/A
O Other (please specify)
24. After return of spontaneous circulation, what is the usual length of time before
cooling is initiated?






25. When cooling, what temperature do you aim for?
O 30-32 degrees Celsius
O 32-34 degrees Celsius
O 34-36 degrees Celsius
O N/A
O Other (please specify)
26. How long do you keep the patient cooled for?






27. Would you cool OHCA patients following: (select all that apply)
O Ventricular Fibrillation arrest
O PEA arrest
O Pulseless VT arrest
O Asystolic arrest
O Traumatic cardiac arrest
O N/A




29. If you don't use MTH routinely for OHCA patients, what reasons best represent
why? (select all that apply)
O N/A
O Equipment not available
O No protocol for use
O TH is commenced in the ITU instead
O Insufficient evidence for use
O Difficulties in practicality
O Too few patients seen
O Unfavourable outcomes observed
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Appendix X
Log of calls to TOPCAT from Edinburgh EMDC
Arrived at AMPDS
Date Call Mobile Scene Despatch Code Despatch Code Description
14 Aug 2008 11:46:44 11:53:46 31E01 Ineffective breathing
15 Aug 2008 10:26:00 10:35:30 29B04 Serious haemorrhage
17 Aug 2008 19:53:00 20:03:00 09E01 Not breathing at all
18 Aug 2008 11:35:34 11:41:30 29D02C High Mechanism - Vehicle v pedestrian
20 Aug 2008 03:19:00 03:31:26 06C01 Abnormal Breathing
20 Aug 2008 17B01 Possibly Dangerous Body Area
20 Aug 2008 33C01 Not alert (acute change)
20 Aug 2008 06D01A Severe Respiratory Distress - asthma
20 Aug 2008 13:24:12 13:41:15 31D01 Unconscious (at end of interrogation)
25 Aug 2008 14:09:00 14:24:00 09E01 Not breathing at all
27 Aug 2008 13:42:57 13:54:00 09E01 Not breathing at all
28 Aug 2008 08:03:34 08:20:00 09E01 Not breathing at all
28 Aug 2008 13:33:00 13:58:51 10D03 Clammy
30 Aug 2008 23:27:31 23:35:28 09E01 Not breathing at all
02 Sep 2008 09E01 Not breathing at all
02 Sep 2008 18:26:00 18:52:47 09E01 Not breathing at all
07 Sep 2008 10:29:58 31E01 Ineffective breathing
08 Sep 2008 20:56:02 21:11:00 09E01 Not breathing at all
10 Sep 2008 16:27:00 16:35:00 06D01 Severe Respiratory Distress
10 Sep 2008 21:45:29 22:08:52 09E01 Not breathing at all
15 Sep 2008 11:07:45 32B03 Unknown status
15 Sep 2008 18:15:39 18:19:17 09E01 Not breathing at all
16 Sep 2008 14:45:01 14:57:00 12D03 Irregular breathing
02 Oct 2008 16:09:00 16:12:39 09E01 Not breathing at all
04 Oct 2008 10:00:05 10:10:00 09E01 Not breathing at all
08 Oct 2008 09E01 Not breathing at all
08 Oct 2008 09:04:37 09:08:00 09E01 Not breathing at all
09 Oct 2008 06:21:07 09D01 Ineffective Breathing
09 Oct 2008 17:57:05 18:02:00 09E03 Hanging
12 Oct 2008 31D03 Not alert
12 Oct 2008 09:38:24 09:53:58 09E01 Not breathing at all
13 Oct 2008 06:37:46 06:49:27 09E01 Not breathing at all
13 Oct 2008 09:56:27 33C06 Emergency response req'd
13 Oct 2008
15 Oct 2008 13:02:55 13:07:00 09E01 Not breathing at all
15 Oct 2008 14:34:40 14:46:04 09E01 Not breathing at all
16 Oct 2008 09:50:00 09:59:06 33D01 Susp cardiac or resp arrest
21 Oct 2008 08:49:24 09E01 Not breathing at all
23 Oct 2008 09:22:00 09E01 Not breathing at all
24 Oct 2008 13:12:48 09E01 Not breathing at all
24 Oct 2008 19:06:49 09E01 Not breathing at all
30 Oct 2008 13:37:52 13:54:26 09E01 Not breathing at all
31 Oct 2008 09E01 Not breathing at all
31 Oct 2008 09:12:13 09:18:00 09E01 Not breathing at all
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04 Nov 2008 22:17:23 22:24:56 31D01 Unconscious (at end of interrogation)
08 Nov 2008 08:24:29 08:37:20 09E01 Not breathing at ail
08 Nov 2008 33C02 Abnorm breathing(acute onset)
09 Nov 2008 06:37:09 06:48:08 09E01 Not breathing at all
09 Nov 2008 18:30:00 19:38:00 09E01 Not breathing at all
11 Nov 2008 08:47:36 09E01 Not breathing at all
11 Nov 2008 22:17:00 22:23:26 11E01 Choking verified/ineffective breath
25 Nov 2008 09B01 Obvious Death (unquestionable)
26 Nov 2008 14:43:58 14:49:40 31E01 Ineffective breathing
27 Nov 2008 10:27:32 10:34:08 09E01 Not breathing at all
Poisoning (without priority symptoms) -
27 Nov 2008 11:18:51 11:21:30 23001A Accidental
27 Nov 2008 13:49:00 13:55:53 28C01 Not alert
30 Nov 2008 11:08:26 11:21:04 09E01 Not breathing at all
01 Dec 2008 09:46:00 09:58:43 09D01 Ineffective Breathing
17 Dec 2008 09:49:28 09:57:03 09E01 Not breathing at all
19 Dec 2008 20:10:20 20:20:00 09E02 Breathing Uncertain (Agonal)
30 Dec 2008 21:21:00 21:30:03 09E02 Breathing Uncertain (Agonal)
03 Jan 2009 17:07:00 09E01 Not breathing at all
05 Jan 2009 06:16:04 06:30:00 09E01 Not breathing at all
05 Jan 2009 08:30:05 08:37:38 17D04 Abnormal breathing
05 Jan 2009 12:58:52 13:14:00 09E03 Hanging
05 Jan 2009 18:01:57 09E01 Not breathing at all
05 Jan 2009 23:28:00 23:37:26 21B01 Possibly Dangerous Haemorrhage
09 Jan 2009 06:54:36 06:55:00 09D01 Ineffective Breathing
13 Jan 2009 15:32:00 15:36:00 09B01A Obvious Death Unquestionable - Cold and stiff
13 Jan 2009 19:40:16 19:45:16 33C02 Abnorm breathing(acute onset)
15 Jan 2009 23:10:16 23:16:00 09E01 Not breathing at all
16 Jan 2009 09:42:04 09E01 Not breathing at all
19 Jan 2009 18:17:00 18:21:26 13D01 Unconscious
20 Jan 2009 08:43:00 08:53:26 09E01 Not breathing at all
20 Jan 2009 12:30:00 12:34:35 31D01 Unconscious (at end of interrogation)
26 Jan 2009 19:08:21 09E01 Not breathing at all
28 Jan 2009 21:16:37 21:30:47 23D01A Unconscious - Accidental
28 Jan 2009 22:07:36 22:14:58 09E01 Not breathing at all
20 Feb 2009 17:50:07 17:56:00 29D04 Trapped victim
21 Feb 2009 10:11:47 10:22:17 31E01 Ineffective breathing
21 Feb 2009 12:44:02 12:56:22 31D01 Unconscious (at end of interrogation)
23 Feb 2009 11:46:41 09E01 Not breathing at all
28 Feb 2009 14:04:00 14:08:12 09B01A Obvious Death Unquestionable - Cold and stiff
01 Mar 2009 13:45:48 09E01 Not breathing at all
03 Mar 2009 09:54:43 09:57:31 09E01 Not breathing at all
15 Mar 2009 19:29:10 19:36:45 06D01 Severe Respiratory Distress
16 Mar 2009 08:35:00 08:42:48 09E01 Not breathing at all
16 Mar 2009 11:17:50 09D01 Ineffective Breathing
16 Mar 2009 13:12:41 09E01 Not breathing at all
17 Mar 2009 05:47:12 05:55:07 09E01 Not breathing at all
17 Mar 2009 08:21:27 08:22:00 09B01A Obvious Death Unquestionable - Cold and stiff
17 Mar 2009 09:34:05 09:42:23 31D01 Unconscious (at end of interrogation)
18 Mar 2009 08:01:00 08:18:43 09E01 Not breathing at all
18 Mar 2009 12:41:00 12:45:14 09E01 Not breathing at all
21 Mar 2009 02:25:54 02:26:00 07C01F Building Fire persons reported inside - Fire
21 Mar 2009 17:32:22 17:34:59 09E01 Not breathing at all
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27 Mar 2009 08:04:00 08:11:35 09B01A Obvious Death Unquestionable - Cold and stiff
03 Apr 2009 12:43:00 12:58:45 09E01 Not breathing at all
06 Apr 2009 11:32:57 11:42:17 09E01 Not breathing at all
06 Apr 2009 13:13:40 13:17:39 09B01A Obvious Death Unquestionable - Cold and stiff
06 Apr 2009 16:57:00 17:05:00 29D04 Trapped victim
07 Apr 2009 18:13:00 18:18:30 09E01 Not breathing at all
08 Apr 2009 13:19:00 13:25:11 09E01 Not breathing at all
09 Apr 2009 11:25:00 11:33:53 09E01 Not breathing at all
13 Apr 2009 20:37:07 20:42:15 09E01 Not breathing at all
16 Apr 2009 13:18:17 13:26:24 09E01 Not breathing at all
18 Apr 2009 12:44:24 12:50:06 09E01 Not breathing at all
18 Apr 2009 16:50:00 16:58:56 09E01 Not breathing at all
18 Apr 2009 17:48:29 18:00:39 09E01 Not breathing at all
19 Apr 2009 31D01 Unconscious (at end of interrogation)
28 Apr 2009 18:29:06 18:41:04 09E01 Not breathing at all
29 Apr 2009 10:13:32 10:21:24 09B01A Obvious Death Unquestionable - Cold and stiff
01 May 2009 09:52:00 09:58:41 09E01 Not breathing at all
04 May 2009 11:44:09 09E01 Not breathing at all
04 May 2009 15:23:00 15:38:50 09E02 Breathing Uncertain (Agonal)
13 May 2009 17:21:11 18:58:58 09E01 Not breathing at all
18 May 2009 21:52:53 22:06:25 31E01 Ineffective breathing
26 May 2009 11:55:31 12:06:54 09E01 Not breathing at all
27 May 2009 19:49:28 19:59:04 09E01 Not breathing at all
01 Jun 2009 11:49:00 12:01:00 09E01 Not breathing at all
02 Jun 2009 10:37:00 10:41:03 09E02 Breathing Uncertain (Agonal)
02 Jun 2009 09E01 Not breathing at all
03 Jun 2009 08:05:00 08:11:38 09D01 Ineffective Breathing
03 Jun 2009 10:24:26 10:29:16 09E01 Not breathing at all
04 Jun 2009 13:28:35 13:45:22 12D03 Irregular breathing
05 Jun 2009 14:45:00 14:49:00 09E01 Not breathing at all
25 Jun 2009 09:27:29 09D01 Ineffective Breathing
25 Jun 2009 15:09:00 15:25:15 31E01 Ineffective breathing
25 Jun 2009 17:37:34 17:42:55 11E01 Choking verified/ineffective breath
26 Jun 2009 31D01 Unconscious (at end of interrogation)
27 Jun 2009 22:06:02 22:10:00 09E01 Not breathing at all
28 Jun 2009 22:00:00 22:08:16 31E01 Ineffective breathing
30 Jun 2009 11:01:00 11:10:37 09E01 Not breathing at all
02 Jul 2009 18:07:36 18:11:55 09E01 Not breathing at all
07 Jul 2009 06:56:00 07:05:23 09E01 Not breathing at all
08 Jul 2009 08:55:13 09E01 Not breathing at all
08 Jul 2009 11:58:00 12:11:59 09E01 Not breathing at all
09 Jul 2009 15:00:00 15:11:37 09E02 Breathing Uncertain (Agonal)
10 Jul 2009 10:35:45 10:41:00 19D01 Severe Respiratory Distress
11 Jul 2009 17:20:00 17:20:00 07C01F Building Fire persons reported inside - Fire
14 Jul 2009 16:21:04 16:30:01 31D01 Unconscious (at end of interrogation)
17 Jul 2009 14:21:00 14:33:00 12D02E Continuous/Multiple Fitting - Epileptic/Hist Fitt
21 Jul 2009 18:30:00 18:39:00 09E01 Not breathing at all
05 Aug 2009 09:27:55 09:40:22 31D01 Unconscious (at end of interrogation)
05 Aug 2009 11:00:35 11:14:26 31D01 Unconscious (at end of interrogation)
05 Aug 2009 13:23:04 13:37:48 09E01 Not breathing at all
10 Aug 2009 09:41:28 09:45:09 09E01 Not breathing at all
10 Aug 2009 13:04:24 31E01 Ineffective breathing
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11 Aug 2009 20:46:11 20:51:00 09E01 Not breathing at all
12 Aug 2009 10:42:00 10:54:48 31E01 Ineffective breathing
12 Aug 2009 17:01:00 17:07:39 31D01 Unconscious (at end of interrogation)
13 Aug 2009 12:46:00 12:46:00 31E01 Ineffective breathing
13 Aug 2009 12:45:00 12:55:49 31E01 Ineffective breathing
20 Aug 2009 07:57:00 08:09:29 09E01 Not breathing at all
24 Aug 2009 12:19:00 12:23:44 09E01 Not breathing at ail
26 Aug 2009 10:17:31 10:30:49 09E01 Not breathing at all
31 Aug 2009 14:35:00 14:43:11 31D01 Unconscious (at end of interrogation)
12 Sep 2009 13:15:22 13:15:22 29B06 Unknown Status
02 Oct 2009 09:03:00 09:10:29 09B01A Obvious Death Unquestionable - Cold and stiff
04 Oct 2009 18:41:02 18:51:50 11E01 Choking verified/ineffective breath
06 Oct 2009 09E01 Not breathing at all
06 Oct 2009 21:17:23 21:21:00 06D01A Severe Respiratory Distress - asthma
15 Oct 2009 22:30:50 22:42:29 09E02 Breathing Uncertain (Agonal)
17 Oct 2009 09E01 Not breathing at all
17 Oct 2009 09E01 Not breathing at all
18 Oct 2009 09E01 Not breathing at all
22 Oct 2009 09E02 Breathing Uncertain (Agonal)
23 Oct 2009 14:28:00 14:40:12 14D01 Unconscious
26 Oct 2009 09B01A Obvious Death Unquestionable - Cold and stiff
28 Oct 2009 10:12:00 09D01 Ineffective Breathing
08 Nov 2009 16:14:00 16:15:59 12D03 Irregular breathing
14 Nov 2009 19:49:39 19:50:00 06D03 Clammy
26 Nov 2009 11:39:00 11:41:08 09D01 Ineffective Breathing
03 Dec 2009 10:03:09 10:10:44 09E03 Hanging
03 Dec 2009 15:17:00 15:29:21 12D02 Continuous or multiple fitting
06 Dec 2009 09B01A Obvious Death Unquestionable - Cold and stiff
06 Dec 2009 26B01 Unknown Status
09 Dec 2009 33D01 Susp cardiac or resp arrest
26 Jan 2010 21:22:00 09E01 Not breathing at all
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